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Abstract 
 
During embryonic development multipotent cells are specified to give rise to the 
different tissues of the body. This process depends on a tightly controlled network 
of signalling pathways. Importantly, tissues, which require differential activity of 
these pathways, can be induced in close proximity, thus suggesting an intricate 
spatial and temporal control of pathway activation. One of the pathways crucial for 
tissue specification is the bone morphogenetic protein (BMP) signalling pathway. 
Its role in the patterning of the ectoderm is well understood during gastrulation but 
unclear for later stages of development. 
Using zebrafish and Xenopus as model organisms, I investigated the spatial 
and temporal control of BMP activity after gastrulation at the border of the neural 
plate as progenitor cells emerge that give rise to cell types such as melanocytes 
and smooth muscle cells, as well as the olfactory epithelium and the lens. I 
identified new players that regulate the formation of distinct domains of BMP 
signalling and thereby enable the specification of adjacent tissues with different 
requirements for BMP activity. 
Previously, Snw1 was identified as a crucial factor for neural crest 
specification during development. Overexpression and depletion of Snw1 in 
Xenopus and zebrafish embryos leads to a loss of the neural crest cell population. 
Snw1 was identified as a regulator of BMP activity at the neural plate border, but 
not as a core component of the pathway downstream of the receptor. Snw1 is 
involved in a step between transcription and expression of the BMP ligands and 
since depletion of Snw1 in zebrafish increases bmp2b ligand transcription but 
prevents expression of the protein. I have further dissected the function of Snw1 
and shown that Snw1 is in a complex with components of splicing machinery, as 
well as several chromatin remodeling and transcriptional elongation factors. I have 
used RNAseq to identify additional Snw1 targets. 
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“So long, and thanks for all the fish.”  
 Douglas Adams, The Hitchhiker's Guide to the Galaxy 
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Chapter 1. Introduction 
1.1 Embryonic patterning 
During vertebrate embryogenesis the early embryonic cells are induced to form the 
three germ layers - endoderm, mesoderm and ectoderm - in a process of cell 
differentiation and morphogenesis. The different germ layers are then further 
specified to give rise to the tissues and organs. The endoderm develops into the 
inner lining of the respiratory and digestive systems. The mesoderm gives rise to 
several organs (kidney, heart, gonads), connective tissue (bone, muscles, blood 
vessels) and blood cells. The ectoderm first differentiates into the non-neural 
ectoderm (NNE), the preplacodal ectoderm (PPE), the neural crest (NC) and the 
neural plate (NP), which together will form the epidermis and the nervous system. 
Thus during embryonic development cells progressively loose their pluripotency as 
they become specified into the various cell types. 
 Understanding the mechanisms underlying these cell fate decisions and 
subsequent organ formation is crucial and has implications beyond deciphering 
normal developmental processes. Many of the pathways that regulate tissue 
specification are deregulated in diseases such as cancer (Kho et al., 2004, 
Dreesen and Brivanlou, 2007) and studying developmental processes has led to 
the identification of novel genes, signal transduction pathways and regulatory 
mechanisms that are implicated in the development of malignancies. An example is 
the transforming growth factor β superfamily (TGF-β) signalling pathway. Although 
the pathway was first described in a tissue culture context, the main effectors of the 
TGF-β signalling pathway, the Smad transcription factors, were first described in 
the fruit fly Drosophila melanogaster (Sekelsky et al., 1995). Subsequently many 
other components of the pathway were identified in a developmental context such 
as the negative regulators Chordin and Noggin in Xenopus laevis (X. laevis) (Sasai 
et al., 1994, Smith and Harland, 1992). Another example is the Hippo signalling 
pathway, which is required for organ size control and cell fate decisions during 
normal development. First identified in Drosophila, Hippo signalling was 
subsequently shown to be evolutionary conserved in mammals and has been 
extensively implicated in cancer development (Harvey and Tapon, 2007). Similarly, 
the hedgehog pathway (Hh), also first described in Drosophila, plays a role in the 
Chapter 1 Introduction 
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development of several cancers (McMillan and Matsui, 2012, Nusslein-Volhard and 
Wieschaus, 1980). Numerous drug development programs in both academia and 
industry have been and are directed to identify pathway inhibitors for cancer 
treatment (Perrot et al., 2013, Yun et al., 2012). These examples demonstrate the 
impact studying signalling pathway regulation in development can have on 
understanding and treating disease. 
Another incentive to understand how tissues are specified from pluripotent 
progenitor cells is to enable the construction of tissues and organs from stem cells 
for medical therapies. Today, we rely on organ and tissue donations to replace 
damaged organs. However, although the numbers of donations in the UK have 
been increasing over the past years, the number of people waiting for a transplant 
still exceeds the number of available donors (NHS Blood and Transplant 
(NHSBT),Organ Donation and Transplantation Activity Report 2012/13). Moreover, 
rejection of donated transplants as a result of an immune response can lead to 
transplant failure and requires the use of immunosuppressive drugs. Therefore, 
using stem cells as a renewable source for tissues is a promising approach for 
treatment of diseases. The development of such methods necessitates a detailed 
understanding of how different tissues are normally specified during embryonic 
development.  
Tissue specification and patterning in developing embryos is known to 
require networks of tightly-regulated signalling pathways, such as those activated 
by the TGF-β, Wnt, FGF and Notch ligands (Stuhlmiller and Garcia-Castro, 2012a, 
Tzahor, 2007). In the following sections I will introduce the current understanding of 
how these pathways are spatially and temporally regulated to orchestrate growth 
and differentiation during ectodermal patterning with an emphasis on BMP 
signalling during NC development.  
1.1.1 Ectodermal patterning 
During vertebrate ectodermal patterning progenitor cells are initially specified along 
the dorsoventral (DV) axis with the neural plate (NP) on the dorsal side, the neural 
plate border (NPB) adjacent and epidermal progenitors in the non-neural ectoderm 
(NNE) ventrally (Figure 1.1)(Hammerschmidt and Mullins, 2002). These relatively 
uncommitted progenitors are then further specified along the DV, as well as the 
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rostro-caudal axis, and the ectoderm differentiates into 4 main functional entities: 
the central nervous system (CNS), the NC and cranial placodes at the NPB, which 
together give rise to structures of the peripheral nervous system, and the skin 
(Figure 1.1)(Kwon et al., 2010). The NC differentiates into craniofacial cartilage and 
bone, melanocytes, smooth muscle and cells of the peripheral nervous system. In 
contrast, the PPE contributes to cranial sense organs such as the eye, the ear and 
the olfactory epithelium (Streit, 2007, Dupin et al., 2006).  
 
 
Figure 1.1 Ectodermal patterning 
Ectodermal progenitors are progressively specified during ectodermal patterning along 
the DV axis. 
 
 
Ectodermal differentiation requires a network of signalling pathways, which is 
temporally and spatially highly dynamic. Moreover, the cellular identity is not only 
determined by exposure to a signalling molecule, but depends on the concentration 
and the combination of signals and whether a cell is competent to respond to the 
signal exposure at a given time. Therefore, it is thought that tissue specification 
occurs in several phases and is conferred by a dynamic network of signalling 
pathways. Thus the changing requirements of tissues for pathway activity can be 
met as progenitors become increasingly specified. 
In the following section I will introduce the main signalling pathways involved 
in ectodermal patterning, namely Wnt, FGF, Notch and BMP signalling. 
1.1.2 Wnt signalling 
The Wnt pathway plays an important role during embryonic development and is 
implicated in diverse processes such as cell fate decisions, polarity, migration and 
proliferation (Grigoryan et al., 2008, Logan and Nusse, 2004). In the canonical Wnt 
Chapter 1 Introduction 
 19 
signalling pathways secreted Wnt proteins bind to Frizzled and LRP family cell 
surface receptors, which ultimately leads to the stabilisation and nuclear 
accumulation of β-catenin (Kim et al., 2013) (Figure 1.2). In the nucleus, β-catenin 
then interacts with transcription factors belonging to the TCF/LEF family to 
modulate gene expression. In the absence of Wnt signalling β-catenin is 
phosphorylated by GSK3β, which is in a protein complex with APC and Axin, and is 
targeted for ubiquitination-dependent proteasomal degradation by the E3 ligase β-
TrCP. Upon ligand binding, however, the cytosolic adaptor protein Dishevelled is 
activated and the β-catenin destruction complex inhibited.  
 
 
 
Figure 1.2 The canonical Wnt signalling pathway 
In the absence of Wnt-signal, β-catenin is targeted and phosphorylated by the 
APC/Axin/GSK3β complex leading to its ubiquitination and proteasomal degradation. In 
the presence of Wnt ligand, the co-receptor LRP5/6 is brought in complex with Wnt-
bound Frizzled. This activated Dishevelled (Dvl), the β-catenin destruction complex is 
inhibited and β-catenin translocates to the nucleus. The Groucho/HDAC co-repressor 
complex is subsequently displaced and β-catenin acts a co-activator for TCF/LEF-
mediated transcription 
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The non-canonical Wnt signalling pathways are β-catenin independent (van 
Amerongen, 2012). In the non-canonical planar cell polarity (PCP) pathway Wnt 
signals are transduced via small G-proteins such as Rho/Rac resulting in 
cytoskeletal changes. In a second main alternative pathway, Wnt assists in 
regulating intracellular calcium levels by regulating the calcium release from the 
endoplasmic reticulum. 
Wnt activity has a long been proposed as positive regulator of NC induction 
in several species. Analyses predominantly in X. laevis has suggested that 
activation of Wnt in combination with attenuation of BMP signalling can induce NC 
(Abu-Elmagd et al., 2006, LaBonne and Bronner-Fraser, 1998, Steventon et al., 
2009, Litsiou et al., 2005). Co-expression of Wnt1 or Wnt3a together with the BMP 
inhibitors Noggin or Chordin in X. laevis animal caps leads to the ectopic 
expression of the NC markers such as slug (Saint-Jeannet et al., 1997). 
Furthermore, overexpression of these ligands in the whole embryos causes an 
expansion of NC marker expression. Knockdown of Wnt3 and Wnt8 and 
expression of a dominant negative Wnt construct suppresses the induction of 
several NC and NPB markers (Elkouby et al., 2010, Hong et al., 2008, Steventon et 
al., 2009). Wnt8 has also been implicated in NC development in zebrafish. Injection 
of a morpholino against wnt8.1 delays, but does not abolish, the expression of the 
NC markers pax3, foxd3 and sox10 (Lewis et al., 2004). Furthermore, expression 
of downstream components of the canonical Wnt signalling pathway such as 
Frizzled3, Frizzled7, LRP6 and β-catenin result in ectopic NC induction in X. laevis 
(Abu-Elmagd et al., 2006, Deardorff et al., 2001, LaBonne and Bronner-Fraser, 
1998, Tamai et al., 2000) and depletion of Dishevelled 1 or 2 leads to a 
suppression of snail2 and twist expression (Gray et al., 2009). 
In the chick, addition of Wnt3a to prospective neural epiblast explants 
promotes the expression of NC markers (Patthey et al., 2009, Wilson et al., 2001) 
and inhibition of Wnt signalling in prospective NC explants results in loss of NC 
markers (Patthey et al., 2009). The role of individual Wnt ligands in chick NC 
development has not been studied, but wnt3a and wnt8a/c expression patterns 
during blastula stages suggest and involvement in NC induction (Skromne and 
Stern, 2001, Wilson et al., 2001). 
In the mouse, Wnt1 and Wnt3a are dispensable for the initial expression of 
ap2 but required for NC marker expression during migration. Double-homozygous 
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null mutants for Wnt1/Wnt3a display severe defects in NC derivatives (Ikeya et al., 
1997). In a transgenic Wnt1Cre mouse line, cells deriving from the neural crest are 
targeted (Danielian et al., 1998). Depletion of β-catenin in the region of Wnt1 
expression affects NC development and thus leads to a failure of craniofacial 
development (Brault et al., 2001). However, the observed phenotype might be due 
to impaired cell adhesion.  
Taken together, there is circumstantial evidence that Wnt signalling is a 
positive regulator of NC induction mostly from overexpression of or treatment with 
Wnt ligands. It remains to be determined, which specific ligands are required for 
Wnt signalling and Wnt8 as well as Wnt3 are possible candidates. 
1.1.3 Fibroblast growth factor signalling 
Fibroblast growth factors (FGFs) are a family of growth factor required for a variety 
of developmental and homeostatic processes such as mesoderm induction, neural 
development and wound healing (Dorey and Amaya, 2010, Turner and Grose, 
2010, Ford-Perriss et al.). FGFs bind to receptor tyrosine kinases (FGF receptors) 
assisted by cell surface associated heparin sulphate proteoglycans. Upon ligand 
binding FGFRs dimerise, which triggers tyrosine kinase activation leading to 
autophosphorylation of the intracellular receptor domain (McKeehan et al., 1998). 
This autophosphorylation regulates the protein tyrosine kinase activity of the 
receptor and leads to the activation of one or more intracellular signalling cascades 
such as the MAPK, PLCγ/Ca2+ and PI3 kinase/Akt pathway (Dorey and Amaya, 
2010). 
 In X. laevis, the role of FGF signalling in early patterning and tissue 
induction has been studied extensively. As the main focus Fgf8a has emerged as a 
NC inducer. Depletion of Fgf8a using a morpholino approach abolishes the 
expression of the NC markers ap2, snail2, sox8/10, hairy2, pax3 and msx1 and 
Fgf8 overexpression expands NC marker domains (Hong et al., 2008, Hong and 
Saint-Jeannet, 2007, Monsoro-Burq et al., 2005, Nichane et al., 2008a). In contrast 
to the Wnts, Fgf8 is able to induce transient NC marker expression in animal cap 
assays without simultaneous inhibition of BMP activity (Monsoro-Burq et al., 2003). 
Fgf8 is also required for the induction of preplacodal markers, while ectopic 
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expression of Fgf8 in chick induces expression of eya2, but no other PPE specific 
marker (Ahrens and Schlosser, 2005, Litsiou et al., 2005, Brugmann et al., 2004).  
NC formation requires Fgfr1, but not Fgfr4a, expression. It has been 
suggested that FGF indirectly regulates NC development acting to induce wnt8 
expression (Hong et al., 2008). Fgf8 cannot rescue the NC phenotype in wnt8 or β-
catenin morphants, whereas overexpression of Wnt8 or β-catenin restores NC 
marker expression in fgf8 depleted X. laevis embryos. Furthermore, Fgf8 is 
required for wnt8 expression in the paraxial mesoderm at late gastrula stages and 
Fgf8 overexpression expands the wnt8 expression territory. Interestingly, Fgf8 acts 
on NC development in a dose-dependent manner; targeted injection of low doses 
of fgf8a mRNA enhances the expression of several NC markers, whereas NC 
induction is inhibited at higher doses. Thus similar to BMP signalling, which I will 
discuss in detail later, there appears to be a specific window of FGF signal strength 
that allows NC development. 
 In zebrafish, the contribution of FGF signalling to NC induction has not been 
extensively studied. Inhibition of FGF activity, beginning at the onset of gastrulation, 
inhibits the expression of the NPB marker pax3, which in turn regulates NC 
induction (Garnett et al., 2012, Meulemans and Bronner-Fraser, 2004, Sato et al., 
2005). In contrast, overexpression of Fgf8 in zebrafish leads to an expansion of the 
ap2 expression domain at the NPB (Furthauer et al., 1997, Furthauer et al., 2004). 
However, FGF/MAPK signalling is also required for DV patterning by contributing to 
the BMP activity gradient formation, thus could indirectly determine NC induction. 
 In chick, inhibition of FGF signalling by targeted expression through 
electroporation of a dominant negative Fgfr1 or the MAPK signalling inhibitor Mkp3 
during gastrulation impairs pax7 and snail2 expression (Stuhlmiller and Garcia-
Castro, 2012b). Electroporation after gastrulation did not result in any effect, again 
suggesting a possible indirect role for FGF signals in NC induction by antagonizing 
BMP signals during DV axis formation. This study indicates, since expression of the 
truncated Fgfr1 acts cell-autonomously, a direct ectodermal requirement for FGF 
as opposed to an indirect role by inducing Wnt signals in the paraxial mesoderm, 
which is suggested in X. laevis (Hong et al., 2008). Moreover, Fgfr1 and Fgfr4 are 
expressed in the prospective NC epiblast but are absent from the mesoderm (Lunn 
et al., 2007, Stuhlmiller and Garcia-Castro, 2012b).  
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 In mouse, no FGF pathway component has been directly linked to NC 
development. Knockouts of Fgfr1 and Fgf8 die before NC induction, as they fail to 
gastrulate properly (Deng et al., 1994, Meyers et al., 1998, Sun et al., 1999, 
Yamaguchi et al., 1994). Later in development, Fgfr1 is expressed in the NC-
derived palate mesenchyme and mice carrying Wnt1Cre and Fgfr1flox transgenic 
alleles display severe craniofacial defects (Wang et al., 2013). All other FGF 
knockouts generated so far do not display defects in NC induction (Itoh, 2007).  
 Taken together, FGF signalling is required for NC development with Fgf8 
being the ligand most likely conferring FGF activity in this process. Several lines of 
evidence support a role for the FGF receptor Fgfr1 during NC induction. It will have 
to be clarified if FGF activity directly regulates NC cell fate or whether the observed 
phenotypes are an indirect result of dorsal patterning defects.  
1.1.4 Notch signalling 
Notch proteins span the cell membrane and are activated by the binding of 
transmembrane ligands, Delta or Delta-like (Dll) and Serrate (Jagged in mammals), 
on the surface of adjacent cells. Upon ligand binding proteolytic cleavage releases 
the Notch intracellular domain (NICD), which translocates to the nucleus to activate 
gene transcription (Fiuza and Arias, 2007)(Figure 1.3). Notch is plays an important 
role in cell-cell communication and is required for cell fate decisions and boundary 
formation for example during neural development (Andersson et al., 2011). 
In X. laevis NC development, Notch/Delta signalling appears to play an essential 
role. However, there is some controversy about the timing of activity and the 
sequence of NC inducing events. One study has demonstrated that inducible 
expression of NICD at late gastrula stages results in an expansion of NC markers 
similar to the effect of NC targeted overexpression of hairy2 (Glavic et al., 2004b). 
The authors show that Notch activates the transcription of hairy2, which acts as a 
transcriptional repressor for bmp4. This would modulate BMP activity to a level that 
allows for NC induction, as NC is induced at specific levels of BMP activity (1.1.5). 
However, in the experimental setup, BMP inhibition occurs in a second phase after 
NC induction when NC progenitors have to be maintained, a process that requires 
active BMP signalling. A different study subsequently provided contradicting 
evidence suggesting that hairy2 is not regulated by Notch but is induced by BMP 
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inhibition, canonical Wnt signalling and Fgf8 (Nichane et al., 2008a). The authors 
suggest that Hairy2 maintains undifferentiated NC progenitors, as overexpression 
of hairy2 represses NC and induces NPB markers. It was then demonstrated that 
Hairy2 acts upstream of Notch by activating Delta1, which in turn upregulates id3, 
snail2 and sox9 (Nichane et al., 2008b). 
 
 
 
Figure 1.3 Core-components of the canonical Notch signalling pathway 
Ligands of the Jagged (JAG1 and JAG2) and Delta-like (DLL1, DLL3, DLL4) families 
interact with Notch family receptors (NOTCH1-NOTCH4). Proteolytic processing by 
ADAM10 or TACE and γ-secretase releases the NICD, which enters the nucleus where 
it forms a complex with RPBJ thus displacing a histone deacetylase (HDAC)-co-
repressor (CoR) complex. Activating factors such as MAML1 and histone 
acetyltransferases (HAT) are recruited to the NICD-RPBJ complex leading to the 
activation of Notch target genes. 
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In chick, overexpression and depletion of Notch represses bmp4 and snail2 
expression (Endo et al., 2002). The Notch inhibition phenotype, however, can be 
rescued by Bmp4 expression, indicating that Notch acts indirectly by modulating 
BMP activity to permissive levels.  
 In zebrafish embryos, Notch seems to act mainly by defining the NPB.  In 
the Delta/Notch mutant mindbomb, NC derivatives are reduced, whereas NP 
derivatives are increased (Jiang et al., 1996). More recent data indicates that 
Delta/Notch restricts the neural domain by negatively regulating the transcription 
factor Prdm1a. Prdm1a is required for NPB specification and antagonises Olig4 
function, which defines the border of the NP and promotes neural cell fates 
(Hernandez-Lagunas et al., 2011).  
 In mouse there so far is no indication of Notch acting at the step of NC 
induction. Delta1 null mutants display aberrant trunk NC migration, but no defects 
in NC induction, arguing for a later role of Notch signalling (De Bellard et al., 2002).  
 In summary, a direct role of Notch signalling in NC induction has yet to be 
demonstrated. The data so far rather suggests an indirect role by modulating BMP 
activity levels. 
1.1.5 BMP signalling 
Another pathway that is crucial for embryonic development and whose 
deregulation is also implicated in human disease is the bone morphogenetic protein 
(BMP) signalling pathway (Blanco Calvo et al., 2009, Lowery and de Caestecker, 
2010, Wu and Hill, 2009). BMPs, together with the growth and differentiation factors 
(GDFs), form a subfamily of the transforming growth factor β (TGF-β) superfamily 
(Schmierer and Hill, 2007). For activation of the canonical BMP signalling pathway, 
BMP ligands bind as homo- or heterodimers to type I–type II serine/threonine 
kinase receptor complexes (Figure 1.4). Upon ligand binding, the constitutively 
active type II receptor phosphorylates the type I receptor within a glycine-/serin-rich 
motif. This activates the type I receptor and promotes the binding and 
phosphorylation of the main signalling effectors, the receptor-regulated Smads (R-
Smads) at a C-terminal SSXS motif in the MH2 domain. In response to BMP and 
GDF signalling the R-Smads activated in particular, Smad1/5. Phosphorylated 
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Smad1 and Smad5 then form complexes with the co-Smad, Smad4, which 
accumulate in the nucleus, where they regulate gene expression.  
 In addition to C-terminal phosphorylation, the R-Smads can also be 
phosphorylated in the linker region between the N-terminal MH1 and the MH2 
domain. The phosphorylation sites are important for the regulation of Smad activity 
and specific to distinct pathways (Kamato et al., 2013)(Figure 1.4).  
 
 
 
Figure 1.4 The BMP signalling pathway 
Schematic of the core BMP signalling pathway. Additional secreted and membrane-
bound BMP-binding proteins are depicted and will be mentioned throughout the 
Introduction. Adapted from (Ramel and Hill, 2012). 
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MAPK-dependent phosphorylation of Smad1, for example, inhibits Smad1 activity 
by attenuating the nuclear accumulation of Smad1 (Kretzschmar et al., 1997, 
Sapkota et al., 2007). 
 BMPs have historically been described as morphogens and 
gradients of BMP signalling can be observed in many species such as sea urchins, 
Drosophila, X. laevis, zebrafish and mouse (Ramel and Hill, 2012). Signalling 
gradients confer positional information in a dose-dependent manner thus giving rise 
to different progenitor cells according to the strength of the signal. With regard to 
BMP activity this is important in many processes such as wing and lens 
development or the establishment of the DV axis (Nellen et al., 1996, Wilson et al., 
1997, French et al., 2009). 
BMP signalling is crucial for ectodermal patterning as the BMP gradient is 
absolutely required for the establishment of the DV polarity and BMP activity 
promotes epidermal over neural cell fates (Nguyen et al., 1998, Wilson et al., 1997). 
Since NC and the PPE are induced at the border between neural and non-neural 
ectoderm it is suggested that this process requires intermediate levels of BMP 
activity with slightly higher activity required in the PPE. Indeed, treatment of 
explanted X. laevis ectoderm with the BMP inhibitor Noggin results in the induction 
of epidermal, NC or neural cell fates in a dose dependent manner (Marchant et al., 
1998, Tribulo et al., 2003). A similar model has been proposed in zebrafish (Mullins 
et al., 1996 {Barth, 1999 #397}) and analysis of BMP pathway mutants supports the 
idea of initial NC induction requiring intermediate BMP signalling levels 
(Schumacher et al., 2011). Recent evidence from zebrafish indicates that the BMP 
gradient is required for the inductive process of NC and adjacent PPE progenitors 
at late blastula/early gastrula stages (Kwon et al., 2010). 
 The establishment of the DV gradient has been studied in great detail. In a 
simplified model, a combination of high BMP ligand expression ventrally and dorsal 
expression of BMP antagonists from the organiser such as chordin and noggin 
results in graded BMP activity levels. Recent studies have added great detail to this 
model. In zebrafish, directly after mid-blastula transition (MBT) the ligands bmp2b, 
bmp7a and bmp4 are ubiquitously expressed, whereas maternally deposited β-
catenin is concentrated to the future dorsal side of the embryo (Schier and Talbot, 
2005). At sphere stage, the transcriptional repressor Dharma is expressed dorsally 
and mediates the earliest DV asymmetry by directly repressing bmp2b transcription 
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(Koos and Ho, 1999, Leung et al., 2003). This initiating event is subsequently 
followed by dorsal FGF activity, which appears to inhibit bmp ligand transcription in 
a dose-dependent manner (Furthauer et al., 2004, Ramel and Hill, 2013). In 
addition, chordin and noggin1 are dorsally secreted to inhibit BMP ligand activity, 
but chordin seems to be essential for this process whereas noggin1 acts to 
enhance the effect (Dal-Pra et al., 2006)(1.2.2.2). The combination of these 
instructive signals results in a graded expression of bmp ligands themselves at the 
end of the blastula stage (Furthauer et al., 2004, Sidi et al., 2003). Interestingly, 
during this process BMP ligands do not seem to act as morphogens in the classical 
sense of generating a gradient through extracellular diffusion, as it has been 
demonstrated in Drosophila (Zhou et al., 2012b). In contrast, the zebrafish DV BMP 
signalling gradient is formed from an initially ubiquitous BMP activity (Ramel and 
Hill, 2013). Importantly, the graded expression of the bmp ligands is initially 
established through dorsal transcriptional inhibition by Dharma and FGF signalling.  
 
 
 
Figure 1.5 BMP activity gradient during gastrulation 
BMP activity is initially inhibited by the dorsal expression of BMP antagonists such as 
Chordin and Noggin. At gastrula stages expression of the BMP ligands is 
autoregulated and thus graded with higher expression levels ventrally. Along this BMP 
gradient cell types such as PPE and NV are initially specified. 
 
 
From about 60% epiboly, bmp ligand transcription is autoregulated by BMP 
signalling thereby maintaining the graded ligand expression (Figure 1.5) (Kishimoto 
et al., 1997, Nguyen et al., 1998, Schmid et al., 2000). Thus, the combination of 
these transcriptional inputs is the gradient forming factor rather than actual diffusion 
or redistribution of Bmp proteins. This is also indicated by immunostaining against 
Bmp2b in zebrafish embryos, where no BMP activity could be observed outside of 
Bmp2b expression domains, as would be expected if BMP proteins could not 
diffuse from their site of expression (Ramel and Hill, 2013). This observation 
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supports other data, which, using mosaic experiments, shows that Bmp2b acts cell 
autonomously during zebrafish ectodermal patterning (Nikaido et al., 1999). 
Similarly, studies in X. laevis determined that in contrast to Activin, Bmp4 
expression does not have any long-range effects on surrounding tissues (Jones et 
al., 1996). Notably, X. laevis Bmp4 is suggested to be functionally equivalent to 
zebrafish Bmp2b (Kondo, 2007). 
 As mentioned above this initial gradient with discrete levels of BMP activity 
along the DV axis defines the position of ectodermal derivatives such as the PPE, 
the NC and the NP (Nguyen et al., 1998). This gradient model is sufficient to 
explain the requirements for progenitor cell induction during gastrulation, but later 
specification processes cannot be explained. For example, during zebrafish PPE 
formation, which is located adjacent to the NC, BMP signalling is required only 
during late blastula stages, but is no longer needed after the onset of gastrulation 
(Kwon et al., 2010). The same study suggested that BMP activity is not only 
dispensable for further PPE induction, but that in fact full attenuation of BMP 
signalling is necessary during late gastrulation, presumably through localized 
expression of BMP antagonists. Indeed, ectopic sources of BMP inhibitors result in 
an expansion of PPE marker expression (Ahrens and Schlosser, 2005, Glavic et al., 
2004a, Litsiou et al., 2005).  
 Experiments in chick support the idea that BMP signalling acts in two 
phases during DV patterning. Treatment of prospective neural crest explants with 
Noggin shows that for NC development BMP signalling is not required during early 
blastula stages to induce NC, but is required from the late blastula stage onwards 
(Patthey et al., 2009). Also, inhibition of BMP signalling after gastrulation results in 
the loss of NP border markers and BMP activity is required for the expression of 
NC specifiers at later stages (Selleck et al., 1998). Thus, the requirement of BMP 
activity in NC and PPE development differs significantly over time. Interestingly, a 
recent study has demonstrated the loss of the BMP gradient after gastrulation and 
BMP activity becomes localised to the NPB (Wu et al., 2011). How this process is 
regulated and how distinct signalling domains are regulated is not understood. 
 Studies concerning the contribution of BMP signalling components in mice 
have been complicated by the fact that BMP signalling is essential for early 
developmental processes. Knockout mice for the type I receptors Alk2 and Alk3, 
type II receptor Bmpr2, and Bmp4 die before gastrulation (Beppu et al., 2000, 
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Fujiwara et al., 2002, Gu et al., 1999, Mishina et al., 1999, Mishina et al., 1995). 
Heterozygous Bmp4 mutants, however, display craniofacial defects indicating 
perturbed NC development (Dunn et al., 1997). To circumvent this problem Wnt1-
Cre lines have been generated. Due to the onset of Wnt1 expression after NC 
induction these lines cannot give any information on early events but they are 
useful tools to analyse later events. Mice with signalling components such as Alk2, 
Alk3, Alk5 and Smad4 conditionally knocked down all display craniofacial, 
pharyngeal and cardiac defects indicating a role in NC development (Dudas et al., 
2004, Jia et al., 2007, Kaartinen et al., 2004, Ko et al., 2007, Nie et al., 2008, 
Stottmann et al., 2004, Wang et al., 2006).  
 Taken together, the importance of BMP signalling for NC development has 
been convincingly demonstrated. There appears to be differential requirements for 
BMP activity at the different stages of DV patterning. How BMP activity is 
temporally and spatially regulated during this process in vivo, especially after 
gastrulation, is yet to be addressed. 
 
1.1.6 Integration of the signalling pathways in NC and PPE induction  
As indicated in the previous sections, the signalling processes implicated in NC 
development and ectodermal pattering are not isolated events but form an 
intertwined, dynamic network. This permits the induction and specification of many 
progenitor cell types with a relatively restricted number of pathways. The molecular 
events and the timings that lead to tissue specification might vary slightly between 
organisms, but an overall model for neural crest induction can be deduced. 
 Current data indicates that the in zebrafish initial induction of NPB cell fates 
occurs at the late blastula/early gastrula stage with different continued signalling for 
maintenance and specification of these progenitors cells at later stages. A first 
phase requires at least partial inhibition on BMP signalling, as high levels of BMP 
activity favour epidermal cell fates. In a later phase BMP signalling must be 
inhibited for PPE development and activated for NC progenitor maintenance. BMP 
signalling also continues to be inhibited in the NP for neural specification. 
Attenuation of BMP activity is achieved through several means. For the early BMP 
activity gradient formation, dorsal FGF signalling is crucial to inhibit bmp ligand 
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transcription, although it is not yet clear how FGF achieves that. In addition to the 
limited expression of Bmp ligands secreted BMP antagonists such as Noggin and 
Chordin help to reinforce and stabilise the gradient. A recent study in chick 
suggested that Wnt signalling temporally regulates BMP activity at the NPB. 
Exposure of gastrula stage prospective neural explants with Wnt3 induces Bmp4 
expression, whereas treatment of prospective NC explants with a Wnt inhibitor 
leads to the downregulation of Bmp4 and loss of NC markers (Patthey et al., 2009). 
Similarly it has been demonstrated in X. laevis that the first NC inductive step 
requires Wnt activation and BMP inhibition, but the later maintenance phase 
requires both signals (Steventon et al., 2009). Whether this hold true in other 
species remains to be tested.  
 FGF signalling is required for the initial induction of NPB markers, however it 
has an important role in many processes such as DV patterning, mesoderm 
induction and gastrulation movements, all of which could influence NC induction. 
As mentioned above, FGFs are able to regulate Wnt and BMP signalling. During 
early DV axis formation FGF negatively regulates BMP activity. Within the NPB 
FGF signalling is required to inhibit epidermal development and BMP activity 
prevents the generation of neural cells (Patthey et al., 2009, Sjodal et al., 2007, 
Stuhlmiller and Garcia-Castro, 2012b). 
 In zebrafish, intermediate levels of BMP activity establish expression of the 
NPB markers zic3 and pax3a and this is enhanced by Wnt and FGF signals during 
mid to late gastrulation (Garnett et al., 2012). By integrating these signals through 
different enhancers a sharp expression domain at the NPB can be achieved. 
Moreover, this study demonstrates a Wnt-independent function of FGF signals in 
zebrafish NPB induction.  
 Taken together, increasing evidence has been gathered as to how different 
signalling pathways are integrated to give rise to the cell types specified during 
ectodermal patterning. It is still a challenge to decipher the contribution of the 
implicated signalling pathways to the patterning process. It will be important in the 
future to directly monitor signalling activity in time and space in order to understand 
the crosstalk between pathways. Moreover, it is important to manipulate pathway 
with regard to the temporal requirements of signalling activity. With the emergence 
of novel tools to manipulate and monitor spatial and temporal signalling events, 
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such as transgenic reporter lines and inducible expression systems, more insight 
will be gained in how signals are orchestrated in vivo at a molecular level.  
 
1.2 Spatial regulation of BMP activity 
BMP activity can be spatially regulated at different levels from transcriptional 
control of the pathway to localised modulation of ligand activity. In the section I will 
give an overview of some of the regulatory mechanisms and how they contribute to 
localised pathway activity. I will introduce how BMP signalling can be modulated on 
the level of the Smad transcription factors as well as the processing of the BMP 
ligands and the regulation of their activity in the extracellular space.  
  
1.2.1 Regulation on Smad transcriptional level 
The Smad transcription factors are ubiquitously expressed in most tissues, but 
Smad protein activity can be regulated through post-translational modifications. 
Smad proteins are highly conserved within their N-terminal MH1 and C-terminal 
MH2 domains (Attisano and Lee-Hoeflich, 2001). Between these two MH domains 
lies a non-conserved linker region.  Smads are activated by ligand-induced 
phosphorylation of the C-terminal MH2 domain in their –SSXS motif by type I 
receptors. However, the linker region can also be phosphorylated on Ser or Thr by 
other kinases such as Erk MAPK, cyclin-dependent kinases (CDKs) or GSK3 
(Alarcon et al., 2009, Fuentealba et al., 2007, Pera et al., 2003, Wang et al., 2009). 
This can both affect protein stability and recruitment of cofactors to regulate gene 
transcription and these processes are interregulated. CDK8 and CDK9, for 
example, can phosphorylate the linker region of Smad1, which results in the 
recruitment of the Hippo pathway transcriptional coactivator YAP (Alarcon et al., 
2009, Aragon et al., 2011). YAP binding enhances Smad-mediated transcription, 
but ultimately the linker phosphorylation is recognised by the ubiquitin ligase 
Smurf1, which is thought to lead to Smad degradation. Similarly it was shown in X. 
laevis that the duration of activity of Smad1, phosphorylated in is MH2 domain, was 
regulated by sequential Smad1 linker phosphorylation and subsequent targeting for 
proteasomal degradation by Smurf1-induced polyubiquitination (Fuentealba et al., 
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2007). MAPK and GSK3 inhibition prolonged BMP activity in response to ligand 
exposure by stabilising Smad1. Mutation of the Mad, the Drosophila R-Smad, 
GSK3 linker phosphorylation sites in the Drosophila wing disk results in a 
phenotype consistent with increased BMP activity (Eivers et al., 2011). Regulation 
of Smad activity through linker phosphorylation has important developmental 
implications, for example, during patterning of the zebrafish DV and anteroposterior 
(AP) axes (Hashiguchi and Mullins, 2013). DV patterning by BMP signalling along 
the AP axis is temporally coordinated with AP patterning by FGF, Wnt and retinoc 
acid (RA) signalling. The temporal coordination is partly mediated by FGF/MAPK-
dependent phosphorylation of the PSmad1/5 linker. This negatively regulates 
PSmad1/5 function in the ventral vegetal (posterior) region of the gastrula stage 
embryo and alteration of the MAPK phosphorylation sites results in precocious 
patterning of DV tissues. This, however, is independent of an altered Smad stability 
and the authors propose an independent mechanism possibly affecting Smad1/5 
activity directly. Exploiting a different mechanism, the Nemo kinase can inhibit BMP 
activity. Drosophila Nemo phosphorylates Mad in the N-terminal MH1 domain, thus 
resulting in an increased nuclear export (Zeng et al., 2007). Taken together, this 
indicates that Smad-mediated BMP signalling can be regulated by kinases other 
than the BMP receptors.  
 Smad activity can be modulated by other posttranslational modifications 
apart from phosphorylation, for example, SUMOylation. SUMO (ubiquitin-related 
modifier) proteins are small proteins, which resemble the three-dimensional 
structure of ubiquitin (Geiss-Friedlander and Melchior, 2007). They are conjugated 
to a substrate through an enzymatic cascade including E1, E2 and E3 enzymes. 
SUMOylation can have different effects on targets ranging from alterations to 
protein activity to changes in subcellular localisation and protein stability. In 
Drosophila, SUMOylation of Medea (Med, co-Smad) negatively regulates the Dpp 
signalling range by promoting the nuclear export of Med (Miles et al., 2008). This 
study proposes that interaction with pMad delays the SUMOylation of Med upon 
entry to the nucleus, thus allowing for the formation of active Smad signalling 
complexes in response to BMP signals. 
The tissue and stage specific expression/activity of transcriptional co-
regulators is another mean to spatially control BMP signalling. A well-studied 
example is the Smad1/Smad4 interacting protein Schnurri. Schnurri’s activating 
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and repressing function has been mostly investigated in Drosophila and it can act 
directly, as well as indirectly, on gene transcription. Schnurri, for example, has a 
direct role in the activation of the ubx and race target gene expression (Dai et al., 
2000, Wharton et al., 2004, Torres-Vazquez et al., 2000?). In an indirect step, 
Schnurri can control BMP target gene transcription by binding in a Smad/Schnurri 
repression complex to the promoter of the brinker gene. Brinker is a transcriptional 
repressor, thus Brinker inhibition results in an upregulation of BMP-dependent gene 
expression (Pyrowolakis et al., 2004). Interestingly, the worm homologue of 
Schnurri also confers tissues specific responses to BMP pathway activation (Liang 
et al., 2003). The vertebrate homologue is yet to be identified 
1.2.2 Spatial regulation of BMP ligand activity 
BMP ligand activity can be regulated at an intracellular level through altering 
transcription levels as well as the processing of BMP ligands. As secreted ligands, 
Bmp ligand activity is also coordinated through binding of activating or inhibiting 
factors in the extracellular space. In the following sections, I will introduce several 
known mechanisms. 
 
1.2.2.1 Intracellular regulation of BMP ligand production/activity 
In zebrafish, early zygotic bmp ligand transcription is under the control of the 
maternally deposited BMP ligand radar/gdf6a (Goutel et al., 2000) and the maternal 
transcription factor Pou2/Oct4 (Reim and Brand, 2006). As described earlier, after 
an initial phase of ubiquitous expression, bmp2b is then repressed on the dorsal 
side by FGF signalling and the localised transcriptional repressor dharma 
(Furthauer et al., 2004, Leung et al., 2003). Later on, bmp transcription is under 
BMP signalling autoregulation and mutants for bmp2b and bmp7a lack BMP activity 
after mid-gastrulation (Schmid et al., 2000).  
 Bmp ligands are initially synthesised as large inactive precursors and have 
to undergo proteolytic cleavage in the Golgi apparatus by pro-protein convertases 
to obtain the biologically active mature form (Zhou et al., 2012a). There are two 
major cleavage sites, S1 and S2. Cleavage at S1 liberates the mature ligand, but 
cleavage at S2 facilitates the release of the pro-peptide (Cui et al., 2001). In the 
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intracellular compartment, the pro-domain regulates the correct folding, 
dimerization, cleavage, and secretion of the mature BMP thus tissue specific 
cleavage can regulate localised BMP activity (Harrison et al., 2011). In Drosophila, 
for example, the BMP type ligand Decapentaplegic (Dpp) is cleaved at two sites in 
the wing but only at S1 in the midgut (Sopory et al., 2010). Cleavage at both sites 
appears to increase the stability of the mature ligand, thus modifying signal 
intensity and range. How the cleavage is tissue-specifically regulated is still 
unknown. A Bmp4 precursor that cannot be cleaved at S2 has been shown to stay 
attached to the pro-domain and as a result is targeted for degradation and thus less 
active when overexpressed in X. laevis (Cui et al., 2001). Mutation of this cleavage 
site in mice results in the severe loss of BMP4 activity in some tissues, whereas 
other tissues developed normally indicating a tissue specific requirement for S2 
cleavage (Goldman et al., 2006). 
 BMP ligands bind to receptors as homo-or heterodimers in Drosophila, X. 
laevis, mouse and tissue culture cells whereas heterodimers are have a higher 
signalling potency (Butler and Dodd, 2003, Nishimatsu and Thomsen, 1998, 
Shimmi et al., 2005, Valera et al., 2010). In contrast, heterodimer formation of 
Bmp2b and Bmp7a is absolutely required for signalling in zebrafish (Little and 
Mullins, 2009). During ectodermal patterning in Drosophila, dpp mRNA expression 
is repressed by the transcriptional repressor dorsal in the ventral half of the embryo 
and thus Dpp is expressed dorsally, whereas screw (scw, another BMP family 
ligand in Drosophila) is expressed ubiquitously (Wolpert et al., 2007). Facilitated 
transport by the extracellular proteins Short gastrulation (Sog) and Twisted 
gastrulation (Tsg), which have a higher affinity for Dpp/Scw heterodimers results in 
a dorsal accumulation of heterodimers compared to broadly distributed Dpp 
homodimers, thus allowing for the patterning of two different dorsal tissues (Shimmi 
et al., 2005). The Dpp/Scw heterodimer also has a higher ability of stimulating Sog 
cleavage by the protease Tolloid (Tld), which allows for the release of the ligand 
complex and receptor binding. In the developing zebrafish embryos, bmp2b and 
bmp7a are expressed in similar domains during gastrulation and mutants of both 
ligands show similar phenotypes (Schmid et al., 2000). Interestingly, it has been 
elegantly demonstrated that injection of a recombinant BMP2/BMP7 heterodimer, 
but not a BMP2 homodimer, can rescue bmp2b/swirl mutants (Little and Mullins, 
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2009). Thus, only in the presence of both ligands signalling can occur, providing an 
additional level of BMP activity regulation in zebrafish.  
 
1.2.2.2 Regulation of BMP ligand activity in the extracellular space 
A plethora of secreted proteins have been implicated in the modulation of BMP 
ligand activity. Some of these regulatory factors are membrane bound and can 
either act to concentrate ligand activity or retain them whilst inhibiting signalling. In 
Drosophila the two activating proteins Dally and Dally-like, which are 
glycosylphosphatidylinositol- anchored Heparan-Sulphate Proteoglycans (HSPGs), 
are believed to counteract endocytosis of Dpp and increase Dpp concentration of 
the cell surface (Raftery and Umulis, 2012). However, if levels of, for example Dally, 
are high this may result a sequestering of Dpp and inhibition of its diffusion (Fujise 
et al., 2003).  
As mentioned above, patterning of the dorsal ectoderm in Drosophila requires 
a BMP signalling gradient, which is formed by an intricate network of regulators. 
The Dpp/Scw heterodimer is bound by Sog/Tsg, which prevents ligand binding to 
the receptors and transport towards the dorsal midline, whilst Tld releases 
Dpp/Scw by Sog cleavage and thus allows for signalling. An additional regulatory 
layer for gradient formation involving collagens has been identified (Wang et al., 
2008). The authors propose a model, in which Sog and the Dpp/Scw heterodimer 
independently bind the type IV collagen Viking (Vkg). This facilitates the formation 
of a Dpp/Scw/Sog/Tsg complex and directional movement of the complex to the 
dorsal midline. Tld triggers the cleavage of Sog and the release of the ligands 
complex, which can form a new inhibitory complex in the presence of Sog in lateral 
regions. In the absence of Sog, the ligand complex binds to receptors for activation. 
Type IV collagens are able to augment Dpp signalling in Drosophila embryos, in a 
process that requires Dpp/Collagen IV interaction. 
The BMP and Activin membrane-bound inhibitor BAMBI acts a 
pseudoreceptor and was first identified in X. laevis (Onichtchouk et al., 1999). 
BAMBI resembles a type I receptor, but lacks the intracellular kinase domain. 
BAMBI expression inhibits BMP activity through its intracellular domain, which is 
similar to the type I receptor homodimerisation interface. Ligand induced 
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incorporation of BAMBI in type I receptor complexes hinders signalling. In zebrafish, 
two BAMBI homologues exist, Bambi-A (Nma) and Bambi-b. Ectopic expression of 
bambi-a in X. laevis and zebrafish inhibits the expression of known BMP target 
genes (Tsang et al., 2000), suggesting the role of BAMBI is conserved across 
species. A role for Bambi-b has not yet been identified. In mice, BAMBI is required 
for vascular development and BAMBI knockdown in HUVEC cells promoted basal 
and TGF-β induced phosphorylation of SMAD1/5 (Guillot et al., 2012). 
 Some of the molecules that modulate BMP activity are secreted and 
diffusible and may even facilitate the transport of BMP ligands across the 
extracellular space. The diffusible factors Noggin and Chordin (Sog in Drosophila) 
are important for DV patterning in vertebrate embryos (1.1.5) and inhibit BMP 
activity by binding the BMP ligands and inhibiting their interaction with the BMP 
receptors. After initial inhibition of bmp2b transcription by Dharma, dorsally 
expressed Noggin1 and Chordin inhibit BMP signalling, thus contributing to the 
gradient formation. Tolloid together with the metalloproteinase Bmp1 degrade 
Chordin in Bmp/Chordin complexes, thus restoring BMP signalling through the 
receptors and allowing for DV pattern formation (Piccolo et al., 1997). Twisted 
gastrulation also promotes BMP activity by facilitating this cleavage (Larrain et al., 
2001, Jasuja et al., 2006).  
Crossveinless2 (Cvl2) is another secreted protein that regulates BMP 
activity during development. As the name suggests, Cvl2 was first described in 
Drosophila wing development (Bridges, 1920) and later implicated as a direct 
positive regulator of BMP signalling often co-expressed with bmps (Conley et al., 
2000, Matsuda and Shimmi, 2012, Serpe et al., 2008). In contrast to Chordin and 
Tsg, Cvl2 acts at a short range and is tethered to the membrane by HSPGs (Serpe 
et al., 2008). Cvl2 contains N-terminal cysteine-rich domains (CR), similar to 
Chordin/Sog, and a C-terminal von Willebrand factor D (vWFD) domain. In 
Drosophila, Cvl2 has been clearly demonstrated to positively regulate BMP 
signalling during wing vein patterning.  During this process Dpp and another ligand, 
Glass bottom boat (Gbb), are produced in the longitudinal veins. Sog and Cvl2 then 
facilitate the transport of the Bmps into the posterior crossvein (PCV), where Sog is 
cleaved by Tolloid-related and the ligands are freed. Cvl2 is also expressed in the 
PCV and assists the ligands binding to the BMP receptors similar to a co-receptor. 
A similar positive role for Cvl2 has been demonstrated in loss-of-function studies in 
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mouse and zebrafish (Ikeya et al., 2006, Moser et al., 2007, Rentzsch et al., 2006) 
and mouse and chick Cvl2 enhances BMP4-mediated Smad1 phosphorylation in 
tissue culture (Kamimura et al., 2004).  
During zebrafish gastrulation, Cvl2 acts as a positive feedback regulator, 
which is partly accomplished by competing with Chordin for binding of Bmp ligands 
(Rentzsch et al., 2006). This study also suggests that proteolytic cleavage can 
convert Cvl2 from a pro- to and anti-BMP factor. Indeed, in different contexts Cvl2 
has been described as a negative regulator of BMP signalling. Overexpression of 
Cvl2 (Bmper) in X. laevis antagonises BMP activity and inhibits BMP-2 and BMP-4 
dependent osteogenic differentiation of in the mouse chondrogenic cell line ATDC5 
(Binnerts et al., 2004, Moser et al., 2003, Ambrosio et al., 2008). Ambrosio et al. 
propose that X. laevis Cvl2 forms a ternary complex containing BMP4 and Chordin. 
This on one hand enhances Chordin function and thus inhibits BMP signalling, but 
on the other hand might in conjunction with Tolloid have a pro-BMP effect ventrally 
ensuring that BMPs are freed for receptor binding (Zhang et al., 2010).  
A later study suggests that a pro-Bmp affect requires binding of Chordin. 
Whether this interaction facilitates the loosening of a BMP/Chordin interaction thus 
allowing the binding of BMPs to the receptor facilitated by Cvl2 or whether a 
Tolloid-dependent mechanism exists is still under debate. The observation that loss 
of Cvl2 enhances and overexpression of Cvl2 inhibits BMP signalling in some 
contexts suggests a possible dose dependent role. Indeed, in fly wing development 
overexpression of Cvl2 could activate or antagonise BMP signalling, depending on 
the level of expression (Serpe et al., 2008). A modelling approach suggests that not 
only levels of the signalling components, but also the affinity of different ligands and 
receptors for Cvl2 binding can influence the choice between and activating or 
inhibiting function of Cvl2. They also demonstrate that Cvl2 regulation in a positive 
feedback could be a mechanism to refine positional BMP signalling. Thus, the 
function of Cvl2 in modulating BMP signalling appears to be context-dependent and 
regulated by the relative expression levels of the players involved. This interplay of 
secreted and membrane-bound BMP activity modulators allows for robust but 
flexible regulation of localised BMP signals, even if the ligands themselves are 
uniformly expressed. 
The mechanisms I described above are examples of an even more complex 
interplay of positive and negative BMP signalling regulators. As BMP activity during 
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developmental processes such as ectodermal patterning has to be tightly regulated 
to allow for the specification of diverse cell types, an intricate network of factors is 
involved in such processes. Great progress has been made in understanding the 
interplay between activating and inhibiting molecules as well as different BMP 
ligands to achieve spatial and temporal signalling control. Still, a lot more research 
is needed to shed light on the regulatory process, especially in vertebrate 
development.  
 
1.3 The Tg(BRE:mRFP) transgenic zebrafish line 
The investigation of spatiotemporal BMP signalling dynamics during ectodermal 
patterning requires a robust readout for BMP activity. Traditionally, staining for C-
terminally phosphorylated Smad1/5 (PS1/5) has been used to detect domains of 
BMP activity during embryogenesis. This, however, only allows for the detection of 
strong signals, such as the DV BMP activity gradient during gastrulation (Tucker et 
al., 2008). Moreover, it has been demonstrated that Smad1/5 are not exclusively 
phosphorylated in response to BMPs/GDFs, but also in a non-canonical fashion 
upon stimulation with TGF-β (Goumans et al., 2002). Thus, PSmad1/5 is not an 
exclusive readout for BMP activity. 
To overcome these limitations, the Hill lab generated a transgenic zebrafish 
BMP reporter line (Wu et al., 2011, Ramel and Hill, 2013). The Tg(BRE:mRFP) 
expresses monomeric red fluorescent protein (mRFP) under the control of a well-
characterised BMP responsive element from the mouse Id1 enhancer (Korchynskyi 
and ten Dijke, 2002). This line faithfully reports BMP activity in tissues where BMP 
signalling was expected such as the somites, the dorsal retina and the tail bud 
(Esterberg et al., 2008, French et al., 2009, Pyati et al., 2006). mRFP fluorescence 
can only be detected from 6 somite stage onwards, with a strong signal in the tail 
bud and in the presomitic mesoderm, as during earlier stages mRFP protein levels 
are too low (Ramel and Hill, 2013). In contrast, mRFP mRNA can be detected in 8-
cell stage embryos and thus ISH can be used as a readout for earlier BMP activity. 
Moreover, mRFP mRNA is much less stable than mRFP protein with a half-life of 
less than 20 minutes compared to a protein half-life of more than 12 hours. 
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Therefore, mRFP ISH can be used as a more dynamic representation of BMP 
signalling events. 
It has been demonstrated that Tg(BRE:mRFP) transgenic zebrafish are a 
bona fide in vivo reporter for BMP/GDF activity using several approaches. 
Overexpression of the BMP inhibitors noggin or chordin substantially reduces the 
levels of detected mRFP at 75% epiboly (Ramel and Hill, 2013, Wu et al., 2011). In 
contrast, activation of BMP signalling by knockdown of chordin or overexpression 
of the ligand bmp2b and the constitutively active receptor CA-Alk8 leads to 
increased mRFP expression. In genetic approach using Bmp2b-deficient swirl (swr) 
embryos (Mullins et al., 1996) the same study demonstrated a strong reduction of 
mRFP expression in homozygous swrTA72A embryos compared to wild-type or 
heterozygous siblings. BMP activity in the dorsal retina is known to be conferred by 
Gdf6a expression (French et al., 2009) thus mRFP expression in this tissue is likely 
to result from Gdf6a ligand activity. Indeed, mRFP expression levels as well as 
mRFP fluorescence are reduced in gdf6a morphants, confirming that the 
Tg(BRE:mRFP) line is also a sensitive readout for GDF subfamily mediated 
signalling (Ramel and Hill, 2013). Finally, inhibition of BMP signalling using the 
chemical inhibitors Dorsomorphin and LDN-193189, which target the type I 
BMP/GDF receptors, resulted in reduced mRFP expression measured by Western 
blot analysis (Ramel and Hill, 2013, Sanvitale et al., 2013). 
Taken together, the Tg(BRE:mRFP) transgenic zebrafish line is a genuine 
readout for BMP/GDF activity. It thus provides a sensitive and accurate tool to 
investigate the dynamic changes in BMP signalling during ectodermal patterning 
and NC development in vivo. 
 
1.4 Snw1 
As described above, BMP signalling and ligand activity can be modulated at many 
levels. So far, there are no reports on co-transcriptional regulation of BMP ligand 
expression or the existence alternative splice variants of BMP ligands. However, it 
has recently been demonstrated that the known splicing factor Snw1 is a potent 
regulator of BMP signalling at the NPB and is required for NC development in X. 
laevis and zebrafish (Wu et al., 2011). Through which mechanism Snw1 confers 
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this regulation is not understood. Snw1 depletion results in a loss of BMP signalling 
after gastrulation, however, bmp ligands can still be detected by whole-mount in 
situ hybridisation (ISH). Tissue culture experiments in this study indicate that Snw1 
is not part of the core BMP signalling pathway downstream of the receptors. 
Moreover, the observed phenotype can be rescued by targeted injection of a 
bmp2b cDNA in X. laevis, indicating that the cells at the NPB are still responsive to 
a BMP stimulus. Taken together, the data so far indicate that Snw1 regulates BMP 
activity at a level upstream of the BMP receptors and downstream or at the level of 
bmp ligand transcription.  
Snw1 is an essential protein in many species and is extremely conserved 
from yeast to human (Wu et al., 2011). The X. laevis Snw1 protein, for example, is 
88% identical to human SNW1, 83% identical to zebrafish Snw1 and 62% identical 
to the Drosophila homologue Bx42. The alternative name Skip (Ski-interacting 
protein) is often used and the S. cerevisiae orthologue is called Prp45. There 
appears to be only one gene per genome, which encodes for a 60-80 kDa nuclear 
protein. The name Snw1 is derived from the conserved sequence motif “SNWKN” 
(Folk et al., 1996), which is identical in all genera. The basic structure, starting from 
the N-terminus, contains the following motifs: a glycine-rich box, a proline-rich box 
(possibly presents a binding site for WW and SH3 domain containing proteins), the 
SNWKN signature domain, highly conserved amphiionic helical repeats, a species-
specific insert and the region of similarity to the N-terminal half of SH2 domains 
(Figure 1.6) (Folk et al., 1996). Overall the protein structure of Snw1 seems to be 
very suitable for the binding of a great variety of interaction partners and the high 
conservation of the Snw1 protein sequence indicates an evolutionary role of Snw1 
in multiple interactions. However, none of these motifs have yet been functionally 
tested. Part of the structure might exist in a natively unfolded state as data from 
Dictyostelium SnwA suggests (Uversky et al., 2000). Such regions can be found in 
proteins that have a high interaction flexibility such as the human papilloma virus 
(HPV)-16 E7 (Alonso et al., 2002).  
Snw1 was first described as the Drosophila homologue Bx42 and was found 
to be a specific protein in a series of transcriptionally-active puffs on salivary gland 
chromosomes (Saumweber et al., 1990). The homologs in Saccharomyces 
cerevisiae (Prp45), Schizosaccharomyces pombe (Snw1p)and Drosophila are 
required for cell survival, splicing (Ambrozkova et al., 2001, Gahura et al., 2009, 
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Makarov et al., 2002), and nuclear export of spliced mRNAs (Farny et al., 2008) 
and Snw1 has been reported to interact with an extensive list of partners. I will 
discuss the evidence for a role of Snw1 in processes such as splicing and 
transcriptional regulation in the following sections. 
 
 
 
Figure 1.6 Overview of the conserved domains of the Snw1 protein 
 
 
1.4.1 A role of Snw1 in pre-mRNA processing 
Pre-mRNA transcribed by RNA polymerase II has to undergo several processing 
steps to become a mature mRNA that can be exported from the nucleus and 
translated. One of these processes is splicing, in which introns are removed and 
exons are joined. Splicing is a two step trans-esterification reaction catalyzed by 
the spliceosome. In the first step, a specific adenine nucleotide at the branch point 
(indicated in red), 18-40 nucleotides upstream of 3’ splice site, attacks the 5’ splice 
side and cuts the sugar backbone at that point. The loose 5’ end is then covalently 
linked to the adenine nucleotide, creating the lariat intermediate. The free 3’OH of 
ExonA reacts with the start of the next exon sequence, joining the exons together 
and releasing the Intron lariat. The spliceosome is a large ribonucleoprotein 
complex of five uridine-rich small nuclear RNAs (snRNA) and around 200 additional 
proteins. The assembly of the spliceosome occurs in a stepwise manner and large 
rearrangements of the spliceosome orchestrate the different splicing steps 
(Makarov et al., 2002). For the first splicing step the U1snRNP together with the 
splicing factors U2AF and SF1 bind the 3’ splice site (complex E), which promotes 
the recruitment of the U2snRNP to the branch point in an ATP-dependent manner 
(complex A). Subsequently the so-called complex B is formed by binding of the U4-
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U6-U5 tri snRNP, which leads to major RNA/RNA and RNA/protein rearrangements 
and the release of U1- and U4snRNP. The resulting complex C is the complex that 
is responsible for catalysing the formation of the lariat, intron excision and exon-
exon ligation. The mRNA is then released and the spliceosome dissembles and is 
recycled for another round of splicing. 
Snw1 has been identified as a component of the activated spliceosome in 
S.cerevisiae, S.pombe and H.sapiens in several independent screens (Neubauer et 
al., 1998, Ajuh et al., 2000, Gavin et al., 2002, Ohi et al., 2002, Zhou et al., 2002). 
More specifically, Snw1 was identified as component of the CDC5/P19 subcomplex, 
which is part of the B* and C complexes and the post-spliceosomal species (Albers 
et al., 2003, Makarov et al., 2002). 
In a yeast two-hybrid screen using Prp22 (DHX8 in humans), also part of the 
CDC5 complex, as a bait, Prp45 and Prp46 (PLRG1 in humans) were identified as 
interaction partners (Albers et al., 2003). Both proteins are associated with the 
spliceosome throughout the splicing process and bind low levels of U2-, U5- and 
U6-, but not U1- and U4- snRNP. Importantly, this study demonstrated that in yeast 
depletion of Prp45 results in splicing defects in vivo.  
A role of SNW1 in human pre-mRNA splicing has been suggested by a 
study, in which a dominant negative truncated version of SNW1 was expressed in 
tissue culture cells (Zhang et al., 2003). This study demonstrated the transient 
accumulation of unspliced transcripts from a human growth hormone reporter gene 
cassette upon disruption of native SNW1 function. In fission yeast the Snw1 
homologue spSNW1 has previously been shown to interact with the U2AF35 
subunit (Ambrozkova et al., 2001) and recombinant SNW1 has been reported to 
bind U2AF65 from HCT116 nuclear extracts (Chen et al., 2011). This interaction is 
thought to gene specifically facilitate the co-transcriptional loading of U2AF65 onto 
the unspliced pre-mRNA in a gene-specific manner. In response to DNA damage 
stress SNW1, as well as DHX8 and Prp19, are required for the splicing of p21 but 
not other p53-induced targets such as PUMA (Chen et al., 2011). 
There have been suggestions of a role for Snw1 at other stages of pre-
mRNA processing. For example, Snw1 binds the poly(A)-binding protein 2 (PABP2), 
which contributes to mRNA nuclear export (Calado et al., 2000, Kim et al., 2001). In 
Drosophila, Bx42/Snw1 was identified in a genome-wide RNAi screen to be 
required for poly(A)-mRNA export from the nucleus (Farny et al., 2008).  
Chapter 1 Introduction 
 44 
More research is required to determine the function of Snw1 in pre-mRNA 
processing. Snw1 is part of the activated spliceosome but does not seem to have 
any catalytic activity itself. Interestingly, a recent study demonstrated by (NMR) that 
the large intrinsically disordered region in Snw1 undergoes a disorder-order 
transition upon binding of peptidylprolyl isomerase-like protein 1 (PPIL1) (Wang et 
al., 2010a). PPIL1 is recruited by Snw1 to the spliceosome by a region other than 
the peptidylprolyl isomerase active site and thus it still functions as a peptidylprolyl 
cis/trans-isomerase when part of the spliceosome. In summary, the unorder region 
of Snw1 is proposed to act as an ‘interaction platform’ that is required to facilitate 
the large structural rearrangements during the splicing process. 
1.4.2 Snw1 as a transcriptional coregulator 
Transcriptional coregulators interact with transcription factors to enhance or 
repress the transcription of specific genes. Snw1 has been associated with many 
different pathways and may act as a coactivator as well as a corepressor. It seems 
unlikely that a single factor is involved in the regulation of such a diversity of 
processes. The recruitment of endogenous levels of Snw1 to the spliceosome has 
been satisfactorily demonstrated using various approaches, as explained above. In 
contrast, most of the interactions and the subsequent implication of Snw1 in 
transcriptional pathway regulation stems from overexpression studies. As I will 
further elaborate on in Chapter 5, Snw1 appears to be prone to unspecific protein 
interactions, thus not all of the proposed functions of Snw1 may validate in the 
future. However, in the following paragraph I will introduce a selection of signalling 
processes Snw1 has been implicated in to date.  
1.4.2.1 Vitamin D receptor (VDR)/Retinoic acid (RA) signalling 
The vitamin D receptor (VDR) belongs to the thyroid hormone/retinoid 
receptor subfamily of nuclear receptors and functions as a heterodimer with retinoid 
X receptor (RXR) in vitamin D3-dependent transcription (Thompson et al., 1998). 
Human SNW1 was identified as an interaction partner of VDR using yeast two-
hybrid and in vitro immunoprecipitation and subsequently named Nuclear Receptor 
Coactivator of 62 kDa (NCoA-62), as it augmented VDR-activated transcriptional 
processes in transient reporter gene assays (Baudino et al., 1998, Zhang et al., 
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2001). SNW1 interacts selectively with the VDR-RXR heterodimer and forms a 
ligand–dependent ternary complex with steroid receptor coactivator (SRC) proteins 
to synergistically act on promoting VDR-dependent transcription. It was later shown 
that human sirtuin 1 (SIRT1), a NAD(+)-dependent deacetylase, associated with 
SNW1 and modulates its activity (Kang et al., 2010). As previously reported, SNW1 
in cooperation with SRC-1 enhanced the transcriptional activity of the retinoic acid 
receptor (RAR). In contrast, overexpression of SIRT1 inhibited transcriptional 
transactivation in a luciferase assay and Sirt1 and SNW1 compete for RAR binding. 
Thus SIRT1 and SNW1 have reciprocal role during RA-induced neuronal 
differentiation of P19 cells. 
 
1.4.2.2 Delta/Notch signalling 
Delta/Notch signal transduction controls differentiation and proliferation 
responses by converting the transcriptional repressors of the CSL family (CBF1, 
Supressor of Hairless, Lag-1) to activators (Bray and Furriols, 2001, Bresnick et al., 
2000). Upon ligand binding the intracellular domain of the Notch receptor (NotchIC) 
is cleaved and translocates to the nucleus where is binds to CSL family members 
like CBF1. This leads to a replacement of the silencing mediator for retinoic acid 
and thyroid hormone receptor proteins (SMRTs) / histone deacetylase (HDAC) 
complex and thus allows for transcription to start at CBF1-controlled promoters. 
Protein interaction assays showed an interaction between SNW1 and SMRTs, 
CBF-1 as well as NotchIC and the biological activity of NotchIC depends on binding 
of SNW1 (Leong et al., 2004, Zhou et al., 2000).  
In Drosophila, global loss of Bx42/Snw1 is embryonic lethal and tissue 
specific depletion phenotypically resembles some classes of Notch mutants 
suggesting a contribution of Snw1 to the Notch pathway (Negeri et al., 2002). 
Overexpression of the CBF1 homologue Suppressor of Hairless in the wing disc 
results in defects in the vein architecture (Furriols and Bray, 2000). This phenotype 
is strongly enhanced by Bx42/Snw1 RNAi arguing for an interaction of both factors 
in the Notch pathway (Negeri et al., 2002). The same study goes on to demonstrate 
that Snw1 depletion affects Notch target gene expression. Moreover, Snw1 RNAi 
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expression in the eye disc leads to an eye to antenna transformation similar to what 
is observed upon overexpression of dominant negative forms of Notch.  
Taken together, the data to date argues for a function of Snw1 as a 
coactivator of the Notch signaling pathway. 
 
1.4.2.3 Wnt signalling 
Another signalling pathway Snw1 has been suggested to modulate is the canonical 
Wnt signalling pathway. As mentioned above, upon Wnt stimulation, β-catenin 
translocates to the nucleus and binds TCF/LEF transcription factors to initiate 
target gene expression (1.1.2). In the absence of Wnt signalling, TCF/LEF act as 
transcriptional repressors on target genes by binding to the transcriptional co-
repressors Groucho-HDAC (Billin et al., 2000). A previous study suggested that 
Snw1 forms a ternary complex with the transcription factor LEF1 and HDAC1 to 
mediate target gene repression (Wang et al., 2000). The authors demonstrate that 
overexpressed Skip interacts with co-transfected Lef1, Tcf1, Tcf3 and Tcf4c as well 
as HDAC1 and β-catenin. Using a 2-step IP assay, they further show SNW1, LEF1 
and HDAC1 to be part of one complex. Expression of SNW1 in HEK293T cells 
inhibits TOPflash reporter activity in response to co-transfected β-catenin in a dose-
dependent manner and overexpression of Snw1 in X. laevis embryos abolishes NC 
development. Interestingly, knockdown of SNW1 in HEK293T cells also impaired 
Wnt target gene expression downstream of β-catenin as well as NC induction in X. 
laevis. Wang et al. suggest that Snw1 acts as a scaffold protein in canonical Wnt 
signalling. Overexpressed Snw1 enhances the formation of a Lef1/HDAC1 
repressive complex thus inhibiting target gene expression. In addition, Snw1 might 
be required for the β-catenin-dependent conversion of TCF/LEF proteins to co-
activators, which is why Snw1 depletion also reduced Wnt reporter activity. 
 Taken together, Snw1 is proposed to regulate Wnt signalling at a 
transcriptional level. This function is important in X. laevis development for NC 
induction. 
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1.4.2.4 TGF-β  signalling 
In a yeast two-hybrid screen SNW1 was identified to interact with SKI 
(hence its alternative name Ski interacting protein, SKIP) (Dahl et al., 1998) and 
SKI/SnoN were subsequently shown to be a transcriptional repressor of the TGF-β 
signalling pathway (Akiyoshi et al., 1999, Luo et al., 1999). Ski and SnoN bind to 
the Smad transcription factors and inhibit TGF-β-dependent transcription through 
the recruitment of a nuclear co-repressor complex. In yeast and mammalian cells, 
Snw1 was demonstrated to interact with Smad2 and Smad4 by yeast two-hybrid 
and using purified proteins (Leong et al., 2001). Moreover, overexpression of 
SNW1 in COS1 cells along with Smad3 augments TGF-β-dependent 
transactivation. However, in another study SNW1 was stably overexpressed in 
C2C12 cells without addition of the Smads (Figueroa and Hayman, 2004). In this 
experimental setup SNW1 was not sufficient to enhance TGF-β dependent gene 
reporter activity. 
TGF-β inhibits myotube formation during muscle development by the 
functional repression of myogenic transcription factors such as MyoD probably 
mediated by Smad3-dependent transcriptional repression (Liu et al., 2001). Since 
SKI has been implicated in muscle development as well (Engert et al., 1995) the 
link between Smad3, SNW1 and SKI appears to be a possible explanation for the 
molecular function of SKI on MyoD-dependent genes. As mentioned in a previous 
section (1.4.1) SNW1 binds the poly(A)-binding protein 2 PABP2, required for 
nuclear export. Interestingly, SNW1 and PABP2 were identified in a ternary 
complex with MyoD and act together to stimulate its transcriptional activity (Kim et 
al., 2001).  
In summary, Snw1 has been implicated in TGF-β signalling as a 
transcriptional activator. However, data generated in our lab does not support an 
interaction of Snw1 with either Smads or Ski and tissue culture experiments 
indicate that Snw1 is not part of the core signalling pathway downstream of 
receptor activation. 
Chapter 1 Introduction 
 48 
1.4.3 Transcriptional elongation 
Snw1 has been implicated in the regulation of several signalling pathways as well 
as splicing. Evidence suggests that Snw1 acts as a platform/scaffold in these 
processes to allow for the rearrangement of large protein complexes such as the 
spliceosome and ternary complexes of transcription factors. By allowing the 
interaction with components of different molecular ‘machineries’, Snw1 might act as 
a mediator between different processes such as transcription initiation and splicing 
and be required for their functional coupling. 
Recent research supports this hypothesis. Brès et al. demonstrated SNW1 
associated with P-TEFb transcriptional elongation complex in a step that is required 
for HIV-1 Tat transactivation (Bres et al., 2005). Moreover, SNW1 associates with 
U5snRNPs and a more active C-terminal truncated SNW1 enhances the use of 
alternative HIV-1 Tat splice sites. SNW1 also associates with c-Myc and Menin, a 
subunit of the MLL1 histone methyltransferase (H3K4me3) complex, which is 
necessary for HIV-1 Tat transactivation (Bres et al., 2009). Interestingly, SNW1 and 
PTEF-b are dispensable for UV stress induced HIV-1 transcription, thus the 
elongation step requiring SNW1, c-Myc and Menin is bypassed under DNA 
damage stress. However, SNW1 is required for basal and stress induced splicing 
of p21 mRNA (1.4.1) (Chen et al., 2011).  
 
In summary, this suggests that depending on the cellular and physiological 
context, Snw1 may adopt different functions to regulate transcription/co-
transcriptional processes. As mentioned at the beginning of this section, many of 
the data that has been generated to identify the molecular role of Snw1 comes from 
yeast two-hybrid screens and overexpression studies. Although these are valid 
approaches, the obtained data has to be rigorously validated in endogenous 
assays. Interaction studies, for examples, that use overexpression of both proteins 
may lead to false positive results and identification of binding partners that do not 
exist in a normal cellular context.  
As mentioned before, Snw1 was identified as a regulator of BMP activity at 
the NPB and thus NC induction (Wu et al., 2011). Knockdown of Snw1 in tissue 
culture cells did not impair their ability to respond to a BMP stimulus. The proposed 
interaction of Snw1 and the Smads as well as the transcriptional repressor Ski 
Chapter 1 Introduction 
 49 
could not be verified. Thus, we suggest that Snw1 regulates BMP activity not on a 
transcriptional level after receptor activation on BMP target genes. In contrast, 
Snw1 might act at the level or downstream ligand transcription, possibly 
transcriptional elongation and co-transcriptional splicing. 
 
1.5 Aim of the thesis 
Studying tissue specification during developmental processes provides novel 
insights into how signalling pathways are regulated and integrated to give rise to a 
variety of tissues. Ectodermal patterning is a crucial early event during 
development that defines neural and non-neural progenitors. It has long been 
known that BMP activity is indispensible for this process. Direct evidence for the 
spatial and temporal sequence of the activation of BMP signaling during 
ectodermal patterning, especially after gastrulation, however is scarce. 
Furthermore, much of the data available has been generated from phenotypical 
analyses of BMP mutants such as the zebrafish swirl (bmp2b), snailhouse (bmp7) 
and somitabun (smad5) mutants (Nguyen et al., 1998, Mullins et al., 1996). These 
mutants, however, lack early BMP signalling required for initiation of DV patterning 
and can therefore only provide limited information on the specific requirements of 
NC and PPE for BMP activity during later stages.  
 It was therefore the aim of my PhD thesis to investigate BMP signalling 
dynamics during ectodermal patterning using the transgenic zebrafish 
Tg(BRE:mRFP) reporter line. I then further investigated the mechanism regulating 
localised BMP activity or inhibition in different tissues thus identifying a BMP 
regulatory network that can explain the changing signalling requirements during NC 
and PPE development.  
 In a second part I aimed to identify the role of the nuclear protein Snw1 in 
regulating BMP activity and NC induction. As mentioned above, it was previously 
demonstrated that Snw1 must act at the level or downstream of ligand transcription 
and upstream of receptor activation (Wu et al., 2011). At what step Snw1 acts 
however and whether it only targets BMP signalling at the NPB is not understood. It 
has also been demonstrated that Wnt signalling is perturbed in Snw1 X. laevis 
morphants. However, whether that is the cause for the defect in NC development is 
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still under debate as a different study identified Snw1 as a regulator of Wnt activity, 
which also contributes to NC development (Wang et al., 2010b). I therefore used a 
combination of embryological and molecular approaches to elucidate the molecular 
function of Snw1. 
 
In summary, my aims were to contribute to the understanding of the spatiotemporal 
regulation of BMP signalling during vertebrate development. I hope the results of 
this work will have implications beyond understanding normal developmental 
processes and further our insight into how BMP signalling is perturbed in disease. 
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Chapter 2. Materials & Methods 
General laboratory chemicals were purchased from Sigma-Aldrich, Roche or Fisher 
Scientific unless otherwise stated. Standard laboratory solutions including 10 x TAE, 
10 x TBE, 5 M sodium chloride, 0.5 M EDTA (pH 8), 1 M Tris-HCl (pH 7.8 or 8), 10 
x PBS, 1 x PBS and autoclaved water were prepared by Cancer Research UK 
Laboratory Services.  
 
2.1 Embryology 
2.1.1 Fish maintenance and strains used 
The zebrafish colony was maintained by the fish facility staff Phil Taylor, Darren 
Martin and Chris Sergeant at 27.5°C as described (Westerfield, 2000). The fish 
were kept in dechlorionated water on a 14/10 hour light/dark cycle and embryos 
were collected from spontaneous spawning. The staging was conducted according 
to KIimmel et al. (Kimmel et al., 1995). The embryos were kept in Petri dishes 
containing autoclaved water supplemented with a 500x “fish water mix” diluted to 
1x up to 5 days post fertilisation The mutant lines used were: 
Tg(hsp70l:dnXla.Bmpr1a-GFP) (Pyati et al., 2006) and Tg(BRE:mRFP) (Wu et al., 
2011) . 
 
500x fish water mix 
6 g  Instant Ocean salts 
0.2 g methylene blue 
  up to 200 ml with H2O 
 
2.1.2 X. laevis husbandry 
All adult X. laevis laevis specimens were obtained from Nasco (Fort Atkinson, WI, 
USA).  Male and female frogs were maintained in separate tanks. 
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2.1.2.1 Materials and solutions 
10x Normal Amphibian Medium (NAM) Salts 
1.1 M NaCl   64.28 g 
20 mM KCl   1.49 g 
10 mM CaNO3  2.36 g 
20 mM MgSO4  2.4 g 
1 mM EDTA  2 ml 0.5 M EDTA pH 8.0 
    Up to 1 litre with H2O 
Filter sterilised, stored at room 
temperature 
10 M NaOH 
40 g NaOH 
Up to 100 ml with H2O 
Stored at room temperature 
 
1 M HEPES pH 7.6 
59.58 g HEPES 
pH  to 7.6 with 10 M NaOH 
Up to 250 ml with H2O 
Filter sterilised, stored at room temperature 
 
0.1 M NaHCO3 
2.1 g NaHCO3 
Up to 250 ml with H2O 
Filter sterilised, stored at room temperature 
 
1 x NAM 
100 ml 10 × NAM Salts 
2 ml 1 M HEPES (pH 7.5) 
10 ml 0.1 M NaHCO3 
Up to 1 litre with H2O 
Stored at room temperature 
 
10 % NAM 
20 ml 10 × NAM salts 
4 ml 1 M HEPES (pH 7.5) 
Up to 2 litres with dH2O 
Stored at room temperature 
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50 % NAM 
200 ml 1 x NAM 
200 ml H2O 
Stored at room temperature 
 
75 % NAM + 2 % (w/v) Ficoll 
150 ml 1 x NAM 
50 ml H2O 
4 g Ficoll 400, Type 400-DL 
Made up to 24 hours before use 
 
2 % (w/v) Cysteine 
4 g L-Cysteine (Fluka) 
195 ml 10% NAM   
pH to 7.8 with 10 M NaOH, up to 200 ml with H2O 
Made fresh before use 
 
10 x Modified Barth’s Saline (MBS) salts 
880 mM NaCl  25.71 g 
10 mM KCl   0.373 g 
10 mM MgSO4  0.6 g 
25 mM NaHCO3  1.05 g 
    pH to 7.8 with 10 M NaOH 
    Up to 500 ml with dH2O  
    Stored at room temperature 
1 M CaCl2 
11.1 g CaCl2 
Up to 100 ml with H2O 
Filter sterilised, stored at 4ºC 
 
1 x high salt MBS 
25 ml 10 × high salt MBS 
1 ml 5 M NaCl 
175 µl 1 M CaCl2 
Up to 250 ml with H2O 
Filter sterilised, stored at room temperature 
 
0.2 % (w/v) Ethyl 3-aminobenzoate methanesulfonate salt (MS222) 
4 g MS222 
Up to 2 litres with H2O 
pH to 7.5 with 10 M NaOH 
Stored at room temperature for up to 1 week 
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10 x MEM 
1 M MOPS   104.63 g 
20 mM EGTA  3.8 g 
10 mM MgSO4  0.6 g 
    pH to 7.4 with 10 M NaOH 
    Up to 500 ml with H2O 
    Filter sterilised, stored at 4ºC 
 
1x MEMFA 
5 ml 10 x MEM 
5 ml 37% formaldehyde solution 
Up to 50 ml with H2O 
Made fresh before use 
 
Pregnant Mare Serum Gonadotropin (PMSG) solution 
5000 IU of PMSG-Intervet (Intervet) was dissolved in 20 ml of 
accompanying solvent 
This provides a 250 units per ml solution 
Stored in aliquots at -20ºC 
 
Human Chorionic Gonadotropin (HCG) solution 
10,000 IU of HCG was dissolved in 8 ml sterile dH2O 
This provides a 1,250 units per ml solution 
Stored in aliquots at -20ºC 
 
2.1.2.2 Collecting mature oocytes 
Adult female X. laevis animals were injected into the dorsal lymph sac 3-7 days 
before the induction of ovulation with 200 µl of a 250 units/ml solution of pregnant 
mare serum gonadotropin (equivalent of 50 units of PMSG, a substitute for Follicle 
Stimulating Hormone) to stimulate follicle and oocyte maturation. Ovulation was 
induced 14-20 hours before oocyte collection by injection of 400 µl of a 1,250 
units/ml solution of human gonadotropin (equivalent of 500 units of HCG). The 
mature oocytes were collected manually by holding the female frog over a clean 
Petri dish and gently massaging the abdomen of the frog to stimulate egg-laying. 
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2.1.2.3 Isolating testes 
Male frogs were sacrificed by submerging in a bath of 0.2 % (w/v) Ethyl 3-
aminobenzoate methanesulfonate salt (MS222) for 20-30 minutes. In addition, 
following the Schedule I procedure, the neck was severed prior to dissection to 
obtain testes. Testes were stored in 70 % L-15 (Leibovitz) medium (Gibco) at 15ºC 
for up to 72 hours. 
 
2.1.2.4 In vitro fertilisation 
Sperm was obtained by crushing a testis in 1 ml 1x high-salt MBS using a pellet 
mixer (Anachem). The sperm solution was evenly pipetted over the unfertilised 
eggs in Petri dishes. To activate the sperm the dish was flooded with 10 % NAM.  
Successful fertilisation leads to the contraction of the animal hemisphere 
(pigmented half of the egg) resulting in the rotation of eggs within the vitelline 
membrane so that the animal hemisphere faced upwards approximately 30 minutes 
post flooding. 
 
2.1.2.5 Dejellying 
Embryos are covered with a protective jelly that must be removed prior to most 
micromanipulation procedures. For that purpose the 10 % NAM was replaced with 
a 2 % (w/v) solution of cysteine, the contents of the Petri dish carefully transferred 
into a beaker and gently swirled for several minutes. The jelly was sufficiently 
removed when the embryos started to sit packed against each other as they settled 
on the bottom of the beaker. This had to be carefully monitored as excessive 
exposure to cysteine damages the embryos. The cysteine solution was then 
removed and the embryos washed five times with large volumes of 10 % NAM.  
Finally, the embryos were gently poured into clean Petri dishes filled with fresh 
10 % NAM. The embryos were then sorted prior to injections, with fertilised 
embryos being firm and resistant to pressure when gently touched with a hair loop.  
Soft, unfertilised embryos were discarded. 
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2.1.3 Capped mRNA preparation for injections 
To prepare capped mRNA for microinjections the required plasmid was digested 
with the appropriate restriction enzyme (2.2.6). 1 µl of the digest was run on a 1% 
agarose gel to check for efficiency of the digestion. The digested DNA was then 
cleaned using QIAquick PCR purification kit. 
The following reaction mix was prepared: 
1 µg DNA template 
5 µl  10x polymerase buffer (NEB) 
3.125 µl DTT 200 mM  
5 µl  ATP 10 mM (Roche)  
5 µl  UTP 10 mM (Roche) 
5 µl  CTP 10 mM (Roche) 
2.5 µl  GTP 1 mM (Roche) 
2.5 µl CAP analogue (10 mM stock) (NEB) 
2.5 µl  RNasin (Promega) 
to 40 µl  H2O 
 
5 µl T7,SP6 or T3 polymerase were added and incubated for 30 min at 37°C. Then 
5 µl 10 mM GTP were added and incubated another hour at 37°C.  
Add:  50 µl  50TE (50 mM TrisHCl pH 7.5, 1 mM EDTA)   
1.25 µl  Ca/Mg/DTT mix (5 µl CaCl2 1 M, 10 µl MgCl2 1 M, 10 
µl DTT 200 mM) 
0.5 µl  RNasin  
2µl   Dnase I 
 
and mix was incubated 30 min at 37°C and mixed once in between. 1 volume 
phenol/chloroform were added, and the solution well mixed and spun 30 min at 4°C, 
13,000 rpm in a microcentrifuge. The aqueous phase was transfered into a new 
tube, 25 µl ammonium acetate (4 M, pH 5.2) and 300  µl cold 100% ethanol added 
and the RNA precipitated for 20 min on dry ice. The tube was spun for 20 min at 
4°C, 13,000 rpm and the supernatant discarded. This was followed by another 
short centrifugation and the remaining supernatant was removed. The pellet was 
dissolved in 100  µl RNase-free water. The RNA concentration was determined by 
measuring the OD using a NanoDrop™ 1000 spectrometer. To check the RNA 
quality, 1 µl of RNA was added to 5 µl formamide buffer (95% formamide, 20 mM 
EDTA). The mix was heated for 3 min at 95°C and run on a 1% agarose gel (2.2.5).  
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2.1.4 Microinjections 
X. laevis  
 
Glass capillaries (INTRAFIL, 1 mm x 0.58 mm) were pulled into fine needles. They 
were calibrated under a microscope using fine pointed forceps to inject a 4 nl sized 
drop. The injection mix was prepared in RNase-free water and the embryos were 
injected using a Narishige IM-300 microinjector in 3% Ficol/ 75% NAM to facilitate a 
faster healing. Embryos were usually injected at the 1-cell stage or, if even spread 
of the injected RNA was crucial, into both cells at the 2-cell stage. For the targeting 
experiments the embryos were injected into the desired blastomere according to 
the developmental fate map. 3 hours after injection the embryos were transferred 
into dishes containing 1/10 NAM. The embryos were fixed for immunostaining or in 
situ hybridisation in MEMFA for 2 hours at room temperature (RT) or overnight at 
4°C. For immunostaining, the embryos were stored in PBS, for in situ hybridisation 
the embryos were dehydrated in a series of PBS/MeOH and stored in 100% MeOH 
at -20°C. 
 
Zebrafish 
 
Glass capillaries (Harvard Apparatus, 1 mm x 0.58 mm) were pulled into fine 
needles. They were calibrated under a microscope using fine pointed forceps to 
inject a 2 nl sized drop. The injection mix was prepared in RNase-free water. 
Fertilised zebrafish embryos were injected using a Picospritzer III (Parker) between 
1- and 4-cell stage into the yolk cell, raised at 28°C to the desired stage and fixed 
in 4% PFA/PBS for 3-10 days. Embryos intended for protein or RNA expression 
analysis were transferred in a microcentrifugation tube,  snap frozen on dry ice and 
stored at -80°C. 
 
2.1.5 Probe preparation for in situ hybridisation (ISH) (X. laevis) 
For antisense probe preparation the plasmid encoding the probe was digested at 
37°C with the appropriate restriction enzyme. 1 µl of the digest was run on a 1% 
agarose gel to check for efficiency of the digestion. The digested DNA was then 
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cleaned using QIAquick PCR purification kit. The following reaction mix was 
prepared for probe synthesis: 
2 µl  linearised DNA template (2 µg) 
5 µl  10 x polymerase buffer 
10 µl 5 x rNTP mix 
5 µl  100 mM DTT 
1 µl  RNasin (Promega) 
5 µl  SP6, T7, or T3 RNA polymerase as appropriate 
22 µl H2O 
 
The reaction mixture was incubated at 37ºC for 2 hours, then 2 µl DNaseI (2.7 
units/µl, Worthington) were added and the reaction incubated for another 30 
minutes at 37ºC to remove the DNA template. The transcribed RNA was extracted 
by adding an equal volume of 25:24:1 Phenol:Chloroform:Isoamyl alcohol (Sigma), 
the mix was vortexed and left to incubate at room temperature for 5 minutes before 
the tubes were centrifuged at 12,000 rpm for 10 minutes at 4ºC. The aqueous 
phase containing the RNA was transferred to a fresh tube.  The RNA was then 
ethanol precipitated by adding 5 µl 3M NaOAc pH 5.2 and 165 µl 100 % ethanol. 
Tubes were left at -20ºC for 20 minutes before centrifuging at 12,000 rpm for 10 
minutes at 4ºC (Biofuge fresco Heraeus). The RNA pellet was washed with cold 
80% ethanol and allowed to air dry for 5 minutes before being dissolved in 20 µl 
H2O.  To check the RNA quality 1 µl samples were run on a 1 % agarose gel using 
the 6 x RNA formamide loading dye (2.2.5).  Finally, the RNA concentration was 
measured (2.2.3) and the sample diluted to 10 µg/ml (10 x stock) with hybridisation 
buffer (2.1.7). 
 
5x rNTP mix 
2.5 mM rATP (Roche)    5 µl of 100 mM rATP 
2.5 mM rCTP (Roche)    5 µl of 100 mM rCTP 
2.5 mM rGTP (Roche)    5 µl of 100 mM rGTP 
1.625 mM rUTP (Roche)   3.25 µl of 100 mM rUTP 
0.875 mM Digoxigenin-11-UTP (Roche)  17.5 µl of 10 mM Stock 
       Up to 200 µl with dH2O 
       Stored at -20ºC 
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2.1.6 Probe preparation for in situ hybridisation (ISH) (zebrafish) 
The probe preparation was essentially performed as described in section 2.1.5. For 
probe synthesis the following reaction mix was prepared: 
 
1 µg DNA template 
2 µl  0.1M DTT 
2 µl  dig-NTP or DNP-NTP mix 
0.5 µl RNase inhibitor 
2 µl  10x transcription buffer 
1 µl  RNA polymerase as appropriate 
to 20 µl H2O 
 
The reaction was well mixed, spun down and incubated for 2-4 hours at 37°C. 80 µl 
1x TE and 1 µl DNase were added and incubated for 20 min at 37°C. The RNA 
probes were then cleaned up using the ZYMO RNA clean up kit and eluted in 25 µl 
RNase free water. Probes were stored at -20°C. 
 
5 mM dig-NTP or DNP-NTP mix 
25.7 µl H2O 
2 µl  100 mM (C,G,A)TP each 
1.3 µl 100 mM UTP 
7 µl  10 mM dig-11-UTP or DNP-11-UTP 
 
2.1.7 Whole-mount in situ hybridisation (ISH) (X. laevis) 
On the first day, the embryos were rehydrated in a series of EtOH washes followed 
by three washes with PBST (all washes were 5 min unless otherwise stated). The 
embryos were then bleached for 10 minutes (solution specified below) with 
exposure to a bright light source, such as a light box. This was followed by three 
washes in with PBST before 20 minutes of refixation using a 4% formaldehyde 
solution made in PBS (a 16% solution from Agar Scientific was diluted 4-fold in 
PBS). The embryos were again washed three times with PBST and then 
equilibrated in 25 % Hybridisation buffer and 75 % PBST.  Finally, the embryos 
were allowed to pre-hybridise in 100 % hybridisation buffer for 3–5 hours at 65ºC in 
a hybridisation oven. After pre-hybridisation, embryos were incubated a 1 x solution 
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of the probe of interest diluted in preheated hybridisation buffer. The embryos are 
left to hybridise overnight at 65ºC. 
 On the following day, the probe was removed and stored at -20ºC for future 
use (up to 10 times).  The embryos were washed for 10 minutes in fresh pre-
heated hybridisation buffer at 65ºC before three 20 minute washes using 2 x SSC + 
0.1 % (v/v) Tween-20, also at 65ºC, followed by three final 10 minute washes at 
65ºC in 0.2 x SSC + 0.1 % (v/v) Tween-20. The embryos were then washed three 
times at room temperature in Malic Acid Buffer (MAB) before 1–3 hours of 
incubation in blocking buffer.  After blocking, the embryos were left in a 1:2000 
dilution of anti-DIG Alkaline phosphatase-conjugated antibody in blocking buffer 
overnight at 4ºC. 
 The next day the embryos were washed in MAB + 0.2 % (v/v) Tween-20 6–
8 times for an hour for each wash. The embryos were washed overnight in more 
fresh MAB + 0.2 % (v/v) Tween-20 at 4ºC. 
 On day four, the embryos were equilibrated by washing three times in 
freshly made Alkaline Phosphatase buffer before incubation with a BM purple 
solution (Roche). The Alkaline Phosphatase reactions were left at room 
temperature and monitored hourly.  In case the staining was very weak, the BM 
purple solution was renewed and the reactions were moved to 4ºC and left 
overnight. The reactions were stopped with 3 washes of PBS-Tween and the 
embryos refixed using 4 % formaldehyde. 
 
Bleaching solution 
1 % (v/v) H2O2   333 µl 30 % (v/v) H2O2 
5 % Formamide     50 µl 100 % Formamide 
0.5 x SCC      25 µl 20 x SSC 
     Up to 1 ml with H2O 
100x Denhart’s Solution 
2 % (w/v) BSA   2 g BSA 
2 % (w/v) polyvinylpyrrolidone 2 g polyvinylpyrrolidone 
2 % (w/v) Ficoll   2 g Ficoll  
     Up to 100 ml with H2O 
     Stored at -20ºC 
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Hybridization buffer 
50 % (v/v) Formamide  50 ml 100 % Formamide 
5 x SCC    2.5 ml of 20 x SSC 
1 mg/ml Yeast RNA (torula) 100 mg Yeast RNA (torula) 
100 µg/ml Heparin   10 mg Heparin 
1 x Denhart’s Solution 1 ml of 100 x Denhart’s Solution 
0.1 % Tween-20   100 µl of 100 % Tween-20 
10 mM EDTA   5 ml of 0.5 M EDTA, pH 8.0 
0.1 % (w/v) CHAPS   100 mg CHAPS 
     Up to 100 ml with dH2O 
     Stored at -20 ºC 
5 x MAB  
750 mM NaCl   43.83 g NaCl 
500 mM Maleic Acid  58.03 g Maleic Acid 
     Up to 800 ml with dH2O 
     pH to 7.5 with NaOH 
     Up to 1 litre with dH2O 
     Autoclaved and stored at RT 
     Diluted to 1x with H2O  
 
Blocking buffer 
2% Blocking reagent (Roche) 2 g 
     Up to 90 ml with 1 x MAB 
Heat on a hot plate while stirring 
to dissolve 
10 % FBS 10 ml after the solution has 
cooled to room temperature 
Alkaline Phosphatase Buffer 
100 mM Tris pH 9.5  10 ml 1 M Tris-HCl pH 9.5  
50 mM MgCl2   5 ml 1 M MgCl2 
100 mM NaCl   2 ml 5 M NaCl 
0.1% (v/v) Tween   500 µl 20 % (v/v) Tween 
     Up to 100 ml with dH2O 
     Made fresh before use 
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2.1.8 Whole-mount in situ hybridisation (ISH) (zebrafish) 
Prior to ISH, embryos were fixed at the appropriate stage for 3-10 days in 4% PFA/ 
PBS. Embryos were then dechorionated, dehydrated in a graded methanol/PBST 
series and stored in methanol for a minimum of 12 hours at -20°C. Embryos were 
transferred to a 3 ml vial, rehydrated and washed in PBST (0.1% Tween20 in PBS). 
All washing and incubation steps were performed with light agitation. If embryos 
were older than bud stage they were treated with proteinase K (at 10 µg/ml) for 30 
s (for somite stage embryos) or 3 min (24 hour old embryos). After two 5 min 
washes in PBST, embryos were post-fixed in 4% PFA/PBS for 20 min and rinsed 
again twice in PBST. Hybridisation buffer was prewarmed to room temperature and 
600 µl added to vial and the embryos pre-hybridised for at least one hour at 67°C. 
After this the hybridisation buffer was replaced with 400 µl probe solution and 
embryos were incubated over night. The next day the probe solution was removed 
and stored for reuse at -20°C. The embryos were washed with wash buffers 1-4 for 
one hour each at 67°C followed by two 10 min washes in PBST at room 
temperature. Next the embryos were incubated in blocking solution (10% FBS in 
PBST) for one hour at room temperature. After removal of the blocking solution, the 
anti-DIG-AP antibody was diluted 1:2000 in blocking solution and 400 µl was added 
to vial. The embryos were incubated in the antibody over night at 4°C. The next 
morning the antibody solution was removed and the embryos washed in PBST at 
least four times for a minimum 15 min/each washing step. They were then 
equilibrated in staining buffer with two 10 min washes. Subsequently, the ISH 
staining was developed using SIGMA FAST™ BCIP/NBT (1 tablet in 10 ml of water). 
When the staining was sufficiently strong the staining solution was replaced initially 
by 50% methanol/PBS. Embryos were then stored in 100% methanol. For taking 
pictures, the embryos were rehydrated and then taken through a series of 
glycerol/PBS gradients to a final concentration of 80% glycerol/H2O.  
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Hybridisation buffer (50 ml final volume): 
25.0 ml formamide 
12.5 ml 20x SSC 
0.5 ml tRNA (stock: 10 mg/ml) 
50 µl heparin (stock: 10 mg/ml) 
460 µl 1M citric acid 
250 µl 20% Tween20 
11 ml using fine pointed forceps 
 
Probe solution: 
Hybridisation buffer was complemented with 5% dextran sulphate. 1 µl of RNA 
probe was added to 400 µl buffer.  
 
Wash buffers: 
1: 50% formamide, 2x SSC, 0.1% Tween20, H2O 
2: 25% formamide, 2x SSC, 0.1% Tween20, H2O 
3: 2x SSC, 0.1% Tween20, H2O 
4: 0.2x SSC, 0.1% Tween20, H2O 
 
Staining buffer 
5 ml  1 M Tris pH 9.5 
12.5 ml 1 M MgCl2 
1 ml  5 M NaCl 
250 µl 20% Tween20 
  to 50 ml with H2O 
 
2.1.9 Double-fluorescent in situ hybridisation (DFISH) 
Double-fluorescent in situ hybridisation was essentially performed as described 
above for ISH using a combination of dig- and DNP-labelled RNA probes. For 
double in situ the embryos were incubated in probe solution containing dig- and 
DNP labelled RNA probes at the same time. After standard ISH washes embryos 
were incubated in 2% H2O2/PBST to inhibit endogenous peroxidase activity. The 
embryos were then washed twice in PBST for 10 min and then blocked in 10% 
FBS/PBST for at least one hour at room temperature. To visualise the dig-labelled 
probes the embryos were incubated over night at 4°C with anti-DIG-HRP antibody 
(1:1000 in blocking solution) and the embryos were then washed in PBST at least 
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four times for a minimum 15 min. Fluorescein-tyramide was added at 1:100 to 
1:500 in PBST depending on the strength of the probe and the embryos incubated 
for 20 min at room temperature.  For the colour reaction H2O2 was added to a final 
concentration of 0.001% for 30 – 40 min. To kill the peroxidase activity of the HRP 
the embryos were incubated in 3% H2O2 for one hour. Antibody incubations and 
washes were performed as above. Anti-DNP-HRP was added 1:250, Cy3-tyramide 
was used at 1:100. After the second colour reaction embryos were washed 
extensively in PBST, usually at least five times for one hour or over night at 4°C. 
Embryos were then mounted in 0.8% low melting temperature agarose and imaged 
using a LSM 780 confocal microscope (Zeiss). 
 
Fluophore tyramide synthesis 
Solutions: 
- 10 mg/ml fluorescein-NHS ester (Pierce) or Cy3-NHS (Amersham) stock 
solution in dimethyl formamide (DMF) (Sigma) 
- DMF-TEA solution (1 ml DMF, 10 µl triethylamine (TEA)) 
- Tyramide solution (10 mg tyramide, 1 ml DMF-TEA) 
 
Reaction: 
4 ml of 10 mg/ml fluorescein-NHS/DMF and 1.37 ml tyramide solution were mixed 
and incubated in the dark for 2 hours at RT before adding 4.6 ml ethanol. Aliquotes 
were stored in the dark at 20°C. 
Cy3-tyramide synthesis was performed as above but reaction mix was 100 µl Cy3-
NHS in 33 µl tyramide solution. 1.2 ml ethanol were added after the room 
temperature incubation step. 
 
2.1.10 Immunofluorescence in embryos 
Embryos were rehydrated, washed in PBST (0.1% Tween20 in PBS) and blocked 
for >1 hour in blocking solution at RT. The embryos were then incubated in a 1:100 
dilution of antibody in blocking solution overnight at 4°C and washed the next day 
for 4 x 15 min in PBST. This was followed by a 1 hour incubation in a 1:500 dilution 
of Alexa Fluor 488-conjugated antibody and repeated washed. Finally, the nuclei 
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were stained using DAPI (Roche) and the embryos were mounted in 0.8% low 
melting agarose. Images were obtained using a LSM 780 confocal microscope 
(Zeiss). 
 
Blocking solution 
10% FBS 
1% DMSO 
0.1% Tween20 
in PBS 
2.1.11 Alcian blue staining 
For alcian blue staining the embryos were fixed in 4% PFA/PBS at the indicated 
stage for 5 days. They were initially dehydrated in first 50% EtOH/H2O and then in 
100% EtOH. They were then left at -20°C for 24 hours. The embryos were 
transferred into staining solution and incubate for 24 hours at room temperature 
with mild agitation. To neutralise, they were washed in saturated sodium borate 
solution for 9-12 hours. The embryos were then bleached in 3% hydrogen 
peroxide/ 1% potassium hydroxide for about 20 min. For preservation and imaging 
the embryos were transferred through a series of glycerol/water containing 1% 
potassium hydroxide and store in 100% glycerol. 
 
Staining solution for 100 ml final volume: 
70 ml 100% EtOH 
30 ml acetic acid 
20 mg Alcian blue 
 
2.1.12 Embryo extracts 
Embryos were stored at -80°C. Extract buffer was prepared fresh before every use. 
10 µl of buffer were used per whole embryo, which meant that the protein 
concentration between different samples was similar. The embryos were 
homogenised using a pestle. The suspensions were then centrifuged at 13,000 rpm 
for 10 minutes at 4ºC (Biofuge fresco Heraeus benchtop centrifuge).  In general 2 
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embryo’s worth of extract supplemented with 4x sample buffer were used per 
Western blot.   
 
Embryo extract buffer 
100 µl 1 M Tris pH 8.0 
20 µl 0.5 M EDTA pH 8.0 
250 µl 10 % (v/v) NP-40 
100 µl 1.25 M sodium β-glycerophosphate 
500 µl 1 M NaF 
5 µl 20 µM Calyculin A 
250 µl 200 mM Na-Pyrophosphate 
0.5 ml complete mini protease inhibitor (Roche, 1 tablet dissolved in 1        
ml H2O) 
Up to 5 ml with H2O 
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2.2 Molecular biology 
2.2.1 Bacterial transformation and culture 
For plasmid amplification the chemically-competent Escherichia coli strain TG1 was 
transformed, unless Dam methylation was a problem in which case JM101 
competent cells were used. The competent cells were prepared by Dr. Becky 
Randall in the lab. After slowly thawing 50 µl of chemically-competent E. coli strain 
on ice either 100 ng of plasmid DNA or a 10 µl ligation reaction were added to the 
cells. The reaction was incubated on ice for 15 min and afterwards heat-shocked 
for 1 min at 37°C. After placing the bacteria on ice for a further 2 min, 150 µl LB 
medium (prepared in house) were added. The bacteria were then shaken at 37°C 
for 30-60 min and plated on agar plates containing the suitable antibiotic (ampicillin 
50 µg/ml or Kanamycin 50 µg/ml as appropriate) to select for the transformed 
bacteria. Agar plates were incubated at 37°C overnight to allow for the growth of 
bacterial colonies.   
2.2.2 Plasmid preparation 
2.2.2.1 Maxipreparation 
E. coli containing the desired plasmid were grown in 200 ml LB medium with the 
appropriate antibiotic over night at 37°C with vigorous shaking. Plasmids were 
isolated from recombinant E. coli using the GenElute™ HP Plasmid Maxiprep Kit 
according to the manufacturer’s instructions. This kit is based on the method 
originally published by Binboim and Doly (Birnboim and Doly, 1979) and works with 
the lysis of bacteria under alkaline conditions in the presence of SDS. Under these 
conditions, both chromosomal DNA and plasmid DNA are denatured. However, 
upon neutralization, plasmid DNA is selectively renatured whereas chromosomal 
DNA remains insoluble. Soluble (plasmid) DNA is subsequently purified by anion 
exchange chromatography. The final purification of the DNA involves the 
precipitation with isopropanol. The precipitate is washed and air-dried before being 
dissolved in H2O (volume depended on the size of the pellet). 
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2.2.2.2 Minipreparation 
For plasmid isolation QIAprep® spin miniprep kits (Qiagen) were used. The 
procedure is based on alkaline lysis of bacterial cells followed by adsorption of 
DNA onto silica in the presence of high salt. A single bacterial colony was picked 
from a selective agar plate and inoculated in 3 ml LB medium with the appropriate 
antibiotic over night at 37°C with vigorous shaking.1.5 ml of this culture were taken 
to perform the miniprep according to the manufacturer’s instructions. The samples 
were eluted in 40 µl H2O. 
2.2.3 Nucleic acid concentration 
The concentration of the isolated DNA or RNA was determined using a NanoDrop™ 
1000 spectrometer (ThermoScientific). After calibration with the elution solution, 1 
µl sample was pipetted onto the measurement pedestal and the nucleic acid 
concentration measured. To calculate the concentration the machine takes optical 
density (OD) readings at the wavelengths of 230 nm (phenol), 260 nm (nucleic 
acids), 280 nm (proteins) and 320 nm (background). An OD260 reading of 1 is 
equivalent to 50 µg/ml for DNA and 40 µg/ml for RNA. The concentration is then 
calculated based on the equations:  
 
DNA:  (OD260 – OD320) x 50	  µg/ml	  
RNA:  (OD260 – OD320) x 40	  µg/ml 
 
2.2.4 Polymerase chain reaction (PCR) 
Standard PCR was performed using GoTaq® DNA Polymerase. As a template, 50 
ng DNA were used in case of plasmid DNA. For PCR reaction from cDNA, the 
cDNA reaction was performed as explained in 2.2.9 and 2 µl of a 1:20 cDNA 
dilution were used. 
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25 µl reaction mix: 
5 µl  5x buffer 
0.5 µl dNTP mic (20 mM) 
0.5 µl  forward primer (10 µM) 
0.5 µl reverse primer (10 µM) 
1 µl  MgCl2 (25 mM) 
0.12 µl GoTaq polymerase 
x µl  template 
up to 25 µl H2O 
 
In general, the PCR reaction was performed in a thermal cycler as follows:  
  95°C 2 minutes 
 
  95°C 30 seconds ⎫ 
  55°C 5 seconds ⎬ x 30 cycles 
  72°C 1 minute/kb ⎭ 
 
  72°C 5 minute 
 
  4°C ∞ 
 
 
The sample was then run on a 1-2% agarose gel (depending on the product size) 
as specified in 2.2.5. The size of the PCR product was confirmed by comparison to 
standard DNA markers (New England Biolabs; NEB) and the appropriate band 
excised. The DNA was extracted using QIAquick Gel Extraction kit (Qiagen) using 
the microcentrifuge protocol according to the manufacturer’s instructions and eluted 
in 30 µl of H2O. For sensitive protocols the DNA was further purified with the 
QIAquick PCR purification kit (Qiagen) and again eluted in 30 µl of H2O. 
 
2.2.5 Agarose gel electrophoresis 
Agarose (Invitrogen) gels of the appropriate percentage were prepared in 1 x TAE 
with 1 µl/50 ml ethidium bromide to visualise nucleic acids. The molten gel was 
poured into a sealed gel tray with the desired gel comb and allowed to set at room 
temperature. Gels were run in 1 x TAE with a Lambda DNA-BstEII digest or 1kb 
DNA ladder (NEB) at 80-120 volts for 15-45 minutes depending on the size of the 
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gel. To visualise and document the nucleic acids the gels were exposed to 
ultraviolet illumination with a Bio-Doc-It™ Imaging system (UVP, LLC). 
 
2.2.6 Restriction enzyme digest 
All restriction enzymes used were purchased NEB and used according to the 
manufacturer’s protocol. Typically, 1 unit enzyme per 1 µg DNA was used in a 
20/50 µl reaction mix. The reaction mix was then incubated at the relevant 
temperature for 2 hours – overnight. To check for efficient and complete digestion 
by the restriction enzyme 1 µl of digested sample was run alongside 1 µg of 
undigested plasmid DNA on a 1% agarose gel (2.2.5). The remainder of the 
sample was cleaned up using the QIAquick® PCR purification kits (Qiagen) 
according to the manufacturer’s protocol.  
2.2.7 Ligations 
A molecular ratio of usually 1:2 (vector:insert DNA) was ligated using 1 µl T4 DNA 
ligase (NEB) and 1x T4 DNA ligase buffer (NEB) in a total volume of a 10 µl 
reaction. A control sample lacking the T4 ligase was used as a control for vector re-
ligation. The samples were incubated for a minimum of 3 hours or overnight at RT 
and then transformed into TG1 bacteria (2.2.1). The transformed bacteria were 
then plated on LB-agar plates containing the appropriate antibiotic and incubated 
overnight at 37°C to allow colonies to grow. Colonies were then picked and the 
plasmid DNA isolated by minipreparation (2.2.2). To test correct insertion of the 
PCR product, the isolated plasmids were tested by restriction enzyme digest and 
positive samples were sequenced as described below to verify the DNA sequence. 
2.2.8 Sequencing 
For sequencing 200 ng of DNA template were mixed with 10 ng primer and 8 µl 
BigDye® Terminator v2.0/v3.1 (Applied Biosystems) in a final volume of 20 µl. The 
sequencing reaction was carried out using the following standard sequencing 
conditions: 
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  96 °C 10 seconds ⎫ 
  50 °C 5 seconds ⎬ x 30 cycles 
  60 °C 4 minutes ⎭ 
 
  60 °C 1 minute 
 
  10 °C ∞ 
 
 
To remove unincorporated dye-terminators from samples, the Dyex 2.0 Spin Kit 
(Qiagen) was used and purified DNA was subsequently dried using a vacuum 
centrifuge. Samples were then submitted to the Cancer Research UK Equipment 
Park for capillary sequencing. 
2.2.9 Total RNA isolation 
Embryos were homogenised in 800 µl TRIzol® (Invitrogen) and lysed for 10 min at 
RT. 160 µl of chloroform were added, the samples vortexed thoroughly and 
incubated for another 3 min at RT. Samples were then spun for 15 min at 4°C at 
13,000 rpm. The aqueous phase was moved into a new tube containing 10 µg of 
glycogen (Ambion) as well as 400 µl isopropanol and the mixture incubated for 10 
min at RT. To precipitate the nucleic acids, the samples were centrifuged for 20 
min at 4°C at 13,000 rpm. After the removal of the supernatant, the pellet was 
washed in 80% EtOH, dried and resuspended in 95 µl of RNase-free water, 1 µl 
RNasin (Promega), 2 µl DNase salts (5 µl CaCl2 1 M, 10 µl MgCl2 1 M, 10 µl DTT 
200 mM) and I µl DNaseI (Worthington). To efficiently eliminate genomic DNA 
contaminations, the samples were incubated for 30 min at 37°C. 300 µl of RNase-
free water was added and the RNA was extracted by addition of 400 µl 
phenol:chloroform:isoamyl alcohol (Sigma), vortexing and spinning for 10 min at 
13,000 rpm. The aqueous layer, containing the RNA, was transferred to a new 
microcentrifugation tube, mixed with equal amounts of 100% EtOH and precipitated 
on dry ice for 30 min. The RNA pellet was obtained by centrifugation at 13,000 rpm 
for 20 min and washed with 1 ml of 80% EtOH. The pellet was then dried and 
resuspended in 30 µl RNase-free water. The RNA was stored at -80°C. The quality 
of the RNA was assessed by agarose gel electrophoresis (2.2.5). 
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2.2.10 RNA sequencing 
The RNA sequencing was performed by the LRI Advanced Sequencing facility. A 
high quality of the submitted RNA was first confirmed using a Bioanalyzer RNA kit 
(Agilent Technologies). The libraries for sequencing were prepared with TruSeq 
Stranded mRNA Sample Prep Kit (Illumina) using 1 µg of total RNA as starting 
material. The data was subsequently analysed in collaboration with Richard Mitter 
(LRI Bioinformatics department). 
36bp single end reads generated on the Illumina GAII were assessed for quality (i.e. 
base quality scores, duplication rates, number of reads, adapter contamination) 
using FastQC v0.10.0.  Reads were aligned to the Danio rerio Zv9/danRer7 
genome using Tophat2 v2.0.8 with default parameters expect for the specification 
to align first to the Ensembl 68 transcriptome. (Only the reads that did not fully map 
to the transcriptome were then mapped on the genome. The reads that did map to 
the transcriptome were converted to genomic mappings (spliced as needed) and 
merged with the novel mappings and junctions in the final tophat output.).  
Differential expression analysis was conducted using the Bioconductor package 
edgeR.  A matrix of gene-level read counts was created by assessing the overlap 
between the co-ordinates of mapped reads and Ensembl 68 exon 
positions.  Sample library size was normalised using the default TMM method.  The 
estimates for the common, trended and tagwise dispersion were calculated using 
edgeR's default methods. (This is basically estimating acceptable levels of variation 
- see here for more details 
http://www.bioconductor.org/packages/release/bioc/vignettes/edgeR/inst/doc/edge
RUsersGuide.pdf) 
An empirical Bayes generalised linear model was used to assess differential 
expression between replicate groups at the gene level.  A false discovery rate 
(FDR) controlled pvalue of <=0.05 combined with an absolute fold change of >=2 
and minimum read count of 200 was set as the threshold for significance. 
Heatmaps of log counts per million (CPM) values were used to visualise the 
expression changes of selected genes across samples.  Genes were hierarchically 
clustered based on a Euclidean distance metric and Ward method. 
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2.2.11 Quantitative real time PCR (qRT-PC) 
For reverse transcription cDNA synthesis the AffinityScript RT-PCR kit (Agilent 
Technologies, Inc.) was used. The reaction mix was as follows:  
10X Buffer   2 µl 
DTT (100 mM)  2 µl 
dNTPs (25 mM each) 0.8 µl 
Primers   3 µl 
AffinityScript RT  1 µl 
RNase inhibitor   0.5 µl 
RNA (1 µg)   x µl 
 
Final volume  20 µl 
 
As a control to assess genomic DNA contaminations, a synthesis reaction without 
addition of the reverse transcriptase (-RT) was included for each sample. The 
cDNA reaction mix was then prepared in a thermal cycler using the following 
program: 
25ºC 5 minutes 
42ºC 20 minutes 
55ºC 15 minutes 
95ºC 5 minutes 
4ºC  ∞ 
 
The cDNA was diluted 1:20 in H2O. For the qRT-PCR reaction a mix was prepared 
and pipetted into 96 well optical plates (Applied Biosystems): 
2.5 µl diluted cDNA 
5 µl  Express SYBR green master mix (invitrogen) 
0.25 µl forward primer (10 µM stock) 
0.25 µl reverse primer (10 µM stock) 
2 µl  H2O 
 
For each sample, triplicates were measured. odc or ef1α were used for input 
normalisation. The qRT-PCR was performed using an ABI 7500 Fast Real time 
PCR machine. The PCR machine carries out 40 rounds of cDNA amplification by 
first denaturing all DNA at 95ºC, then reducing the temperature to 60ºC for 
amplification.  At the permissive temperature of 60ºC, as double stranded DNA is 
synthesised by DNA Polymerase, SYBR Green binds the double stranded DNA 
and the resulting SYBR Green-DNA complex is capable of emitting green light 
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(~522 nm wavelength) when excited by light with a wavelength of 497 nm. Thus, 
during each round of amplification, the amount of green light emitted should 
effectively double. The machine tracks the amount of fluorescence and plots it on a 
log-scale in order to identify the Ct value, which is set to 10-fold above a threshold 
value (the average baseline or background fluorescence) in the linear range of 
amplification (before any component becomes limiting and the signal plateaus). 
The higher the level of cDNA found in a sample, the fewer the rounds of 
amplification are required for the fluorescence to reach the Ct value. The machine 
then provides a list, indicating the cycle number when each sample has reached 
the Ct value. Samples with Ct values over 30 were not taken into account and the 
revelant mRNA was considered not to be expressed. The relative amount of cDNA 
present in a sample was calculated using the equation: 
 
[cDNA]relative = 2 Ct(control)- Ct(Gene of interest) 
 
The calculation was performed for each of the triplicates and then the mean and 
the standard deviation determined. The Ct values of the –RT control samples 
provides information about possible contamination by genomic DNA. Finally a 
melting curve for each primer pair was determined to ensure that the primers were 
specific and did not amplify multiple products. 
2.2.12 In vitro protein translation 
For in vitro translation, the TNT® Coupled Reticulocyte Lysate Systems (Promega) 
was used according to the manufacturer’s instructions.  
12.5 µl TNT 
1 µl Buffer 
0.5 µl Amino acids (+/- Met) 
0.5 µl RNA guard 
0.5 µl Polymerase (T3, T7 or SP6) 
9 µl H2O 
1 µl DNA template (1 µg/µl) 
 
The mix was incubated for 1.5 hours at 30ºC and aliquots stored at -80ºC. For 
analysis by SDS-PAGE (2.2.16) usually 1 or 3 µl of the reticulocyte lysate 
supplemented with 4x sample buffer was processed. The proteins could then be 
detected using Western blot analysis. 
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In order to generate 35S-labelled proteins 1 µl amino acids without Met replaced 
amino acids +Met. Then 1 µl 35S-Met was added on the expense of H2O. Proteins 
were also separated by SDS-PAGE and the gel dried. To detect the radioactive 
protein bands the gel was exposed to an X-ray film (SuperRX, Fujifilm) overnight 
inside a sealed cassette. 
2.2.13 Bandshift assay 
2.2.13.1  Probe synthesis 
For generating labelled DNA probes the following reaction mix was prepared: 
2 µl  5x GoTaq PCR buffer 
0.4 µl MgCl2 (25 mM) 
1 µl  fwd oligo (50 ng/µl) 
1 µl  rev oligo (50 ng/µl) 
0.5 µl DNA template (100 ng/µl) 
1 µl  dATP [α-32P] (3000Ci/mmol, 10mCi/ml) 
1 µl  dCTP [α-32P] (3000Ci/mmol, 10mCi/ml) 
0.5 µl dGTP (0.5 mM)  
0.5 µl dTTP (0.5 mM) 
0.5 µl dATP (50 µM) 
0.5 µl dCTP (50 µM) 
0.5 µl GoTaq polymerase 
0.6 µl H2O 
The PCR was carried out using the following standard conditions: 
 
  94 °C 3 minute 
 
  94 °C 25 seconds ⎫ 
  37 °C 25 seconds ⎬ x 31 cycles 
  72 °C 25 minutes ⎭ 
 
  72 °C 3 minute 
 
  10 °C ∞ 
 
After the probe synthesis, 1 µl of the reaction mix was kept for later quantitation. 
The remainder of the samples were run on a 5% (w/v) acrylamide gel, assembled 
with 0.4 mm spacers and comb. The gel was run at 150V and 150 mA in 0.5x TBE 
for 1 hour. The gel was then exposed to a film (SuperRX, Fujifilm) to identify the 
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position of the labelled bands on the gel. The probe bands were cut using a scalpel 
and transferred into a microcentrifugation tube. 350 µl elution buffer were added, 
the samples vortexed and the probes eluted overnight at 37°C. The next day 350 µl 
phenol were added and the samples well mixed prior to a 3 min centrifugation step 
at 13,000 rpm. The upper aqueous phase was transferred into a new tube and the 
DNA probes precipitated by adding 1 µg tRNA (Roche) and 700 µl cold 100% EtOH 
and incubating mix for 20 min on dry ice. Next, the samples were centrifuged for 20 
min at 13,000 rpm at 4°C, the EtOH removed and the pellet rinsed with 350 µl cold 
100% EtOH (centrifugation was repeated for an additional 5 min). After removal of 
the EtOH the pellets were allowed to dry on the bench. The pellet was the 
resuspended in 30 µl TE and quantitated. 
All probes used in bandshift reactions were dissolved to 0.2 ng/µl. In order 
to calculate the isotope incorporation and thereby quantitate the probes, 1 µl of the 
TE-resuspended probe was counted in the scintillation counter (Beckman LS 6500 
multi-purpose scintillation counter) along with 1 µl of the original pre-PCR probe 
mix. The probe was then quantitated as follows: 
From comparing the count numbers of the original PCR mix and the eluted probes 
the % incorporation of radioactivity in the probe were determined. Then the 
maximum possible yield of a probe in moles and ng was calculated by working out 
how much dATP and dCTP was in the reaction (hot + cold), as this was the limiting. 
This then allowed the prediction of how many labelled As and Cs were incorporated 
per probe, and taking the molecular weight of each probe into account it was 
possible to calculate the total ng of probe synthesised and to dilute the probes 
accordingly. 
 
          (% incorporation) x (no. moles dATP + dCTP in reaction) x mol wt probe   
109x                                                     (no. As and Cs in probe) 
 
5% (w/v) acrylamide gel (25 ml) 
3.125 ml 40% (w/v) acrylamide 
2.15 ml 2% (w/v) bisacrylamide 
1.25 ml 10 x TBE 
Up to 25 ml with deionised water 
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25 ml gel mix is polymerised with 60 µl 20% (w/v) APS and 50 µl 
Temed 
 
Elution buffer 
0.3 M Na acetate (pH 5.2) 
0.1 % (w/v) SDS 
1 mM EDTA 
 
2.2.13.2  Bandshifts using whole cell extracts 
In the absence of a suitable Dlx3b antibody, a Flag-tagged version of Dlx3b was 
transfected in HEK293T cells. Control cells were transfected with pcDNA3. The 
cells were harvested with D0.4 lysis buffer (2.3.4), centrifuged for 10 min at 13,000 
rpm and the protein concentration determined (2.2.15). 5 µg of control extract as 
well as 2.5 µg and 5 µg of Flag-Dlx3b extracts were diluted to a volume of 10 µl in 
D0.4. They were then pre-incubated with or without 1 µl anti-Flag antibody for 5 min 
at RT prior to addition of 10 µl probe mix. The samples were briefly centrifuged and 
incubated for 15 min at RT. 
 
Probe Mix (10 µl) 
1 µl 200 mM KCl 
1 µl 110 mM MgCl2 
1 µl probe (0.2 ng/µl) 
1 µl pdI-dC (1 mg/ml stock) (Sigma) 
4 µl 50 % (v/v) glycerol 
2 µl H2O 
 
To prepare the bandshift gel two glass plates (19 cm x 20 cm) were assembled 
using 1.5 mm spacers and sealed using tape. The non-denaturing gel mix was 
poured between the plates and a 1.5 mm comb inserted. The bandshift gels were 
pre-run at 150 V and 150 mA for 1-2 hours in 0.5 x TBE prior to loading. The wells 
were then rinsed with 0.5 TBE and the samples loaded onto the gel. The gels were 
run for 2 hours 45 min at 150 V and 150 mA and the transferred on Whatman 
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paper to be dried on a gel drier. The bandshift was visualised by overnight 
exposure to an X-ray film (SuperRX, Fujifilm) at room temperature.  
 
Non-denaturing acrylamide gel mix 
6.25 ml 40 % (w/v) acrylamide 
3.125 ml 2 % (w/v) bisacrylamide 
2.5 ml 10 x TBE 
2.5 ml 50 % (v/v) glycerol 
Up to 50 ml with deionised water 
 
50 ml gel mix is polymerised with 125 µl 20 % (w/v) APS and 100 µl 
Temed 
 
2.2.14 Mass Spectrometry analysis 
LRI Cell services grew up and harvested 30 large (T175) tissue culture flasks of 
HEK393T cells expressing Flag-SNW1 (2.3.3) or Flag (obtained from LRI Cell 
services) by itself. All steps were carried out at 4°C to avoid protein degradation. 
The cells pellet was resuspended in 28 ml benzonase lysis buffer supplemented 
with protease inhibitors (PI) and left on a nutator for 10 min prior to a 10 min 
centrifugation step at 300 g. An aliquot of the cytoplasmic extract (supernatant) was 
kept for expression analysis by Western blot. The pellet was resuspended in 5x the 
pellet volume with benzonase buffer + benzonase nuclease (25 µl/10 ml) 
(Novagen) + PI and left rotating for 20 min. The NaCl concentration was then 
adjusted to 450 mM and the samples rotated for another hour in the cold room. The 
extracts were centrifuged for 10 min at 3500 rpm using a Beckman Coulter Allegra 
X-15R centrifuge and an aliquot of the nuclear extract taken for expression analysis. 
For the following dialysis step the nuclear extracts were transferred into 6-8 kDa 
molecular weight cut-off dialysis tubing (Spectra/Por), which was tightly sealed to 
avoid leaking of the extracts into the buffer. The tubes were then placed into 1 litre 
of buffer D + PI and left under gentle stirring for 3-4 hours. The solution was then 
replaced with 2 litres of fresh buffer and the extracts further dialysed overnight.  
 The following day the extracts were divided into 2 ml centrifugation tubes 
and spun for 20 min at 13,000 in a microcentrifuge. A 100 µl aliquot was taken as 
an input control for Western blot. 600 µl slurry of M2 Flag agarose beads (Sigma) 
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were washed twice with cold PBS in 15 ml Falcons. The amount of slurry used was 
increased for large volumes of nuclear extracts. After the washes the nuclear 
extract was added to the beads and the samples incubated for 4 hours on a wheel 
at about 10 rpm. This was followed by a 10 min centrifugation step at 300 g. A 100 
µl aliquot was taken to assess the binding efficiency of Flag-Snw1 to the Flag 
beads using Western blot. The beads were then washed twice with 15 ml cold 
WB150 (+ TritonX) with 10 min on the wheel between washes. This wash was 
repeated with 15 ml cold WB100. The last wash, including the beads, was loaded 
on autoclaved Poly-Prep Biorad chromatography columns. Flag-Snw1 and the 
control Flag-tag including the associated proteins were released from the beads by 
the addition 3xFlag peptide (prepared by LRI peptide synthesis laboratory) in 5 
elution rounds. For each round 300 µl of 400 µg/ml 3xFlag peptide diluted in 
WB100 were added to the beads and incubated for 15 min. The tap on the columns 
was released and the eluate collected in a centrifugation tube. 5 µl of each fraction 
were analysed by Western blot to ensure that the samples were not degraded, and 
to assess which fraction should be pooled for mass spectrometry analysis (2.2.20). 
Generally, fractions 2, 3 and 4 were combined and concentrated using Ultracell 
centrifugal filter units (10K, Millipore). 4x sample buffer was added to the columns, 
the samples boiled and eluted by centrifugation, as specified in the manufacturer’s 
manual.  
 Next the samples were run on a 12.5% SDS-PAGE and Coomassie stained. 
For further analysis the lanes were cut into 1 mm thick stripes using a razor blade 
and each strip transferred into a 96-well plate (provided by the Mass Spectrometry 
facility) containing 100 µl H2O.  
 To avoid contamination all surfaces and tools were carefully cleaned and 
only fresh and filtered solutions were used. 
 
Benzonase lysis buffer 
25 mM Tris (pH 7.5) 
40 mM NaCl 
2 mM MgCl2 
0.5 % (v/v) NP-40 
 
25 mM NaF, 25 mM sodium β-glycerophosphate, 0.4 mM Pefabloc SC, 1 mM DTT, 
and 1 x Protease Inhibitors were freshly added (Roche). 
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Buffer D 
 
20mM HEPES pH 7.9 
0,1 M KCl 
0.2 mM EDTA pH 8 
0.2 mM EGTA pH 8 
20% Glycerol 
1 mM Benzamidine   
0.5 mM DTT   
0.4 mM Pefabloc   
 
 
WBX (X= 150 mM KCl or 100 mM KCl) 
 
20mM HEPES pH 7.9 
X M KCl 
0.5 mM EDTA 
10%  Glycerol 
+PI Roche tablets 
NO DTT or Pefabloc 
 
 
3xFlag peptide 
The Flag peptide was dissolved at 8mg/ml in 200 mM Tris HCl pH 7.9 and aliquots 
and store at -80°C. 
 
2.2.15 Measuring protein concentration 
The protein concentrations in lysates were determined using the Bradford method. 
A standard curve to calculate protein concentrations of the lysates was determined 
using 1 µg increments of 0 – 5 µg of BSA (NEB) in a flat bottom 96-well plate. 
Duplicates of 1 µl of each lysate sample was pipetted into subsequent wells of the 
96-well plate before pipetting 200 µl of 1x BioRad Protein Assay solution (Biorad) 
into all the wells to be read. The absorbance at 595 nm was measured on a 
SpectraMax Plus Spectrophotometer (Molecular Devices) and the protein 
concentrations of lysate samples were determined from the BSA standard curve. 
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2.2.16 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins were separated by size using SDS polyacrylamide gels. 
The gels were usually prepared in the lab using the following recipes: 
 
15 % resolving gel mix 
5.625 ml 40 % (w/v) acrylamide 
0.645 ml 2 % (w/v) bisacrylamide 
3.75 ml 1.5 M Tris-HCl pH 8.8 
Up to 15 ml with H2O 
Mix well 
40 µl of 20 % (w/v) APS and 30 µl TEMED were added before 
pouring 
 
Stacking gel mix 
0.625 ml 40 % (w/v) acrylamide 
0.333 ml 2 % (w/v) bisacrylamide 
0.625 ml 1.5 M Tris-HCl pH 6.8 
Up to 5 ml with H2O 
Mix well 
Add 15 µl of 20 % (w/v) APS and 10 µl TEMED before pouring 
 
After the gel polymerised it was inserted into an electrophoresis apparatus 
(Cambridge Electrophoresis Ltd.) and the reservoirs filled with 1x SDS running 
buffer. 
 
5x SDS Running buffer 
1.92 M Glycine  1440 g 
250 mM Tris  300 g 
0.5 % (w/v) SDS  250 ml 20 % (w/v) SDS  
    up to 10 litres with H2O 
 
The protein samples in 1x sample buffer were boiled for 5 min before loading. To 
determine the presence of specific proteins in cell lysates, usually 30 µg of total 
protein were loaded. Molecular weight markers were loaded on the same gel to 
estimate the protein size. The gel was then run at 230 V and 45 mA for around 1 
hour 40 min (depending on the size of the proteins to be detected). The gel was 
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then either Coomassie stained (2.2.17) or specific proteins detected by Western 
blotting (2.2.20) 
 
4x sample buffer 
4 ml 20 % (w/v) SDS 
2 ml 1 M Tris-HCl (pH 6.8) 
4 ml 100 % glycerol 
0.4 ml 2-mercaptoethanol 
 
Molecular weight markers 
50 µg/ml each of myosin (212 kDa), β-galactosidase (116 kDa), phosphorylase 
(97.5 kDa), BSA (66.5 kDa), catalase (57.8 kDa), glutamate dehydrogenase (55.5 
kDa), GAPDH, ovalbumin (42.7 kDa), carbonic anhydrase (28.9 kDa), SBTI (20 
kDa) and RNaseA (13 kDa) in 1 x SDS running buffer.  Prepared by Dr. Debipriya 
Das. 
 
2.2.17 Coomassie staining 
For Coomassie staining the gel was incubated in staining solution for around 15 
min and then destained in destaining solution for about 1 hour under gentle rocking. 
The destaining solution was refreshed several times until the blue background 
staining was sufficiently reduced to clearly visualise the specifically stained protein 
bands. 
 
Coomassie stain 
0.5 % (w/v) Coomassie blue R-250 (Merck) 
45 % (v/v) methanol 
10 % (v/v) acetic acid 
 
Destain 
25 % (v/v) methanol 
7 % (v/v) acetic acid 
 
The gel was than scanned and dried using a vacuum gel drier for preservation if 
required. 
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2.2.18 Direct antibody coupling to beads 
For endogenous SNW1 IP the rabbit anti-Nco62A antibody (Bethyl Laboratories) 
was crosslinked to Protein A beads to minimise nonspecific binding. Per 30 µl of 
Protein A sepharose bead slurry (Sigma), 5 µl antibody was used. First the Protein 
A slurry was transferred into a 15 ml tube and washed twice with 10 ml PBS. All 
centrifugation steps were performed at 4°C for 2 min at 230 g. The bead pellet was 
resuspended in 10 ml PBS, the antibody added and incubated for 1 hour at RT with 
gentle rocking. The beads were then washed twice in 0.2 M Sodium Borate (pH 
9.0) and resuspended in 10 ml 0.2 M Sodium Borate. Prior to 30 min incubation at 
RT, 0.05 g dimethylpimelimidate (DMPD) were added to a final concentration of 20 
mM. The beads were washed twice in 0.2 M Ethanolamine (pH 8.0) to quench the 
crosslinker and incubated for 2 hours in 0.2 M Ethanolamine in a third washing step 
with gentle mixing. This was followed by 2 wash steps in PBS. Beads were then 
resuspended in PBS supplemented with 0.02% sodium azide using 10x the volume 
of the initial slurry input. Beads are stored at 4°C. The crosslinking efficiency was 
tested by Western blotting. 
2.2.19 Immunoprecipitation (IP) 
Cells were washed with cold PBS and lysed in Co-IP lysis buffer. They were 
transferred into a 1.5 ml centrifugation tube and sonicated for 13 seconds on ice. 
The samples were then centrifuged at 13,000 rpm for 10 min at 4°C before the 
protein concentration of the supernatant was measured by Bradford assay (2.2.15). 
35 µg were retained as the input control and usually 300 µg of total proteins were 
used per IP and incubated with 5 µl of antibody for 2 hours on ice. If the antibody 
had not been crosslinked to beads, depending on the source of the antibody 30 µl 
protein G (mouse) or protein A (rabbit) beads, that were pre-equilibrated in Co-IP 
buffer, were added and incubated for 2 hours at 4°C with rotation. In case of Flag-
IPs (Flag M2 agarose beads, Sigma) or IPs using beads with crosslinked antibody 
the cell lysate supernatant was directly added to these beads, also equilibrated in 
Co-IP buffer, for incubation. After incubation with cell lysates the beads were 
washed a minimum of 3 times with Co-IP buffer, resuspended in 4x sample buffer 
and the experiment analysed by Western blot (2.2.20). 
 
Chapter 2 Materials and Methods 
 
 84 
Co-IP lysis buffer 
20 mM Tris, pH 7.5 
150 mM NaCl 
0.5% NP-40 
10% glycerol 
1 mM DTT  
25 mM NaF 
25 mM Na β-glycerophosphate  
complete mini protease inhibitors (Roche) 
 
 
2.2.20 Western blot analysis 
For Western blotting, proteins were transferred from an SDS gel onto PVDF 
membrane. For that purpose 3 mm Whatman Paper and Immobilon-P PVDF 
0.45 µm membrane (Millipore) was cut into pieces slightly larger than the gel. One 
piece of PVDF membrane was first activated in 100% MeOH and the soaked in 1x 
Transfer buffer. Two pieces of Whatman Paper were incubated in Transfer buffer 
as well. The transfer itself was performed using a SemiPhor Transfer Unit (Hoefer). 
First, two pieces Whatman Paper were placed in the transfer unit, the PVDF 
membrane and then the gel were added on top. Finally two more pieces of 
Whatman Paper were added. Throughout the whole process the inclusion of 
bubbles was avoided, as this disturb the transfer process. A roller was also used to 
remove any air bubble before closing the transfer apparatus. Proteins were 
transferred for 1 hour 30 min at 0.8 mA/cm2 of gel. 
After the transfer, the apparatus as dissembled and the blot soaked in 
Ponceau S solution (Sigma) until protein bands were visible. The blot was then 
quickly washed in consecutive rounds of water until the background staining was 
removed. The molecular weight marker sizes were labelled with a pen and the 
membrane cut in appropriate pieces for further analysis. The membranes were 
then blocked in the blocking solution containing 5 % (w/v) skimmed milk in PBS-
Tween or 5% BSA in PBS-Tween for about 30 min at room temperature. After 
blocking, the blot was left rocking in primary antibody diluted in blocking solution for 
1 hour at room temperature or overnight at 4ºC. The following day the blot was 
washed a minimum of 3 x 10 min with PBS-Tween before incubation in the 
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appropriate HRP-conjugated secondary antibody. The blot was then again washed 
in PBS-Tween as previously described. The HRP was detected using Luminata 
western HRP substrate (Millipore) and blots were exposed to an autoradiography 
film (SuperRX, Fujifilm) inside sealed cassettes. The film was developed using a 
JP-33 Automatic X-Ray Film Processor (Jpi). 
 
10x Transfer buffer 
1.5 M Glycine  1126 g 
200 mM Tris   242 g 
0.1 % (w/v) SDS  50 ml 20 % (w/v) SDS  
    Up to 10 litres with dH2O 
    Stored at room temperature. 
Dilute fresh to make a 1x solution 
containing 20 % methanol. 
PBS-Tween 
1 x PBS   1 litre 10 x PBS 
0.2 % (v/v) Tween-20 20 ml Tween-20 
    Up to 10 litres with H2O 
Stored at room temperature  
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2.3 Cell culture 
2.3.1 General culture conditions  
Human Embryonic Kidney 293T (HEK293T) cells were cultured in DMEM 
supplemented with 10 % FBS, 100 units/ml Penicillin, and 100 µg/ml Streptomycin 
on plastic dishes or flasks of tissue culture grade (Corning®, Falcon®, NUNC) at 
37ºC with 10 % CO2 in HeraCell incubators (Heraeus).  To isolate individual cells in 
suspension, cells were washed once with PBS before treating with a 
trypsin/versene solution for 2-3 minutes.  The trypsin was inactivated by adding 
four times the same volume of DMEM with all supplements. 
 
2.3.2 Plasmid transfections 
The following protocol describes transfection for 10 cm plates. If transfections were 
performed in a different format, the volume of reagents was accordingly scaled. 
Cells were seeded in a 10 cm plate to be 80% confluent at the time of the 
transfection. Usually a maximum of 6 µg of DNA were transfected per 10 cm dish. If 
the experiment required transfection with different plasmids in various ratios, the 
same amount of plasmid was transfected in all conditions and differences balanced 
by adding pcDNA3 as an empty vector. In a sterile centrifugation tube, 500 µl Opti-
MEM® I Reduced Serum Medium (Invitrogen) was combined with 125 µl FuGENE 
HD transfection reagent (Roche) and incubated at RT for 5-10 minutes. The DNA 
was added, everything well mixed and left at RT for another 15 min. The 
transfection mixture was then added dropwise to the cells on a 10 cm dish with 4 
ml DMEM/10% FBS. The next morning fresh medium was added to the cells. 1-2 
days after transfection, the plates were washed with cold PBS and harvested as 
outlined in section 2.3.4 
2.3.3 Cell line generation 
To generate stable cell lines that expressed Flag-SNW1, HEK293T cells were 
transfected as described above with pcDNA3 Flag-SNW1 and pSuperRetro (to 
convey puromycin resistance) in a 10:1 ratio. After 48 hours of transfection the cells 
were trypsinised and very sparsely seeded on 15 cm dishes to obtain single cell 
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colonies. The medium was supplemented with 0.8 µg/ml puromycin. This dose was 
previously determined by performing a concentration-killing curve experiment. 
When the single cell colonies reached a sufficient size, the cells were expanded 
and analysed for Flag-SNW1 expression by Western blot.  
 
2.3.4 D0.4 whole cell extracts 
Prior to harvesting, cells were washed with cold PBS and all liquid removed 
carefully. The cells were scraped with the appropriate amount of D0.4 buffer, 
collected in a microcentrifugation tube and sonicated for 30 s on ice. The extracts 
were then centrifuged in a cold centrifuge at 13,000 rpm for 10 min to remove cell 
debris. The protein concentration was measured as described in section 2.2.15. 
 
D0.4 Buffer 
20 mM HEPES, pH 7.5 
10% (v/v) glycerol 
0.4 M KCl 
0.4 % (v/v) Triton X-100 
10 mM EGTA 
5 mM EDTA 
Add fresh 25 mM NaF, 25 mM sodium β-glycerophosphate 1 mM 
DTT, 1 x Protease Inhibitors, 0.4 mM Pefabloc SC, 20 µg/ml 
Pepstatin. 
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2.4 Reagents 
2.4.1 Morpholinos 
Gene Morpholino sequence Position in gene Reference  
Human β-
globin  
CCTCTTACCTCAGTTA
CAATTTATA Negative control MO GeneTools LLC 
cvl2 MO1 
TTACTGGAGGAGACA
GACACAGCAT +1 to +25 
(Rentzsch et al., 
2006) 
cvl2 MO2 
CTA AAT TCG CTC 
CAG ACG CAC GGG -25 to -2 in the 5'UTR 
(Rentzsch et al., 
2006) 
cvl2 MO3 
CCAAAGTATCCCAAG
CCTGTAGAAA -72 to -48 in the 5'UTR 
(Moser et al., 
2007) 
dlx3b 
TTTCCAAGGCAGACC
GAAGCAAGTC -64 to -40 in the 5’UTR 
(Solomon and 
Fritz, 2002) 
dlx4b 
TCAGACATGAAACTC
ATAGACATCA  +2 to +26 
(Solomon and 
Fritz, 2002) 
bambi-b 
CACACACTTTTCCTCT
CAGATTCGC -36 to -11 
(Reichert et al., 
2013) 
p53 
GCGCCATTGCTTTGC
AAGAATTG -16 to +7 
(Robu et al., 
2007) 
gdf6a 
MO1 
GCAATACAAACCTTTT
CCCTTGTCC exon1/intron1 boundary 
(Sidi et al., 
2003) 
gdf6a 
MO2 
GAGATCGTCTGCAAG
ATAAAGAGAA intron1/exon2 boundary 
(French et al., 
2009) 
bmp6 
GCGCTCGTCATATTTA
CATCCAGTC -14 to +11 
(Reichert et al., 
2013) 
snw1 
ACAGCTTCTCTGCGT
CTTACCTTGT exon1/intron1 boundary (Wu et al., 2011) 
 
2.4.2 Plasmids 
2.4.2.1 For ISH probes 
Unless stated, all probes are against zebrafish transcripts. 
Construct Usage 
Constructed by/ 
obtained from Reference 
pExpress-1 
bambi-b 
linearise with EcoRV, 
transcribe with T7 RNA 
polymerase Source BioScience 
Image clone ID 
7038842 
pGEMT-zBMP2bp 
linearise with NotI, 
transcribe with T7 RNA 
polymerase M.C. Ramel 
(Wu et al., 
2011) 
pGEMT bmp6 
linearise with NcoI, 
transcribe with SP6 
RNA polymerase S. Reichert 
(Reichert et al., 
2013) 
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pCS2+-zBMP7 
linearise with EcoRI, 
transcribe with T7 RNA 
polymerase From A. Lekven 
(Schmid et al., 
2000) 
pCS2+ cvl2 
linearise with BamHI, 
transcribe with T7 RNA 
polymerase 
From M. 
Hammerschmidt 
(Rentzsch et 
al., 2006) 
dlx3b 
linearise with SalI, 
transcribe with T7 RNA 
polymerase From Westfield 
(Akimenko et 
al., 1994) 
pGEMT eya1 
linearise with NotI, 
transcribe with T7 RNA 
polymerase S. Reichert 
(Reichert et al., 
2013) 
pGEMT gdf6a 
 linearise with NcoI, 
transcribe with SP6 
RNA polymerase S. Reichert 
(Reichert et al., 
2013) 
pSK-EGFP 
linearise with BamHI, 
transcribe with T7 RNA 
polymerase  From A. Lekven   
hgg 
linearise with NcoI, 
transcribe with SP6 
RNA polymerase From A. Meng 
(Thisse et al., 
1994) 
pGEMT easy 
kctd15a 
linearise with KspI, 
transcribe with Sp6 RNA 
polymerase  From I. Dawid   
pGEMT kctd15b 
linearise with SalI, 
transcribe with T7 RNA 
polymerase  From I. Dawid   
pBluescriptKS-
krox20 
linearise with PstI, 
transcribe with T3 RNA 
polymerase From M. Mullins 
(Oxtoby and 
Jowett, 1993) 
pGEMT mRFP 
linearise with NotI, 
transcribe with T7 RNA 
polymerase M.C. Ramel 
(Wu et al., 
2011) 
myod 
linearise with XbaI, 
transcribe with T7 RNA 
polymerase From P. Ingham 
 (Weinberg et 
al., 1996) 
pCS2+-
zNCADHERIN 
linearise with XhoI, 
transcribe with Sp6 RNA 
polymerase  M.C. Ramel 
 (Wu et al., 
2011) 
pGEMT six4.1 
linearise with NotI, 
transcribe with T7 RNA 
polymerase S. Reichert 
(Reichert et al., 
2013) 
snai1b 
linearise with XbaI, 
transcribe with T7 RNA 
polymerase From P. Scotting 
 (Thisse et al., 
1995) 
sox10 
linearise with SalI, 
transcribe with T7 RNA 
polymerase From C. Linker 
 (Dutton et al., 
2001) 
pMX363-Xl Slug 
(in pSP72) 
linearise with BglI, 
transcribe with SP6 
RNA polymerase From M. Sarget 
(Mayor et al., 
1995) 
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pGEMT Xl sox9 
linearise with NotI, 
transcribe with T7 RNA 
polymerase From C. LaBonne 
(Spokony et 
al., 2002) 
 
2.4.2.2 For mRNA synthesis 
Construct Usage 
Constructed by/ 
obtained from Reference 
pCS2+ mCherry 
H2B 
linearise with NotI, 
transcribe with SP6 
RNA polymerase From S. Woolner 
(von Dassow et al, 
2009) 
pCS2+ GFP 
linearise with NotI, 
transcribe with SP6 
RNA polymerase From P. Blader 
Image clone ID 
5083691 
pCS2+GFP bmp6 
Mo binding side 
linearise with NotI, 
transcribe with SP6 
RNA polymerase R.A. Randall 
(Reichert et al., 
2013) 
pCMVSport6 
XlSKIP 
linearise with ClaI, 
transcribe with SP6 
RNA polymerase GeneService   
pCS2+ Xl noggin 
linearise with NotI, 
transcribe with SP6 
RNA polymerase From R. Harland 
 (Smith and 
Harland, 1992)  
pCS2+ Xl dkk1 
linearise with NotI, 
transcribe with SP6 
RNA polymerase From Heasman 
 (Krupnik et al., 
1999) 
pFTX4K EGFPC1 
SNW1 
linearise with XbaI, 
transcribe with T7 
RNA polymerase S. Reichert   
 
2.4.2.3 Other constructs and cloning strategy 
Construct 
Constructed 
by/obtained from Reference 
pCDNA3 Flag hSNW1 From F. Oswald   
pEF Flag hSNW1 S224A R.A. Randall   
pCDNA3 Invitrogen   
pCS2+ Flag dlx3b S. Reichert (Reichert et al., 2013) 
pGL3 basic Flag 
5'upstream bambi-b long S. Reichert (Reichert et al., 2013) 
pGL3 basic Flag 
5'upstream bambi-b long 
mut R.A. Randall (Reichert et al., 2013) 
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The 5’ upstream bambi-b region was initially cloned into pGL3 basic using the 
primers indicated in section 2.4.3.2 by introducing SacI and SmaI binding sites. The 
Dlx3b binding sites were then mutated by R.A. Randall.  
2.4.3 Primers 
2.4.3.1 qRT-PCR primers 
Target Primer sequence 
bambi-b (fwd) CCCAAAGCACGAACTCTCCT 
bambi-b (rev) GTGCAATCACATGACGGCTG 
bmp6 (fwd) GGCTTCGCATCATGACACTG 
bmp6 (rev) TGGGATCTGGGACAGGTTGA 
ef1a (fwd) TGCTGTGCGTGACATGAGGCAG 
ef1a (rev) CCGCAACCTTTGGAACGGTGT 
gdf6a (fwd) TCAATGCGAGCTTTTTCCGC 
gdf6a (rev) TCTTCGCAAAGGAGAGAGCG 
odc (fwd) ACACTATGACGGCTTGCACCG  
odc (rev) CCCACTGACTGCACGATCTGG 
gdf6a (fwd)      
to test Mo 
TCAATGCGAGCTTTTTCCGC 
gdf6a (rev)       
to test Mo 
TCTTCGCAAAGGAGAGAGCG 
bambi-b (fwd)      
to test Mo2 
GCGATGGCTCTTCTCCTCAC 
bambi-b (rev)       
to test Mo2 
TTCAGCTCCGACTTGCACAT 
bmp2b (fwd) 
ex1 
TGCGATCTCGCGCTGTCACTT 
bmp2b (rev) 
ex1 
CGTCGCAGCTCAAGTCGCCT 
bmp2b (fwd) 
ex1/2 
GCGACGACTCTCTGTCGTGGG 
bmp2b (rev) 
ex1/2 
AACAGCACCGTGAGAGCGCG 
bmp2b (fwd) 
ex1-int 
GACGACGGGAACGCAGACCG 
bmp2b (rev) 
ex1-int 
GGCACGCACACGCAGTGATG 
bmp2b (fwd) 
int-ex2 
GTTCACTGTGGGCCCTAAAAAGGT 
bmp2b (rev) 
int-ex2 
CGGACCACGGCGACCATGAT 
bmp2b (fwd) 
ex2-int 
GCCAGCAGAGCAAACACGATACG 
bmp2b (rev) 
ex2-int 
CCAAACGGTTGCATCACATCATTCC 
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bmp2b (fwd) 
int-ex3 
ATCCAGCGCAGGCCAGACCA 
bmp2b (rev) 
int-ex3 
TCAGGCTGGACAGTGCCTCGAA 
bmp2b (fwd) 
ex2/3 
AGGGCAGCCAGCAGAGCAAA 
bmp2b (rev) 
ex2/3 
GCGGAGATCAGCTCCTCGCC 
bmp2b (fwd) 
ex1 
AAAGCGGCAGGCTCGACGAG 
bmp2b (rev) 
ex1 
GGCGGTGCCACGATCCACTC 
dlx3b (fwd)    
ex1 
GATGGGGGCAACACCCGGAG 
dlx3b (rev)     
ex1 
TGTGGTGGCGTCTGCAGGTC 
dlx3b (fwd)    
ex3 
CCCCCAGCCACCCCTCAGTT 
dlx3b (rev)     
ex3 
ATACACGGCCCCCACGCTCT 
bmp2b (rev) 
int1 
TCACAACAGACTTGCGGTCGCT 
dlx3b (fwd)    
int1 
CGTGACATCTAGCCTACACCGAGC 
bmp2b (rev) 
int2 
ACTGCCACTTGGCATTGCGT 
dlx3b (fwd)    
int2 
GCGGGCAATGACATTTCAACACA 
foxi1 (fwd)     
ex2 
CGAGGACGCGCTTAAATTGG 
foxi1 (rev)      
ex2 
TGGAAGTCGGGGAGTTTTGG 
gadd45aa 
(fwd) 5' 
CGGTGACAGCCAGAGAAAGA 
gadd45aa 
(rev) 5' 
TGCATGTAAAATCCAGAACGGAC 
gadd45aa 
(fwd) 5' 
CTGAGAGTTCAGACCGGACG 
gadd45aa 
(rev) 5' 
CGTCCTCAGAAAGTCCCACA 
rbl2 (fwd)         
ex8 
AGAAGACATCGGCACACCAG 
rbl2 (rev)         
ex8 
CATCGAGTTCTGCAGTGGGT 
rbl2 (fwd)         
3' 
TGCTGACCGCGATACCATTT 
rbl2 (rev)         
3' 
GCTCCGTGAAGACTGCTCAA 
rbl2 (fwd)         
int9 
ATCTTTGCTCGGGCACTTCA 
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rbl2 (rev)         
int9 
GGGCCTTCACCTGAGACATT 
foxo3b (fwd)    
ex2 
GTGGCCAGTCAACAGCAAAC 
foxo3b (rev)  
ex2 
GTCTCTTGTCAGGGGTGCTC 
foxo3b (fwd)    
ex2 
GGCTTGGAATCTGTCACCCT 
foxo3b (rev)  
ex2 
ACGTCACAATCCAGACTGCC 
mdm2 (fwd)   
ex8 
TCGGACAGCTTTTCCCTGAC 
mdm2 (rev)   
ex8 
TTTGCATCCGAAGACTCGCT 
mdm2 (fwd)   
ex11 
GCTTTCCATCTCCTGCCACT 
mdm2 (rev)   
ex11 
GGGTCTCTTCCTGACTGCTG 
mat2al (fwd)     
ex9 
ACAGCCTGCTATGGACACTT 
mat2al (rev)     
ex9 
AGCACGTCTTCATCTTGAGGG 
phlda2 (fwd)    
ex1  
AGCTCAAGCTGCAGTCCATT 
phlda2 (rev)    
ex1  
TCTTCTCGTCCGAGCACCTA 
rasl11b (fwd)     
5' 
TTGCTTTTACGGCGTCTGTG 
rasl11b (rev)     
5' 
GCTCGGGTACTCCGCAATAG 
rasl11b (fwd)     
3' 
AGGAGCAGATCTCCAGAGCA 
rasl11b (rev)     
3' 
ATCAGAGGTCAGGTTTCGGG 
dem1 (fwd)     
ex6 
CCTACTGGACGGGACAGAGA 
dem1 (rev)     
ex6 
GAATGAGCCGCTTGTTGGTC 
p21 (fwd)      
ex1 
TCCCGAAAACACCAGAACGA 
p21 (fwd)      
ex1 
GTTGGTCTGTTTGCGCTTCA 
ccng1 (fwd)    
ex3 
TCAGGATCAGCCAGAATCGC 
ccng1 (rev)    
ex3 
AAGTGAAGAGCAGTCGGAGC 
sesn3 (fwd)    
ex1   
GACCAACACACCGTCTGTGA 
sesn3 (rev)    
ex1   
TCGTGTTTCGGCAGTGGTTA 
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sesn3 (fwd)       
3'   
AGAATTGTGGGTGAGCAGTCA 
sesn3 (rev)       
3' 
TCAGGCCAAGTCCAAGGAT 
sesn3 (fwd)      
int9   
GGTGCCCGTTATGCTTGTTT 
sesn3 (rev)       
int9 
CTGCTTGTGAAGCCCTGTTG 
rps6ka3a (fwd) 
ex17  
TGATGGCCGATCAGTGTACC 
rps6ka3a (rev) 
ex17 
AGCGCTTGCTTCTCTCTCAG 
rps6ka3a (fwd) 
3'  
GCAGCCACTTATTCAGCCCT 
rps6ka3a (rev) 
3' 
CAGCTTTTTGAGACCACGGC 
rps6ka3a (fwd) 
5' 
TCCGCGATTGAATTACGGGT 
rps6ka3a (rev) 
5' 
TTTAACTTACGGTCGCCCCG 
lnx1 (fwd)      
ex2 
AGTGATCAAGAAGAGGCGGG 
lnx1 (rev)      
ex2 
TGTGGCAGAGATCAGGAGGA 
lnx1 (fwd)      
ex2 
CACTAACCCCACACTAGGGG 
lnx1 (rev)      
ex2 
GCTCCCGAAGTGCAGTCTTT 
2.4.3.2 Primers for cloning 
Construct Primer sequence Comments 
GFP-Snw1 
(fwd) 
CCGGGTCGACGATGGCGCTAGCCAGT
TTTTTG 
insertion of SalI restriction 
site for cloning into pFTX4K 
EGFPC1 
GFP-Snw1 
(rev) 
CCGGACTAGTTCACTCCTTCCTGCGC
TTCTTCATATC 
insertion of SpeI restriction 
site for cloning into pFTX4K 
EGFPC1 
Flag-Dlx3b 
(fwd) 
CCGGGAATTCTTAATACACGGCCCCC
ACGCTCTGCGG N-terminal Flag-tag, pCS2+ 
Flag-Dlx3b 
(rev) 
CCGGGGATCCATGAAGGACTACAAGG
ACGACGATGACAAGGCCATGAGTGGA
CCGACATATGACAGGAAGATAC N-terminal Flag-tag, pCS2+ 
Flag-Bambi-
b (fwd) 
CCGGGGATCCATGCAGCGGAACAGCA
GTCTCG C-terminal Flag-tag, pCS2+ 
Flag-Bambi-
b (rev) 
CCGGGAATTCTCAGGCCTTGTCATCG
TCGTCCTTGTAGTCCTTCACAAACTCC
AGCTTTCCTCGGTTGCTGTAC C-terminal Flag-tag, pCS2+ 
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Bambi-b 5' 
(fwd) 
CCGGGAGCTCGCTTTTCTATACCGTG
ACTCA 
For cloning a 1800 bp 
fragment of the Bambi-b 5' 
upstream region containing 
two Dlx3b binding site 
Bambi-b 5' 
(rev) 
CCGGCCCGGGACACTTTTCCTCTCAG
ATTCGC 
For cloning a 1800 bp 
fragment of the Bambi-b 5' 
upstream region containing 
two Dlx3b binding site 
Bambi-b 
(fwd) 
TAATACGACTCACTATAGGG 
ISH probe, pGEMT 
Bambi-b 
(rev) 
GGATCCATTAACCCTCACTAAAGGGAA
GTTTCGCTCCGGAATTCCCGGG ISH probe, pGEMT 
Bmp6 (fwd) GTGGAGCTGTTGTTTGGCAG ISH probe, pGEMT 
Bmp6 (rev) ATGAGCCGGTCCCTTTGATG ISH probe, pGEMT 
Eya1 (fwd) GCCGAGTAAGTGGAAGCAGT ISH probe, pGEMT 
Eya1 (rev) CCCGACGCAATCGATCTGAA ISH probe, pGEMT 
Gdf6 (fwd) CGAGTTTCGTGGACAAGGGA ISH probe, pGEMT 
Gdf6 (rev) GAGTTTTGTGGGGACGCAAC ISH probe, pGEMT 
Six4.1 (fwd) GCCAAGAGGACTTGTCACCA ISH probe, pGEMT 
Six4.1 (rev) ACATCGGAGTTGGAGAGGGT ISH probe, pGEMT 
 
 
2.4.3.3 Primers for Bambi-b bandshift probes 
Construct Primer sequence Comments 
Bambi-b 
probe1  (fwd) 
 
 
GACGAAAATGTTACTAAAGGT 
Primer to generate  bandshift 
probe 1 
Bambi-b 
probe1 (rev) 
 
CGAAAATACTGTCCACGATGAC 
Primer to generate bandshift 
probe 1 
Bambi-b 
probe2 (fwd) 
 
CTTTTGCTTGGCCCACATGC 
Primer to generate  bandshift 
probe 2 
Bambi-b 
probe2 (fwd) 
 
AAGCCAGACTAGGTCCAATCA 
Primer to generate bandshift 
probe 2 
 
2.4.4 Antibodies 
2.4.4.1 Primary antibodies 
Antibody Company 
Catalogue 
number 
Actin Sigma A3853 
Cdcl5 abcam ab129114 
zBmp2 AnaSpec 55708 
Bmp2 abcam ab17885 
Dhx8 abcam ab70588 
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Flag Sigma F7425 
Flag-HRP Sigma A8592 
GFP Roche 11814460001 
HA-HRP Roche 12013819001 
Helic2 Santa Cruz sc-68563 
Mcm6 Santa Cruz sc-9843 
NcoA62 
(Snw1) Bethyl Laboratories A300-785A 
Prpf8 abcam ab157114 
Ski Santa Cruz sc-9140 
PSmad1/5 
Cell signaling 
Technology 9511L 
Smad5 GeneTex GTX124559 
Snw1 Santa Cruz sc-30139 
Tubulin Roche ab6160 
Xab2 abcam ab57515 
 
2.4.4.2 Secondary antibodies 
Antibody Company  
Catalogue 
number 
rabbit-HRP  DakoCytomation  P0448 
mouse-HRP  DakoCytomation  P0450 
goat-HRP  DakoCytomation  P0049 
DNP-HRP  PerkinElmer  FP1129 
Dig-HRP  JacksonImmunoResearch  200-032-156 
Dig-AP  Roche  12486523 
Alexa Fluo 488  invitrogen  A11008 
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Chapter 3. A BMP regulatory network controlling 
ectodermal cell fate decisions at the neural plate 
border 
3.1 Introduction 
Embryonic development requires the tight control of a combination of signalling 
pathways in order to convey the temporal and spatial information that is necessary 
for processes such as organ patterning and organ size control. An example of this 
is the patterning of the ectoderm in the early vertebrate embryo that gives rise to 
progenitor cells such as the NC and the PPE.  Extensive research has given insight 
into which signalling pathways and transcription factors are required for this 
process. However, the timing and localisation of the signalling output of pathways, 
such as BMP signalling, is not well understood. 
To study BMP signalling during development our lab generated a transgenic 
BRE-mRFP zebrafish line (Tg(BRE:mRFP)) that expresses monomeric red 
fluorescent protein (mRFP) under the control of a well-characterised BMP 
responsive element from the mouse Id1 enhancer (Ramel and Hill, 2013). Here I 
explore BMP signalling dynamics during ectodermal patterning in the developing 
zebrafish embryo and develop a new 2-step model outlining differential BMP 
activity requirements for different tissues during and after gastrulation. I also give 
mechanistic insight into the intricate spatio-temporal regulation of BMP activity 
during this process.  
3.2 Results 
3.2.1 Distinct domains of BMP activity at the NPB 
To investigate the dynamic temporal and spatial regulation of BMP signalling during 
ectodermal patterning that leads to the specification of distinct progenitor cells at 
the NPB I used the Tg(BRE:mRFP) transgenic zebrafish line (Ramel and Hill, 2013, 
Wu et al., 2011). At early developmental stages the fluorescence generated in 
response to BMP signalling is too weak to be detected, which is why I used ISH for 
the mRFP mRNA as a dynamic readout for pathway activity.  
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ISH performed at different developmental stages revealed a very dynamic 
nature of BMP activity during gastrula and neurula stages. During gastrulation 
(80% epiboly) I detected a clear ventral to dorsal gradient as has been previously 
reported (Ramel and Hill, 2013) (Figure 3.1.A).  
As morphogenetic movements shape the embryo, cells converge to the 
dorsal side and this gradient is lost. By the onset of somitogenesis the gradient  
 
 
 
Figure 3.1 Dynamic domains of BMP activity during ectodermal patterning 
(A) ISH for mRFP in Tg(BRE:mRFP) embryos. A clear ventral to dorsal gradient is 
detected at 80% epiboly (lateral view, ventral to the left). During somitogenesis stages 
an outer horseshoe-shaped domain of BMP activity is visible at the NPB and an inner 
domain that resembles the neural crest domain. Depicted is a dorsal view with anterior 
to the top. In the lower panel ISH for sox10 on embryos at the respective stages in the 
same orientation as above is shown. The black arrow indicates the outer domain 
whereas the red arrow marks the inner NC domain. 
(B) DFISH using probes against mRFP (Fast Blue, red) and sox10 (Fluorescein-TSA, 
green). The white arrow indicates the two distinct domains of BMP activity. Dorsal view 
with anterior to the top.  
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reshapes into a distinct horseshoe-shaped domain of BMP activity at the neural 
plate border, which then further evolves into a distinct inner and an outer domain. I 
noticed that the inner domain resembles the pattern of the NC population, which 
can be visualised using ISH against NC markers such as sox10 (Figure 3.1.A). To 
verify this, I performed DFISH using probes directed against mRFP and sox10, 
revealing that indeed the inner BMP activity domain coincides with the NC cell 
populations (Figure 3.1B). 
Prior to the generation of this zebrafish line immunofluorescence staining for 
nuclear PSmad1/5 was primarily used to detect localised BMP activity. To compare 
the sensitivity of ISH against mRFP and to substantiate my results, I performed 
immunostaining for PSmad1/5 on 80% epiboly and 5 somite stage embryos (Figure 
3.2). At 80% epiboly I could detect a ventral to dorsal BMP gradient as described 
above. At the 5-somite stage, nuclear PSmad1/5 was present at the neural plate 
border confirming the results using Tg(BRE:mRFP) embryos. The inner NC domain 
of BMP activity, however, could not be detected, suggesting that ISH against 
mRFP on Tg(BRE:mRFP) is a more sensitive readout for BMP pathway activity 
during zebrafish development. 
Next I wanted to investigate the precise requirements for BMP signalling 
during NC induction and specification. For that purpose I made use of a transgenic 
zebrafish line that expresses GFP-tagged dominant negative BMP type I receptor  
(dnBMPR1a) in response to heat-shock (Tg(hsp70l:dnXla.Bmpr1a-GFP)) (Pyati et 
al., 2006). This enabled me to perturb BMP activity at specific critical 
developmental stages around 1.5 hours after the initial heat-shock (Hashiguchi and 
Mullins, 2013). The robust inhibition of BMP activity was confirmed by loss of 
PSmad1/5 in embryos expressing GFP-dnBMPR1a (Figure 3.3.A).  
Early inhibition of BMP signalling initiated at 30% epiboly, when the BMP 
gradient is first established (Ramel and Hill, 2013), resulted in a loss of ventral 
tissues, an expansion of the neuroectoderm (shown by the hindbrain rhombomere 
3 and 5 marker krox20) as well as NC, demonstrating the requirement of the BMP 
signalling gradient for the initial ventral to dorsal patterning. 
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Figure 3.2 PSmad1/5 staining detects the strong outer domain of BMP signalling 
at the 5 somite stage 
Immunofluorescence staining using an antibody against PSmad1/5 at the two 
developmental stages indicated. Nuclei were visualised using DAPI Lateral view of 
80% epiboly stage embryos with ventral to the left. The embryo at 5 somites was 
mounted to centre the NPB. Anterior is to the top, dorsal to the left.  
 
 
In contrast, embryos that were heat-shocked at early gastrula stages (60% epiboly) 
displayed only a slight expansion of the krox20 expression domain, demonstrating 
that by 70-80% epiboly DV specification is mostly completed. Expression of sox10, 
however, was reduced indicating that BMP signalling is necessary during NC 
induction. Most importantly, inhibition of BMP signalling from early somitogenesis 
onwards also led to a decrease in sox10 expression, demonstrating a requirement 
for BMP activity in the maintenance of the NC cell population and the importance of 
the inner BMP signalling domain detected in Tg(BRE:mRFP) embryos.  
Interestingly, the induction of dnBMPR1a expression in 
Tg(hsp70l:dnXla.Bmpr1a-GFP) x Tg(BRE:mRFP) embryos at bud stage also 
resulted in a reduction of the mRFP staining at the three somite stage (Figure 3.4), 
arguing for a short half-life of the mRFP mRNA, and justifying mRFP ISH as a 
dynamic readout of BMP activity. This is also supported by the observation that 
during the establishment of the early BMP activity gradient mRFP transcripts are 
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cleared with 20 min of the gradient detection by PSmad1/5 immunostaining (Ramel 
and Hill, 2013). The staining for mRFP is not completely lost as crossing the two 
transgenic backgrounds leads to a reduced copy number of both transgenes. Thus 
BMP signalling is not as efficiently blocked compared with 
Tg(hsp70l:dnXla.Bmpr1a-GFP) incrosses.  
 
 
 
 
Figure 3.3 BMP activity is required for NC development at several embryonic 
stages 
(A) Western blot analysis of 5 somite stage Tg(hsp70l:dnXla.Bmpr1a-GFP) embryos  
heat-shocked at bud stage confirms the loss of PSmad1/5. 
(B) sox10 and krox20 ISH on Tg(hsp70l:dnXla.Bmpr1a-GFP) embryos heat-shocked at 
indicated stages. Brackets indicate the width of the neural ectoderm marked by krox20. 
Numbers indicate the embryos with the observed phenotype for a representative 
experiment. 
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Figure 3.4 mRFP has a short half-life 
ISH for mRFP on Tg(hsp70l:dnXla.Bmpr1a-GFP) x Tg(BRE:mRFP) embryos, heat-
shocked at indicated stages, demonstrates inhibition of BMP signalling. Black arrows 
indicate outer domains and red arrows indicate inner domains of BMP activity. Note the 
inhibition of BMP signalling as read out by mRFP expression shown here is not as 
strong as in Figure 3.3, as the embryos from the Tg(hsp70l:dnXla.Bmpr1a-GFP) x 
Tg(BRE:mRFP) cross have less copies of the dnBMPR1a compared with the incrosses 
used in Figure 3.3. Numbers indicate the embryos with the observed phenotype for a 
representative experiment. 
 
 
The BMP ligands bmp2b and bmp7a are expressed at the NPB and have 
been implicated in NC induction in several organisms (reviewed in (Stuhlmiller and 
Garcia-Castro, 2012a)). However, neither bmp2b nor bmp7a mRNA were detected 
in the inner domain of BMP activity during NC maintenance, suggesting the 
involvement of alternative ligands (Figure 3.5A).  
BMP6, BMP7, GDF5 and GDF6 can all induce differentiation of rat cortical 
neural stem cells into various NC lineages (Gajavelli et al., 2004). To examine a 
possible function for these ligands in vivo in NC development, I assessed their 
temporal and spatial expression patterns at different developmental stages. gdf5 is 
only expressed from 40 hpf onwards (Bruneau et al., 1997), and was therefore not 
further investigated. In contrast, bmp6 and gdf6a were both detected by qRT-PCR 
at the end of gastrulation (bud stage) (Figure 3.5E), when the horseshoe-shaped 
domain of BMP activity at the NPB is first formed. To confirm the presence of these 
ligands during somitogenesis, I cloned ~1000 bp cDNA fragments to generate RNA 
probes and performed ISH on embryos after gastrulation. bmp6 is expressed at the 
border with the epidermis after the end of gastrulation (Figure 3.5B), with an 
expression pattern similar to the outer domain of BMP activity. gdf6a, on the other 
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hand, is expressed in the NC and the anterior NPB at the 6 somite stage, as 
confirmed by DFISH using probes against sox10 and gdf6a (Figure 3.5C and D). 
Thus, bmp6 and gdf6a are likely candidates to be involved in the localised 
regulation of BMP signalling at the NPB after gastrulation. 
To test this hypothesis, I knocked down bmp6 and gdf6a using a morpholino 
(MO) approach. bmp6 morphants displayed no reduction in sox10 staining and 
mRFP expression was not inhibited, indicating that Bmp6 activity is not essential 
for formation of the outer horseshoe-shaped domain of BMP signalling (Figure 
3.6A). To test whether this is due to an inability of the bmp6 MO to block Bmp6 
expression, I tested the MO efficiency in vitro. For this purpose Becky Randall in 
the lab cloned the morpholino binding site from the bmp6 transcript in front of GFP. 
I then tested whether GFP expression could be blocked in a rabbit reticulocyte in 
vitro translation assay. Indeed, increasing amounts of the bmp6 MO were able to 
efficiently inhibit GFP expression (Figure 3.6B). Thus the lack of phenotype is likely 
not to be due to a lack of knockdown efficiency  
In contrast, injection of two distinct splice blocking gdf6a MOs (Sidi et al., 2003) 
(French et al., 2009) resulted in loss of BMP activity in the inner NC domain and 
drastically reduced the number of sox10 positive cells (Figure 3.6C). As both 
morpholinos prevent splicing of the gdf6a transcript, I could confirm the knockdown 
efficiency by qRT-PCR using intron spanning primers (Figure 3.6D). 
Taken together, these data provide direct evidence for the remodelling of the 
BMP gradient after gastrulation. Two distinct domains of BMP activity are formed at 
the NPB. The inner domain of BMP signalling, which corresponds to the NC, requires 
the BMP/GDF ligand, Gdf6a, which in turn is essential for NC development.  
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Figure 3.5 Ligands required for the BMP signalling domains at the NPB 
(A) ISH for bmp2b and bmp7a. The black arrow indicates the position of the neural 
crest at this developmental stage. 
(B) ISH for bmp6 at indicated developmental stages. 
(C) ISH for gdf6a at indicated developmental stages. 
(D) DFISH for sox10 (NC, green) and gdf6a (red) shows expression of gdf6a in the NC 
cell population. 
(E) qRT-PCR time course assessing the expression profiles of bmp6 and gdf6a during 
early zebrafish development at the indicated stages. mRNA levels were normalised to 
ODC expression. 
 
Embryos are dorsal anterior view with anterior to the top.  
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Figure 3.6 gdf6 but not bmp6 is essential for BMP activity at the NPB 
(A) Wild type or Tg(BRE:mRFP) embryos were injected with 10 ng of bmp6 MO and 
stained for sox10 or mRFP. Red arrows indicate the inner domain of BMP signalling as 
visualised by mRFP. 
(B) Rabbit reticulocyte in vitro translation assay to test bmp6 MO efficiency. The 
amounts (ng) of MO indicated have been adjusted to correspond to the amounts 
generally injected into embryos scaling the input proportional to reaction volume. 
(C) Wild type or Tg(BRE:mRFP) embryos were injected with 10 ng of the indicated MO 
and stained for sox10 or mRFP. Red arrows indicate the inner domain of BMP 
signalling 
(D) qRT-PCR to confirm MO efficiency using intron spanning primers. gdf6a mRNA 
levels were normalised to ef1α mRNA expression levels. 
 
Numbers indicate the embryos with the observed phenotype for a representative 
experiment. 
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3.2.2 cvl2 expression coincides with BMP activity domains 
As mentioned above, both Bmp2b and Bmp7a are required for normal NC induction 
(reviewed in (Stuhlmiller and Garcia-Castro, 2012a)) at the NPB and null mutants 
of both ligands, swirl (bmp2b) and snailhouse (bmp7a), display defects in the 
ectodermal patterning and hence specification of the NC domain (Nguyen et al., 
1998, Schmid et al., 2000). ISH analysis of bmp2b and bmp7a mRNA indicates 
their presence at the NPB. However, both ligands are expressed in the entire non-
neural ectoderm, whereas BMP activity is tightly restricted to the NPB, where the 
NC is located (Figure 3.5A, Figure 3.7A). This suggests that a mechanism exists to 
“concentrate” the activity of these ligands at the NPB by the onset of somitogenesis. 
To determine spatial regulators that might promote localised BMP signalling, 
I reviewed the expression of known BMP modulators, and identified the secreted 
BMP binding factor Crossveinless2 (Cvl2) as a possible candidate. Cvl2 is a known 
positive regulator of BMP signalling during zebrafish gastrulation (Rentzsch et al., 
2006, Conley et al., 2000). Functionally, Cvl2 is thought to enhance BMP activity 
predominantly by increasing the availability of BMP proteins for receptor activation 
(Rentzsch et al., 2006, Serpe et al., 2008).  
The expression pattern of cvl2 overlaps with domains of BMP activity in a 
ventral to dorsal gradient during epiboly stages (Figure 3.7B) (Rentzsch et al., 
2006). Similarly, ISH revealed that cvl2 mRNA is detected in an outer horseshoe-
shaped domain and an inner NC-like domain during somitogenesis (Figure 3.7A 
and B), very reminiscent of the pattern of BMP activity described above. I 
confirmed that cvl2 was expressed in the horseshoe-shaped BMP signalling 
domain by performing DFISH using probes against mRFP and cvl2 (Figure 3.7C). 
In addition, DFISH showed that the inner cvl2 expression territory is localised to the 
NC (Figure 3.7D).  
These findings demonstrate that cvl2 expression overlaps with domains of 
BMP activity during ectodermal patterning. Given the described function of Cvl2, 
this suggests that Cvl2 may stabilise domains of BMP signalling by concentrating 
ligands at the receptors at early somitogenesis stages. As a result, despite the 
broad expression of bmp2b and bmp7a, BMP signalling would only be active in a 
discrete domain at the NPB.  
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Figure 3.7 cvl2 co-localises with domains of active BMP signalling and NC 
(A) ISH for bmp2b, mRFP and cvl2. Upper panels: dorsal anterior view; lower panels: 
the same embryo turned 45° to the left. Black arrows mark the sharp expression 
domain of mRFP and cvl2 at the NPB. 
(B) Time course of cvl2 expression. Arrows indicate the two domains of cvl2 
expression. 
(C) DFISH reveals co-localisation of mRFP (red) and cvl2 (green) at the NPB, dorsal 
anterior view.  
(D) DFISH for sox10 (red) and cvl2 (green). Strong green staining reveals the outer 
domain of cvl2 expression (white arrow). Weaker green staining is visible in the NC 
(sox10) (red arrow). 
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3.2.3 cvl2 is required for localised BMP activity and NC development 
The presence of cvl2 in the NC suggested a role for Cvl2 in BMP-dependent NC 
development. I therefore carried out loss-of-function experiments using a 
translation-blocking MO against cvl2 (Rentzsch et al., 2006). At both doses of the 
MO used, I observed a dramatic loss of mRFP expression in Tg(BRE:mRFP) 
embryos, as well as reduced levels of PSmad1/5 and loss of NC markers sox10 
and snai1b (Figure 3.8A, B and C). Importantly, these effects were not due to an  
 
 
 
Figure 3.8 cvl2 is required for NC induction 
(A) ISH on Tg(BRE:mRFP) embryos injected with either 4 ng or 8 ng of cvl2 MO1. 
Dorsal anterior views, with anterior to the top.  
(B) Western blot analysis showing dose-dependent reduction of PSmad1/5 levels in 
the 80% epiboly cvl2 morphants. Smad5 is used as the loading control. 
(C) ISH analysis of control embryos and cvl2 morphants using probes against the 
neural crest marker snai1b and the myogenic marker myod.  
Dorsal anterior views, anterior to the top. 
 
Numbers indicate the embryos with the observed phenotype for a representative 
experiment. 
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early defect in DV patterning (Rentzsch et al., 2006), as the krox20 expression 
domain was not substantially ventrally expanded at the 4 ng dose of MO (Figure 
3.8A). Interestingly, expression of the bmp2b ligand was unaffected by Cvl2 
knockdown, supporting a role for Cvl2 at the level of Bmp2b protein (Figure 3.8A). 
To ensure that the observed loss of NC markers was not a result of a 
developmental delay, I performed ISH for myod on 5 somite stage embryos 
injected with either control or cvl2 MO. myod is a marker for satellite cells during 
muscle development (Koishi et al., 1995) and can therefore be used to visualise 
and compare the number of somites in control and morphant embryos. The 
analysis shows that the embryos were assayed at the same somite stage ruling out 
that the phenotypes observed are due to a developmental delay of the morphants 
Figure 3.8C). 
To substantiate my data and to exclude that the observed phenotype is due 
to off target effects of the morpholino initially used, which potentially could result in 
 
 
Figure 3.9 cvl2 regulates NC development 
ISH on Tg(BRE:mRFP) embryos injected with 4 ng control or 4 ng of the indicated cvl2 
MO using probes again the NC markers sox10 and snai1b or mRFP. 
 
Numbers indicate embryos with the observed phenotype for a representative 
experiment.  
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a loss of the NC cell population, I decided to corroborate the data using two 
additional, independent MO against cvl2 (cvl2 MO2 and MO3). Injection of 4 ng of 
either MO phenocopied the effects of cvl2 MO on the expression of NC cell 
markers as well as BMP activity (Figure 3.9). Similarly, I assayed cvl2 morphants at 
later times for NC derivatives. Alcian blue staining on 5-day-old embryos revealed 
the malformation of craniofacial cartilage confirming inhibition of NC development 
(Figure 3.10A and B). In order to prevent apoptotic effects a p53 MO was 
coinjected. However, there seemed to be extensive cell death occurring in the cvl2 
MO1 injected embryos indicated by the much smaller head and eye size (Figure 
3.10A). This might contribute to the radical loss of craniofacial cartilage in these 
cvl2 morphants. The pigmentation of the embryos was not substantially perturbed 
(data not shown). 
In various systems cvl2 is regulated in a positive feedback loop and its expression 
depends on BMP signalling (Ramel and Hill, 2012). To test whether that holds true 
in our experimental setup I inhibited BMP signalling using the 
Tg(hsp70l:dnXla.Bmpr1a-GFP) transgenic line and confirmed that indeed cvl2 
mRNA levels were dramatically reduced in treated embryos (Figure 3.9A).  
 
 
Figure 3.10 cvl2 is required for NC development 
(A) Alcian blue cartilage staining of 5-day old zebrafish larvae, injected with 2 ng p53 
morpholino (Robu et al., 2007) and either 4 ng control or 4 ng cvl2 MO.  
(B) Alcian blue cartilage staining as described above using cvl2 MO2 and MO3. 
Numbers indicate embryos with the observed phenotype for a representative 
experiment.  
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Thus, the data demonstrates a requirement for Cvl2 in NC formation, presumably 
by focusing BMP signalling activity into distinct domains at the NPB. In this process 
Cvl2 and BMP signalling are likely to act in a positive feedback loop thereby 
stabilising distinct BMP activity domains. 
 
Figure 3.11 BMP signalling regulates cvl2 
expression 
ISH of Tg(hsp70l:dnXla.Bmpr1a- GFP) 
embryos heat-shocked at bud stage  using 
probes against sox10 and cvl2. 
Numbers indicate embryos with the observed 
phenotype for a representative experiment.  
 
 
 
 
 
 
3.2.4 Temporal and spatial analysis of the formation of distinct BMP 
signalling domains 
Ectodermal patterning requires discrete levels of BMP signalling for the induction of 
cell fates such as the PPE and NC at the NPB. NC development depends on BMP 
activity during induction and specification (Figure 3.3B) whereas specification of the 
PPE requires complete inhibition of BMP activity after gastrulation (Kwon et al., 
2010). This inhibition of BMP signalling has previously been postulated to be 
mediated by an antagonistic role of Cvl2 on BMP signalling (Esterberg and Fritz, 
2009). That study suggested that the functionally-redundant Distalless transcription 
factors Dlx3b/4b, which are considered to be PPE markers, activate the expression 
of cvl2 in the PPE. In contrast, our data points to Cvl2 being a positive regulator of 
BMP activity during ectodermal patterning (Figure 3.8A and B, Figure 3.9B). In 
addition, I hypothesise that dlx3b and cvl2 are not expressed in the same domains 
at the NPB. The reasoning comes from the observation that cvl2 is localised to the 
territories of BMP activity (Figure 3.7); the inner coinciding with the NC, and the 
outer at the border with the epidermis. In between is a region devoid of BMP 
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signalling, which is likely to be the dlx3b-expressing PPE. This would suggest that 
the PPE is specified in the gap between the two domains of BMP activity/cvl2 
expression. 
To determine the exact spatial and temporal expression pattern of NC and 
PPE markers during ectodermal patterning I performed DFISH with a number of 
probe combinations at different somitogenesis stages. I visualised the neural plate 
by staining for n-cadherin (n-cad), and used dlx3b as a PPE marker. The analysis 
showed that the NC, marked by sox10 expression, is specified adjacent to the 
neural plate and is ventrally bordered by the PPE (Figure 3.12A). The inner domain 
of cvl2 expression could not be visualised by DFISH during early somitogenesis, as 
the expression in the NC is still weak (Figure 3.7B). However, at a later somite 
stage, cvl2 expression was visible in the NC, and dlx3b was clearly expressed in 
the region between the two cvl2 expression domains (Figure 3.12B).  
Judging from their expression patterns, cvl2 and dlx3b are likely to be co-
expressed during epiboly stages (Figure 3.7B) (Akimenko et al., 1994). To clarify 
this and to analyse the establishment of distinct cell populations after gastrulation, I 
monitored dlx3b/cvl2 expression at four stages from the end of gastrulation to the 
formation of the first somite (Figure 3.13). At 95% epiboly it is not entirely clear 
whether cvl2 and dlx3b are co-expressed or expressed in intermingled cells, but it 
is apparent that both are present in the same domain (Figure 3.13). At later times 
however, as dlx3b expression sharpens to the NPB, the cvl2 and dlx3b expression 
domains become increasingly separated, until two clearly distinct domains are 
visible at the one-somite stage (Figure 3.13).  
Analysis of Tg(BRE:mRFP) embryos using mRFP DFISH in combination 
with dlx3b showed that formation of the outer mRFP expression domain follows a 
similar pattern to that of the outer cvl2 expression domain (Figure 3.14A). A dorsal 
anterior view of one-somite stage embryos revealed that compared with cvl2 and 
dlx3b, the mRFP horseshoe-shaped domain at the NPB was transiently slightly 
broader, with the outer edge co-localising with cvl2 expression, and the inner edge 
overlapping with dlx3b (Figure 3.14B). At later stages, however, mRFP co-localised 
exclusively with cvl2 (Figure 3.7C). 
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Figure 3.12 dlx3b, cvl2 and mRFP are expressed in distinct domains at the NPB 
(A) DFISH to visualise expression pattern of sox10 (red, NC), dlx3b (green, PPE) and 
n-cad (green, NP) in early (left panel) and later (right panel) somitogenesis. 
(B) Expression pattern analysis of cvl2 (green), dlx3b (red, PPE) and n-cad (red, NP) 
at same stages as A. White arrows indicate the two cvl2 expression domains. 
All views show dorsal anterior view with anterior to the top, or to the top right. 
 
 
Figure 3.13 cvl2 and dlx3b expression increasingly separates into distinct 
domains at the end of gastrulation 
DFISH of cvl2 and dlx3b. Lateral views, with dorsal (NP) to the right. Developmental 
stages as indicated. 
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Figure 3.14 Formation of domains of dlx3b, mRFP and cvl2 expression at the 
NPB 
(A) DFISH for dlx3b/mRFP and cvl2/mRFP at different developmental stages. Dorsal 
anterior view, with anterior to the top. Developmental stages are indicated at the top. 
(B) dlx3b/mRFP and cvl2/mRFP DFISH at the one-somite stage. White brackets 
indicate width of the respective mRNA expression domains. Dorsal view; anterior to the 
top.  
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Taken together, these data show that although cvl2, dlx3b and mRFP are 
initially expressed in the same territories during gastrulation, distinct expression 
domains form by the onset of neurulation. The PPE separates the two domains of 
BMP activity, confirming an absence of BMP signalling in the PPE at somitogenesis 
stages.  
 
3.2.5 dlx3b/4b are required for BMP activity in the NC 
The expression of dlx3b between the two domains of BMP activity/cvl2 expression 
and the known requirement for Dlx3 in NC induction in X. laevis (Pieper et al., 
2012) prompted me to investigate the role of Dlx3b in regulating BMP activity at the 
NPB. Knockdown of dlx3b in conjunction with the functionally-redundant dlx4b 
(Solomon and Fritz, 2002) resulted in reduced sox10 expression (Figure 3.15A). 
This phenotype cannot be attributed to a developmental delay as shown by ISH for 
myod (Figure 3.15B). Contrary to previous reports I did not observe a general 
reduction of cvl2 mRNA levels (Esterberg and Fritz, 2009), but a specific loss of the 
inner cvl2 expression domain (Figure 3.15A). I went on to investigate whether this 
holds true on the level of BMP activity as well. Indeed, I could no longer detect the 
NC domain of BMP activity in dlx3b/4b morphants of Tg(BRE:mRFP) embryos 
(Figure 3.15A).  
To exclude the possibility that this effect is due to an expansion of neural 
tissue and hence a loss of the tissue competent for NC specification, I performed 
DFISH of cvl2 and n-cad on dlx3b/4b morphants embryos. This analysis confirmed 
the absence of the inner cvl2 expression domain and revealed that the NP (n-cad) 
is not expanded upon dlx3b/4b depletion (Figure 3.15B). Moreover, ISH for other 
PPE markers (eya1, six4.1) showed that they were still present in dlx3b/4b 
morphants (Figure 3.16A), suggesting a direct effect of dlx3b/4b knockdown on 
BMP activity, rather than a loss of PPE per se. Our results therefore show that 
dlx3b/4b in the PPE are essential for formation of the neighbouring inner BMP 
signalling domain and hence the NC.  
Previous data has suggested that expression of dlx3b depends on BMP 
signalling during early stages, as bmp2b mutant embryos lack dlx3b mRNA 
expression (Nguyen et al., 1998). 
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Figure 3.15 dlx3b/4b are required for NC induction and formation of the NC BMP 
signalling domain 
(A) sox10 and cvl2 ISH on wild-type embryos (left panels) and sox10 and mRFP ISH 
on Tg(BRE:mRFP) embryos (right panels). Embryos were injected with 14 ng control 
MO or 7 ng each of MOs against dlx3b and dlx4b. Red arrows, inner expression 
domain of cvl2 and mRFP. 
(B) myod ISH of dlx3b/4b morphants.  
(C) Analysis of expression domains at the NPB in dlx3b/4b morphants compared to 
control MO-injected embryos using DFISH against n-cad and cvl2. White arrows, inner 
cvl2 expression domain. Dorsal anterior view, anterior to top left. 
Numbers indicate embryos with the observed phenotype for a representative 
experiment.  
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The observation that dlx3b/4b morphants lacked NC therefore prompted me to re-
analyse the cvl2 morphants to exclude the possibility that the NC phenotype we 
observed in these embryos was due to inhibition of early BMP activity and a 
concomitant loss of dlx3b expression. However, I could show that levels of dlx3b 
were not diminished in the cvl2 morphants, demonstrating a direct effect of Cvl2 on 
NC (Figure 3.16B).  
Taken together these data suggest that the requirement of dlx3b/4b for NC 
development depends on the ability of dlx3b/4b to regulate localised BMP activity. 
 
 
 
Figure 3.16 PPE markers are still present in dlx3b/4b morphants and dlx3b 
expression does not depend on BMP activity 
(A) ISH on embryos injected with dlx3b/4b or control MOs using probes directed 
against PPE markers eya1 and six4.1. Dorsal anterior view, anterior to the top. 
(B) sox10, mRFP and dlx3b ISH on embryos injected with 4 ng cvl2 or control MO. 
Numbers indicate embryos with the observed phenotype for a representative 
experiment.  
 
3.2.6 Dlx3b regulates expression of the BMP inhibitor bambi-b in the PPE 
cvl2 and dlx3b are expressed in similar domains during gastrulation, but then 
become mutually exclusive at the onset of somitogenesis with dlx3b situated 
between the outer and inner domains of cvl2 expression/BMP activity. This 
observation suggests an active inhibition of BMP signalling in the PPE, as the 
process of domain formation is rapid and spatially, tightly regulated. Such an 
inhibition could be achieved by the localised expression of BMP antagonists in the 
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PPE. As Dlx3b is a transcription factor, its loss-of-function phenotype might be at 
least partially be explained by the loss of a localised BMP inhibitor that is under the 
transcriptional control of dlx3b at the onset of neurulation.  
Analysis of the expression patterns of potential BMP inhibitors led me to 
identify bambi-b (BMP and activin membrane-bound inhibitor) as being expressed 
at the right time and place to locally attenuate BMP signalling at the onset of 
neurulation. This putative membrane-spanning protein is highly similar to the X. 
laevis BAMBI, which has been shown to function as a pseudoreceptor, inhibiting 
BMP activity in a cell autonomous manner (Onichtchouk et al., 1999). BAMBI 
resembles a TGF-β-family type I receptor but lacks an intracellular kinase domain. 
Functionally, it inhibits the formation of active signalling complexes by sequestering 
TGF-β-family type II receptors (Onichtchouk et al., 1999). qRT-PCR analysis 
revealed the onset of bambi-b expression at the end of gastrulation (Figure 3.17A). 
At bud stage bambi-b is weakly expressed in the non-neural ectoderm. From the 
onset of somitogenesis a new stripe of bambi-b mRNA 
 
 
 
Figure 3.17 Temporal bambi-b expression analysis 
(A) qRT-PCR for bambi-b at indicated stages. 
(B) ISH for bambi-b. Orientation of the embryos is indicated by arrows on cartoon 
embryos. Anterior view with anterior to the top. The bottom row of embryos shows a 
different orientation of the same embryos shown in the top row.  Black arrowheads 
indicate stripe of bambi-b expression at the NPB. 
ss – somite stage 
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expression was detected in a similar territory to dlx3b expression, and this 
expression domain was still present at the four-somite stage (Figure 3.17B). As 
mentioned above, zebrafish Bambi-b is highly similar to human and X. laevis 
BAMBI, but had not been previously been shown to act in the BMP pathway. To 
test whether Bambi-b can indeed inhibit BMP signalling I cloned a FLAG-tagged 
Bambi-b for overexpression in tissue culture cells. Becky Randall then 
demonstrated that expression of Bambi-b in HEK293T cells inhibited BMP-induced 
phosphorylation of Smad1/5, particularly when cells were exposed to low levels of 
BMP4 (Figure 3.18A).  
Mechanistically, X. laevis BAMBI has been shown to function by forming a 
non-productive signalling complex with the BMP type I receptors. Similarly, I could 
demonstrate that Bambi-b interacted with the BMP type I receptor ALK3 (Figure 
3.18B). To test the requirement for Bambi-b during embryonic development for 
domain formation I performed loss-of-function studies using a translation-blocking 
MO. The functionality of this MO can be demonstrated in a rabbit reticulocyte in 
vitro translation assay, in which expression of [35S]-methionine labelled Bambi-b is 
inhibited in the presence of the bambi-b MO (Figure 3.19A). The expression of the 
NC marker sox10 is significantly reduced in the bambi-b morphants and the inner 
NC cvl2 expression domain can no longer be detected (Figure 3.19A). This 
phenotype is similar to the observed dlx3b/4b phenotype, suggesting that bambi-b 
may be downstream of dlx3b. I therefore tested whether dlx3b is in fact required for 
induction of the stripe of bambi-b expression. Knockdown of dlx3b/4b led to a loss 
of this specific bambi-b expression domain (Figure 3.19B). Importantly, expression 
in the non-neural ectoderm, where dlx3b/4b are not expressed, was not affected.  
myod ISH on bambi-b morphants shows that the reduction in NC is not due 
to a developmental delay of the bambi-b MO injected embryos (Figure 3.19C). To 
confirm that bambi-b is indeed required for PPE development I analysed bambi-b 
morphants for phenotypes in PPE derivatives such as the otic vesicle. dlx3b is 
necessary for otic placode development and loss of dlx3b results in otic vesicle 
defects (Figure 3.20. (Solomon and Fritz, 2002)). Similarly, knockdown of bambi-b 
affects otolith formation in the otic vesicle indicating that indeed bambi-b is involved 
in PPE development (Figure 3.20). 
Finally, I investigated whether Dlx3b might be directly responsible for 
regulating bambi-b expression. I used PreMoTF (Predicted Motifs for Transcription 
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Factors) to predict the DNA-binding specificity of Dlx3b (Christensen et al., 2012), 
which was identified as TAATTG/A (Figure 3.21A). I found two possible sites in the 
bambi-b gene and flanking region: one in the 5’-UTR (+199 to +204, probe 1) and 
the other is upstream of the start of transcription (-851 to -846 bp; probe 2). In a 
bandshift assay I could demonstrate direct binding of FLAG- tagged Dlx3b to both 
of these sites, that supershifted with an anti-FLAG antibody, and was abolished by 
specific mutation of the binding site (Figure 3.21B). 
 
 
Figure 3.18 bambi-b inhibits BMP signalling in tissue culture and binds ALK3 
(A) HEK293T cells transfected with control plasmid or pCS2+-FLAG-Bambi-b were 
treated with different concentrations of BMP4 (2 ng/ml, 4 ng/ml, 10 ng/ml and 20 ng/ml) 
for 1 h, or with the BMP receptor inhibitor LDN-193189 for 3 h. Whole cell extracts 
were Western blotted using the indicated antibodies.  
(B) HEK293T cells were transfected with control plasmid or pCS2+-FLAG-Bambi-b or 
HA-ALK3. FLAG-Bambi-b was immunoprecipitated from whole cell extract and the 
immunopreciptates were Western blotted for HA. The inputs are also shown. Actin is a 
loading control. 
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Figure 3.19 bambi-b morphants lack inner BMP signalling domain. bambi-b 
expression is dependent on dlx3b/4b 
(A) Upper panel: ISH for sox10, cvl2 and mRFP on bambi-b morphants compared with 
controls. Embryos were injected with 10 ng bambi-b or control MO. Dorsal anterior 
view, anterior to the top. Lower panel: synthetic mRNA corresponding to native bambi-
b was translated in reticulocyte lysate in the presence of 0.2 mM bambi-b MO and 
[35S]-methionine. Translation products were separated by SDS-PAGE and visualised 
by autoradiography. 
(B) ISH for sox10 and bambi-b on dlx3b/4b morphants compared with control MO-
injected embryos. Arrows mark the inner bambi-b expression domain. Views are as in 
Figure 3.17B 
Numbers indicate embryos with the observed phenotype for a representative 
experiment. 
(C) myod ISH of bambi-b morphants. 
 
 
 
In conclusion, Bambi-b, which is expressed after bud stage under the control 
of Dlx3b, is an excellent candidate to inhibit BMP activity in these dlx3b-expressing 
cells and as a result enable them to be specified as PPE. Moreover, it is required 
for the formation of the NC domain of BMP activity and thus NC development. 
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Figure 3.20 bambi-b is required for otic placode development 
(A) ISH for sox10 on dlx3b/4b and bambi-b morphants embryos (upper panel).  
(B) Otoliths are absent in the otic vesicle of dlx3b/4b MO injected and greatly reduced 
in bambi-b MO injected embryos. 
 
 
Figure 3.21 dlx3b can bind to bambi-b gene 
(A) Dlx3b DNA-binding motif predicted using PreMoTF.  
(B) FLAG-Dlx3b expressed in HEK293T cells was assayed for binding to DNA using a 
bandshift assay. The wild-type probes correspond to the two putative Dlx3b binding 
sites in the bambi-b gene and the mutant probes contain point mutations in the binding 
sites. The Dlx3b–DNA complexes are indicated, as are the supershifted complexes 
that additionally contain the anti-FLAG antibody.    
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3.3 Discussion 
3.3.1 Summary of results 
• BMP activity is dynamically regulated and two distinct BMP signalling 
domains arise at the NPB after gastrulation with an inner domain coinciding 
with the NC 
• cvl2 is expressed in domains of BMP activity  
• cvl2 is a novel regulator of NC development through modulating BMP 
signalling 
• The PPE is devoid of BMP activity and resides between the two domains of 
BMP signalling 
• dlx3b/4b, which are expressed in the PPE, are required for formation of the 
NC BMP activity domain 
• The transcription factor dlx3b is required for the expression of an BMP 
inhibitor, Bambi-b, in the PPE, which in turn is necessary for the 
establishment of the NC domain of BMP signalling 
3.3.2 Identification of dynamic BMP signalling domains at the NPB during 
ectodermal patterning 
I have used a transgenic zebrafish BMP reporter line to identify distinct territories of 
BMP activity at the NPB. I show that at the end of gastrulation, BMP activity 
concentrates into a horseshoe-shaped domain at the border of the neural plate, 
which then resolves into two distinct domains: an outer domain abutting the 
epidermis and an inner domain. DFISH reveals this inner domain corresponds to 
the NC directly demonstrating on-going BMP activity in the NC cell population. I 
further show that BMP signalling is absolutely required for the maintenance of NC 
progenitors, as inhibition of BMP signalling at the onset of neurulation reduced the 
expression of NC markers. These results give direct proof of a dynamic spatial and 
temporal regulation of BMP signalling domains during ectodermal patterning. 
Previous evidence has been rather circumstantial as it has relied on the use of 
mutants or addition of BMP inhibitors at various developmental stages and 
furthermore imaging endogenous BMP activity using IF against PSmad1/5 is not 
very sensitive. This approach has allowed for the detection of strong signals such 
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as the initial BMP signalling gradient during gastrulation. During somitogenesis, 
using PSmad1/5 staining, I was also able to visualise the outer horseshoe-shaped 
domain at the NPB. However, the BMP activity in the NC could not be detected. 
The transgenic Tg(BRE:mRFP) reporter line on the other hand now enables us to 
reveal weaker signals using ISH against mRFP as a readout. A recent publication 
from our lab provides evidence of a short half-life of mRFP mRNA. During the 
establishment of the early BMP activity gradient at the onset of epiboly mRFP 
transcripts are cleared within 20 min of the gradient detection by PSmad1/5 
immunostaining (Ramel and Hill, 2013). Therefore Tg(BRE:mRFP) embryos are 
proving to be a useful tool to assess in vivo signalling dynamics. Moreover, larger 
numbers of embryos can be processed in ISH compared to the time consuming 
analysis of IF stained embryos with confocal microscopy. 
I further went on to determine which ligands contribute to the localised BMP 
activity. Historically bmp2b, bmp7a and bmp4 have been implicated in NC 
development. After gastrulation bmp4 expression differs from the patterns 
observed for bmp2b and bmp7a and can be detected in the posterior epidermis 
and the polster, but not at the NPB (Thisse et al., 2001). Analysis of two zebrafish 
bmp4 mutants demonstrates the requirement of Bmp4 for ventroposterior cell fates 
(Stickney et al., 2007). However, although X. laevis bmp4 overexpression can 
rescue bmp2b and bmp7a mutants (Kishimoto et al., 1997, Nguyen et al., 1998), 
zebrafish bmp4 does not seem to be directly involved in NC development. I have 
also demonstrated that bmp6 is expressed in the horseshoe-shaped domain of 
BMP activity that abuts the epidermis. Bmp6 alone, however, is not responsible for 
formation of this domain, but is likely to reinforce and sharpen the signalling domain 
in concert with Bmp2b and Bmp7a. Moreover, I have identified Gdf6a as the BMP 
ligand required for BMP signalling activity in the NC and also for NC cell fate, thus 
solving the conundrum of how BMP signalling is activated in the NC given the 
absence of bmp2b, bmp4 and bmp7a expression in this specific domain. How 
transcription of gdf6a is induced in this specific domain remains to be determined. 
There are several gdf6a mutants available, which could be used for further analysis 
(den Hollander et al., 2010, Gosse and Baier, 2009). I have also reviewed the 
published expression pattern of other known Bmp and Gdf ligands. However, most 
of them are either expressed later in development such as bmp10, bmp15, bmp16, 
gdf5, gdf9 and dvr1 (gdf3) {Thisse, 2004 #430;Laux, 2013 #402;Liu, 2007 
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#432;Schwend, 2009 #431} or their expression patterns do not suggest a a role in 
NC and PPE development such as bmp1a, bmp2a, bmp7b, gdf2, gdf6b, gdf11 and 
mstnb (gdf8) {Bruneau, 1997 #404;Jasuja, 2006 #365;Shawi, 2008 #401;Thisse, 
2004 #430}. bmp3 and bmp5 are expressed in the pharyngeal arches and have 
been implicated in cranial development suggesting a role in later stages of NC 
development for example in the signalling cues leading to correct NC migration 
{Schoenebeck, 2012 #399;Thisse, 2004 #430}. gdf10a can be detected in the 
epidermis at the anterior at early somitogenesis {Thisse, 2004 #430}. It would be 
interesting to review its expression pattern and test the requirement for this ligand 
for BMP activity in a morpholino approach. 
 
3.3.3 Cvl2 focuses BMP activity at the NPB and is required for NC 
development 
The reshaping of BMP activity at the end of gastrulation from a gradient to sharply 
defined domains at the NPB prompted me to search for spatial regulators of BMP 
signalling. I identified the secreted BMP-binding protein Cvl2 as playing a critical 
role in “focusing” BMP activity into the two distinct domains at the NPB. Cvl2 has 
been described as both an activator and an inhibitor of BMP signalling (Binnerts et 
al., 2004, Kamimura et al., 2004, Moser et al., 2003, Conley et al., 2000, Ambrosio 
et al., 2008). Cvl2 is bound to the membrane via glycosylphosphatidylinositol- 
anchored Heparan-Sulphate Proteoglycans (HSPGs) and thus is thought to act at 
short range compared to other secreted BMP modulators such as the BMP 
antagonist Chordin (Serpe et al., 2008). Like many other proteins that interact with 
BMPs, Chordin amongst them, Cvl2 contains cysteine-rich domains (Conley et al., 
2000). Indeed, Cvl2 has been shown to interact with Bmp2, Bmp4 and Bmp7, as 
well as Chordin and type I BMP receptors (Ambrosio et al., 2008, Rentzsch et al., 
2006, Serpe et al., 2008, Zhang et al., 2010). Different mechanisms have been 
proposed for its activatory effect on BMP signalling. In the posterior crossvein of 
the Drosophila pupal wing it is thought to act at short range by promoting binding of 
BMPs to receptors (Serpe et al., 2008). In zebrafish, Cvl2 has been shown to act 
during gastrulation in BMP gradient formation by stabilising BMP signalling 
territories, at least partly by competing with Chordin for binding to BMPs (Rentzsch 
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et al., 2006). That study also suggested that proteolytic cleavage converts Cvl2 
from an anti- to a pro-BMP factor, with the cleaved form being predominantly 
present during zebrafish development. The same lab then proposed a ternary 
complex consisting of Chordin, Cvl2 and Bmp. This leads to a conformational 
change in the Chordin protein thus releasing Chordin and making Bmp more 
available for receptor activation (Zhang et al., 2010). During X. laevis development, 
Cvl2 has been suggested to act as a Bmp4-dependent feedback inhibitor 
(Ambrosio et al., 2008). Other evidence for an inhibitory function of Cvl2 comes 
from overexpression studies. However, this is likely to result in sequestering Bmp 
ligands accounting for the inhibitory behaviour (Moser et al., 2003, Binnerts et al., 
2004). In contrast, I have not seen evidence of endogenous cvl2 being expressed 
in regions devoid of BMP activity at the stages examined. I have shown that at 
neurula stages cvl2 expression recapitulates patterns of BMP activity and is also 
under BMP control. My loss-of-function data using three independent MOs against 
cvl2 further demonstrate a pro-BMP function of Cvl2 at these stages and its 
requirement for BMP domain formation at the NPB. This constitutes a novel role for 
Cvl2 in NC development. The fact that pigmentation in cvl2 morphants is not 
severely affected suggests a specific role for cranial NC rather than trunk NC. My 
experiments demonstrate that Cvl2 and BMP signalling act in a positive feedback 
loop, and the non-diffusible nature of the BMP ligands probably contributes to this 
(Ramel and Hill, 2013). I propose that Cvl2 may focus BMP activity in the discrete 
domains at the NPB via a mechanism analogous to that suggested to operate at 
the Drosophila posterior crossvein. This would ensure robust levels of BMP activity 
while the territories of BMP signalling are being reshaped. 
 
3.3.4 The PPE is specified in the region that lacks BMP activity 
Previous work has indicated that PPE specification requires full inhibition of BMP 
signalling at the end of gastrulation (Kwon et al., 2010), and I directly demonstrate 
this here using DFISH. Using dlx3b as a marker for the PPE, I reveal the process of 
separation of dlx3b and cvl2/mRFP-positive cells into distinct domains at the NPB. 
Taking advantage of the high resolution of DFISH, I carefully analysed how cvl2 
and dlx3b expression changes from the end of gastrulation to the one-somite stage. 
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cvl2 and dlx3b are expressed in similar domains during gastrulation. However, by 
the one-somite stage dlx3b and cvl2 are expressed in mutually exclusive domains. 
This separation occurs as the cells converge dorsally as a result of gastrulation 
movements (Schier and Talbot, 2005). I could not definitively determine whether 
cvl2 and dlx3b are co-expressed in the same cells, or are expressed uniquely in 
intermingled cells. However, the observation that the formation of the distinct dlx3b 
and cvl2 expression domains is very rapid (around 1 hour) would support a 
mechanism whereby intermingled cells are separated by cell sorting, with dlx3b-
expressing cells migrating slightly more dorsally than the cvl2-expressing cells. It 
will be important in the future to determine how this is achieved. There are several 
examples of cell sorting in vivo being regulated by Eph/ephrin signalling and the 
differential expression of cadherins (Batlle and Wilkinson, 2012). Reciprocal 
expression of the Eph receptors and the ephrin ligands is sufficient for the 
segregation of intermingled cells (Tanaka et al., 2003, Cortina et al., 2007, Poliakov 
et al., 2008). Reviewing the expression patterns of several of the Eph/ephrin 
pathway components did not yield any plausible candidates. Nevertheless, this 
pathway poses an intriguing possibility as a mechanism to separate cvl2/mRFP 
and dlx3b expression domains. 
 
3.3.5 Expression of bambi-b under control of Dlx3b/4b inhibits BMP activity 
in the PPE  
The DFISH analysis demonstrated rapid clearance of BMP activity from dlx3b 
expressing cells by the one-somite stage. This indicates that active inhibition of 
BMP signalling occurs in the dlx3b-positive cells and hence predicted the 
expression of a cell autonomous BMP inhibitor in the PPE. I have identified Bambi-
b as an excellent candidate that would fulfil this role. As mRNA expression levels of 
bambi-b are very low, I was unable to formerly prove that bambi-b is indeed 
expressed in the PPE, but careful visual analysis of the stained embryos strongly 
suggests that the inner bambi-b expression domain coincides with dlx3b 
expression. The data show that Bambi-b is able to inhibit BMP activity in response 
to a signal in tissue culture cells. I also attempted overexpression of Bambi-b in 
zebrafish embryos to test the BMP inhibitory function in vivo. The mRNA, however, 
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appears to be highly regulated, as even after injection of high doses of bambi-b 
mRNA I was unable to detect protein expression in the embryos. This is not due to 
a faulty expression construct, as the mRNA was readily translated in a rabbit 
reticulocyte in vitro translation assay (data not shown) and I used the same 
expression construct for expression of bambi-b in tissue culture (Figure 3.18). I 
have demonstrated that bambi-b morphants lack the inner domain of cvl2/BMP 
activity, and thus they display a similar phenotype to dlx3b/4b morphants. This 
strongly suggested that bambi-b expression is regulated by dlx3b/4b, which I was 
able to demonstrate. This is the first transcriptional target described for Dlx3b. To 
substantiate the data it would be interesting to perform ChIP experiments from 
zebrafish embryos. The limiting factor, however, is the availability of a suitable 
antibody. The antibodies tested so far were not able to detect zebrafish Dlx3b. 
Thus, a tagged version of Dlx3b would be required. In addition, Dlx3b expression 
alone is not sufficient to induce bambi-b transcription, as bambi-b mRNA can only 
be detected from bud stage onwards, whereas dlx3b is already expressed during 
gastrula stages. Moreover, bambi-b is not only present in the PPE, but also in the 
non-neural ectoderm, which does not express dlx3b, suggesting that bambi-b 
transcription is subject to a different mode of regulation in these cells.  
 
3.3.6 A two-step model for controlling cells fate decisions during 
ectodermal patterning 
Different tissues require distinct levels of BMP signalling at specific times during 
ectodermal patterning. NC requires intermediate to low levels of BMP signalling for 
induction (Schumacher et al., 2011) and as I show here, continues to require BMP 
activity for its maintenance. PPE in contrast only requires BMP activity during its 
induction phase, but is devoid of BMP signalling after gastrulation. The classical 
BMP gradient model fails to explain how these contrasting patterns of BMP 
signalling in neighbouring cell populations are established in time and space. The 
data I present here provides direct evidence for a two-step model of ectodermal 
patterning (Figure 3.22). I show that the early BMP DV gradient, present during 
gastrulation, is remodelled into distinct BMP signalling domains at the NPB. I 
further demonstrate active BMP signalling in the NC and at the epidermal border, 
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whereas BMP activity is completely inhibited in the intervening PPE. The ligand 
responsible for the inner BMP activity domain is Gdf6a, and the activity is focused 
in this domain by coincident expression of Cvl2. The ligands responsible for the 
outer BMP activity are Bmp2b, Bmp7a and Bmp6. Again, I demonstrate a crucial 
role for Cvl2 acting in a positive feedback loop to concentrate their BMP activity at 
the epidermal border. I show that the region between these two domains of BMP 
activity is specified as the PPE, which expresses the homeobox transcription factor 
Dlx3b. I demonstrate that Dlx3b is responsible for inducing expression of the BMP 
inhibitor Bambi-b, thereby allowing BMP repression in the presumptive PPE. Thus, 
rather than a linear gradient of BMP specifying cell fates at the NPB, I propose a 
model which involves dynamic expression of BMP inhibitors and activators that can 
explain the differential requirements of NC and PPE for BMP activity at different 
developmental stages.  
 
 
 
Figure 3.22 A 2-step model for zebrafish ectodermal patterning 
Step 1 depicts the DV gradient present during gastrulation. High BMP activity is 
observed ventrally, generated by bmp2b/4/7 ligand expression and reinforced by Cvl2. 
BMP activity is inhibited dorsally by expression of the diffusible antagonists Chordin 
and Noggin. Prospective PPE and NC are formed at intermediate levels of BMP 
signalling. In step 2 the initial gradient has reshaped into distinct BMP activity domains 
during neurulation. The regulatory network is depicted. Components in black act 
positively, whilst those in red act negatively. 
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Chapter 4.  
Chapter 5. The role of Snw1 during vertebrate neural 
crest development 
5.1 Introduction 
Snw1 has previously been identified as a regulator of neural crest fate in a large-
scale in vivo functional screen in X. laevis conducted by our lab (Wu et al., 2011). 
This study identified Snw1 as being required for BMP activity at the NPB. The 
molecular function of Snw1, however, had not been described. In this chapter I 
describe the use of X. laevis and zebrafish embryos to further investigate Snw1 
function during early vertebrate development. 
 
5.2 Results 
5.2.1 Snw1 is cell-autonomously required for NC induction in X. laevis 
As previously described, Snw1 has an important function in NC development (Wu 
et al., 2011). Both overexpression and depletion of Snw1 resulted in a substantial 
loss of NC markers such as slug and sox9 in neurula stage (stage 14) X. laevis 
embryos (Figure 5.1). This indicated that expression levels of Snw1 have to be 
tightly regulated. However, these previous experiments modulate Snw1 globally in 
the embryo and do not give information regarding the cells in which Snw1 is 
required for its function.  
To address this question, I made use of the fate map that has been 
produced for 32-cell stage X. laevis embryos (Dale and Slack, 1987). This fate map 
enabled me to specifically manipulate the levels of Snw1 in the blastomere that 
contributes to the tissues at the NPB (and thus the NC), whereas for example 
maintaining its wild type expression patterns in the underlying mesoderm. I co-
injected fluorescein isothiocyanate–dextran (Fdx) to trace the cells that arise from 
this blastomere and have received the injected MO. Fdx can be visualised under a 
fluorescent microscope with an excitation and emission spectrum peak 
wavelengths of approximately 495 nm/519 nm. Alternatively, I used an anti-FITC 
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antibody and BCIP for colourimetric detection. The analysis clearly showed that 
slug ISH staining (blue) is lost in the cells that have been injected with the snw1 
MO (marked by turquoise) whereas loss of Snw1 in adjacent cells did not affect the 
NC (Figure 5.2). This suggests that Snw1 function is required in the NC cell 
population itself. 
 
 
Figure 5.1 Overexpression and knockdown of Snw1 in X. laevis 
(A) ISH of X. laevis embryos injected with indicated amounts of gfp or snw1 mRNA 
using probes against the NC markers slug and sox9.  
(B) ISH of embryos injected with 20 ng of cont. or snw1 MO, using probes against the 
NC markers slug and sox9. 
All views show embryos dorsal view with anterior to the top. 
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Figure 5.2 Targeting of the snw1 MO to the neural folds (X. laevis) 
ISH of embryos injected with the indicated MO and Fdx to trace the targeted tissue. 
slug ISH staining visualises the NC (dark blue) whereas Fdx (turquoise) labels the cells 
that have received the MO. Upper panel shows embryos with cont. MO targeted to the 
neural folds. Middle panels show targeted snw1 MO. Left is the uninjected side as a 
control, on the right is the injected. At the bottom left is a magnification of an example 
embryo with the snw1 MO targeted to the NC. The lower right panel shows embryos 
with the snw1 MO targeted adjacent to the NC, as visualised using Fdx. The white 
dashed line depicts the expected wt territory of slug NC marker expression.  
 
 
To demonstrate that the NC cell fate in these cells was not merely delayed 
but permanently abolished, I monitored the NC cell population of injected embryos 
at a later developmental stage when the NC cells have migrated to populate the 
four branchial arches (reviewed in (Minoux and Rijli, 2010)).  
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Figure 5.3 NC lacking Snw1 fails to populate the branchial arches (X. laevis) 
(A) Schematic indicates the blastomere that contributes to the NC. Successful 
targeting was monitored by visualising Fdx using a fluorescent microscope (lower 
panel). 
(B) Embryos injected with either a control or snw1 MO were analysed for migration of 
the NC into the branchial arches. The injected cells were visualised using Fdx. The 
white arrows indicate the four brachial arches. 
Embryos shown are representative for several experiments. 
 
 
 
 
 
Chapter 4 Results 
 
 134 
I again injected embryos with a control or snw1 MO into blastomere a2 and 
confirmed efficient targeting under a fluorescence microscope (Figure 5.3A). The 
successfully injected embryos were then further analysed at stage 26. In control 
embryos I could indeed detect targeted cells in the branchial arches (Figure 5.3B). 
The number of these cells was drastically reduced in Snw1-depleted embryos 
(Figure 5.3B). Instead a greater number of “scattered” fluorescent cells were 
detected in the dorsal ectoderm, visible in the upper panel of Figure 5.3B, 
indicating that loss of Snw1 does not lead to a depletion of the targeted cell 
population but a loss of NC identity. 
5.2.2 The role of Snw1 is conserved in zebrafish 
The Snw1 protein is highly conserved between vertebrates (Wu et al., 2011), 
suggesting that its function might also be conserved amongst species.  
 
 
 
 
Figure 5.4 Temporal expression pattern of snw1 during early zebrafish 
development 
ISH for snw1 at the indicated stages. Lateral views; from 2 ss onwards lateral view 
(upper panel) and dorsal anterior view (lower panel). 
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Figure 5.5 SNW1 function is conserved in zebrafish 
ISH of embryos injected with 10 ng control or snw1 MO using probes against sox10. 
Numbers indicate the embryos with the observed phenotype for a representative 
experiment. Embryos shown in dorsal view with anterior to the top. 
 
 
As shown in X. laevis, in zebrafish snw1 is ubiquitously expressed from early 
embryogenesis onwards and becomes then restricted to the NP after gastrulation ( 
Figure 5.4, (Wang et al., 2010b, Wu et al., 2011)). Furthermore, depletion of Snw1 
in zebrafish embryos resulted in a loss of the NC marker sox10 (Figure 5.5, (Wu et 
al., 2011)).  
Taken together, these analyses confirm a conserved expression pattern as 
well as a requirement for Snw1 in NC induction. 
 
5.2.3 Snw1 is essential for BMP and Wnt signalling in zebrafish 
Using the transgenic Tg(BRE:mRFP) zebrafish BMP reporter line, our lab had 
previously demonstrated that Snw1 is required for NPB formation by regulating 
BMP activity in this domain (Wu et al., 2011). Indeed I could confirm that l.1oss of 
Snw1 resulted in a global reduction of BMP activity visualised by mRFP ISH 
staining in Tg(BRE:mRFP) embryos (Figure 5.6). 
In X. laevis Snw1 has been shown to modulate Wnt/β-catenin signalling 
(Wang et al., 2010b)(1.4.2.3), thus giving a possible alternative explanation for the 
loss of NC in snw1 morphants. I wanted to test whether this also holds true in 
zebrafish embryos. For this purpose I used the transgenic Tg(7xTCF-
Xla.Siam:GFP)ia4 Wnt reporter line, which expresses eGFP under the control of 
seven multimerised TCF responsive elements upstream of the minimal promoter of 
the X. laevis direct ?-catenin target gene siamois (Moro et al., 2012). At the two 
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somite stage ISH using probes against gfp revealed Wnt activity in the posterior NP, 
but not in the NC, although BMP activity can be detected in NC derived cells at 
later stages (Figure 5.7A, (Moro et al., 2012)). 
I then went on to test the requirement of Snw1 for Wnt signalling in zebrafish. 
Indeed, depletion of Snw1 resulted in a loss of Wnt activity in Tg(7xTCF-
Xla.Siam:GFP)ia4 embryos (Figure 5.7B), as had been previously reported in X. 
laevis and in tissue culture cells (Wang et al., 2010b). 
 
 
 
 
Figure 5.6 Snw1 is required for BMP activity at the NPB during NC development 
(zebrafish) 
ISH on Tg(BRE:mRFP) embryos injected with 10 ng of a control or snw1 MO using 
probes against the NC marker sox10 or mRFP for detection of BMP activity. 
Numbers indicate the embryos with the observed phenotype for a representative 
experiment. sox10 phenotype is weaker as embryos were injected at the 2-4 cell stage 
(instead of 1-2 cell stage). All views show embryos dorsal view with anterior to the top. 
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Figure 5.7 Snw1 is required for canonical Wnt signalling in zebrafish embryos 
(A) gfp ISH on 2 somite stage embryos. Orientations are as indicated. 
(B) ISH on embryos injected with either 10 ng control or snw1 MO using probes 
against sox10 and gfp. sox10 are displayed in a dorsal anterior view with dorsal to the 
top, gfp stained embryos are oriented in a lateral view with anterior to the left. 
Numbers indicate the embryos with the observed phenotype for a representative 
experiment. 
 
 
5.2.4 The dependence of the NC on BMP and Wnt signalling at different 
developmental stages 
As demonstrated in Chapter 3, BMP signalling is required throughout early 
development for NC induction and maintenance (Figure 3.3). Similarly Wnt 
signalling has been implicated at different steps of NC development (Dorsky et al., 
1998, Lewis et al., 2004, Steventon et al., 2009). In X. laevis, global inhibition of 
BMP and Wnt signalling by overexpression of the BMP antagonist noggin 
(Zimmerman et al., 1996) or the Wnt antagonist dickkopf 1 (dkk1) (Glinka et al., 
1998) prevents the expression of NC markers (Figure 5.8).  
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Figure 5.8 Inhibition of BMP and Wnt signalling abolishes NC cell fate in X. laevis 
ISH on X. laevis embryos injected with the indicated mRNA. Probes against slug and 
sox9 mark the NC cell population. Dorsal view with anterior to the top. 
 
The previous experiment demonstrated that both BMP and Wnt signalling are 
important in NC development (Figure 5.8). Loss of Snw1 impaired the activity of 
both pathways (Figure 5.7). Thus it is not clear whether the NC phenotype in snw1 
morphants is due to an inhibition of BMP or Wnt signalling or a combination of both. 
It was therefore important to determine what the contribution of either pathway to 
NC development in the context of this study is at the time of NC induction. For this 
purpose I made use of chemical modulators that were added to the water of 
dechorionated developing embryos at early-gastrulation to achieve inhibition when 
NC is induced. This also recapitulates the timing of effective Snw1 depletion (Wu et 
al., 2011).  
I added Leflunomide (White et al., 2011) to inhibit BMP activity (6.2.7 1) and 
the tankyrase inhibitor XAV939 was added to inhibit Wnt signalling (Huang et al., 
2009). I then monitored the expression of the NC marker sox10 as well as the 
activity of the signalling pathways using the respective transgenic reporter lines. 
 
                                               
1  I show in Chapter 5 that Leflunomide, a known regulator of NC development, 
effectively inhibits BMP activity.   
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Figure 5.9 Modulation of BMP and Wnt activity during NC induction in zebrafish 
ISH using probes against sox10, gfp and mRFP of embryos treated with the indicated 
chemical modulators from 60% epiboly onwards. Numbers indicate the embryos with 
the observed phenotype for a representative experiment. All views show embryos in an 
dorsal view with anterior to the top. 
 
Inhibition of BMP signalling, confirmed by loss of mRFP in Tg(BRE:mRFP) 
embryos, efficiently prevented NC induction. In contrast, I did not observe an effect 
on Wnt signalling activity, indicating that inhibition of BMP activity alone is sufficient 
to abolish NC cell fate. Furthermore, inhibition of Wnt signalling did not affect BMP 
activity and did not perturb NC induction. 
Taken together, this data indicates that the NC phenotype observed in snw1 
morphants is most likely due to a loss of BMP activity, rather than inhibition of Wnt 
signalling. 
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5.2.5 Ectopic expression of Snw1 does not modulate BMP activity in X. 
laevis embryos 
Depletion of Snw1 inhibits BMP activity in Tg(BRE:mRFP) embryos, which is also 
demonstrated in a loss of PSmad1/5 levels detected by Western blot analysis, 
especially in post-gastrulation embryos (Wu et al., 2011). Additionally, 
overexpression of Snw1 in X. laevis resulted in an increase of PSmad1/5 in 
Western blots (Wu et al., 2011). Knockdown studies in tissue culture, however, 
indicate that Snw1 does not act downstream of the BMP receptors as depletion in 
MDA-MB-231 cells does not impair the cellular response to recombinant ligand 
stimulation (Wu et al., 2011). Moreover, the Snw1 phenotype can be rescued in X. 
laevis by targeted injection of bmp2b cDNA, indicating that the cells are competent 
to respond to a BMP stimulus (Wu et al., 2011). 
To further elucidate the prevalent mechanism I cloned a X. laevis GFP-
tagged Snw1. Snw1 has been described as a nuclear factor (Dahl et al., 1998).  
 
 
Figure 5.10 Snw1 is localised to the nucleus (X. laevis) 
X. laevis embryos were injected with 250 pg either gfp or gfp-snw1 mRNA as well as 
375 pg mcherry-h2b. Embryos were injected in both cells at the 2-cell stage, fixed at 
stage 14 and then bisected along the dorsal anterior-posterior axis for imaging under a 
fluorescent microscope. 
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Figure 5.11 Ectopic expression of Snw1 does not increase PSmad1/5 levels (X. 
laevis) 
X. laevis embryos were injected as in Figure 5.10. PSmad1/5 staining was performed 
and neural folds were imaged using a fluorescent microscope. 
 
 
Indeed, GFP-Snw1, overexpressed in X. laevis from injected mRNA, could be 
detected exclusively in the nucleus, whereas GFP alone was also present in the 
cytoplasm (Figure 5.10). Coinjection of mcherry-h2b marked the nucleus and also 
indicated injected cells. 
I next wanted to test whether overexpression of Snw1 in X. laevis was 
sufficient to increase cellular PSmad1/5 levels. I injected embryos as detailed in the 
previous experiment and performed PSmad1/5 immunostaining on embryos that 
where bisected along the dorsal-ventral axis to image the neural folds where the 
NC is induced. No increase in PSmad1/5 could be detected compared to gfp-
injected control embryos and there were clearly cells present that expressed high 
levels of GFP-Snw1, but were low in nuclear PSmad1/5. This indicates that 
overexpression of Snw1 is not sufficient to activate cellular BMP activity or that 
Snw1 is not a limiting factor for BMP activity in the neural folds. Please not that I 
here assume the GFP-Snw1 is active as it is folded well enough to be localised to 
the nucleus. However, I don’t formerly show this. 
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5.2.6 Loss of Snw1 increases bmp2b mRNA levels at the NPB but reduces 
Bmp2b protein levels 
As outlined in the Introduction, Snw1 has been implicated as a transcriptional co-
regulator that recruits, depending on the cellular context, activating or repressing 
complexes to mediate various signalling pathways. Moreover, previous work in our 
lab indicated, that Snw1 likely acted downstream/at the level of ligand transcription 
and upstream of receptor activation (Wu et al., 2011) (1.4). It was therefore 
conceivable that Snw1 acts on the transcriptional regulation of BMP signalling 
components to regulate pathway activity. To test this I performed ISH using probes 
against Bmp ligands that are required for BMP activity at the NPB. Surprisingly, I 
observed a dramatic increase in bmp2b mRNA (Figure 5.12). This effect is specific 
to the NPB where the bmp2b expression domain is likely to overlap with snw1 
expression (Wu et al., 2011). In contrast, bmp7a levels did not seem to be 
significantly changed (Figure 5.13).  
Thus, I observed an increase in bmp2b transcripts despite a loss of BMP 
activity at the NPB. A possible explanation would be inefficient mRNA processing 
or subsequent translation.  
 
 
Figure 5.12 bmp2b is increased at the NPB in snw1 zebrafish morphants 
ISH using probes against sox10 and bmp2b on embryos injected with the indicated 
amounts of snw1 MO. All views show embryos in an dorsal view with anterior to the 
top. 
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Figure 5.13 Loss of Snw1 in zebrafish does not affect bmp7a transcript levels 
ISH using probes against sox10, bmp7a and mRFP on snw1 morphants. Numbers 
indicate the embryos with the observed phenotype for a representative experiment. . 
All views show embryos in an dorsal view with anterior to the top. 
 
 
 
 
 
 
Figure 5.14 Bmp2b expression is decreased in snw1 morphants 
Western blot analysis of Snw1-depleted embryos using the indicated antibodies. 
Lysates of 3 somite stage embryos from two independent experiments were analysed. 
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I investigated this using two antibodies against the Bmp2b protein. A zebrafish 
specific antibody, that recognises the pro-protein, but not the mature form 
(AnaSpec) and an antibody against the human, processed Bmp2 (abcam). In two 
independent experiments I could show decreased levels of Bmp2b in 3 somite 
stage snw1 morphant embryos (Figure 5.14). 
5.2.7 Gene expression at the NPB does not seem to be global changes 
 
 
Figure 5.15 Expression of NPB markers in snw1 morphants 
ISH using probes against sox10, cvl2 and the NPB markers dlx3b, prdm1, kctda15a 
and kctd15b on snw1 morphants. Orientation is as labelled above. . All views show 
dorsal view with anterior or posterior to the top as indicated. 
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To investigate how general the change of gene expression at the NPB was in snw1 
morphants and whether tissue patterning per se was changed I performed ISH 
using probes against several NPB markers. Consistent with a requirement of Snw1 
for BMP signalling, expression of cvl2 was significantly decreased in Snw1-
depleted embryos. However, expression of none of the other NPB markers was 
changed (Figure 5.15). Note also that the NP does not seem to be extensively 
broader, indicating that Snw1 is not required for early BMP activity during dorsal-
ventral axis formation. This is consistent with experiments that showed a significant 
reduction in PSmad1/5 only after gastrulation in snw1 morphants ((Wu et al., 2011). 
 
Taken together, I demonstrated that the defect in NC development in snw1 
morphants is likely to result from an inhibition of BMP activity rather than Wnt 
signalling. Surprisingly, BMP signalling is inhibited upon loss of Snw1 despite an 
increase in bmp2b transcripts at the NPB.  
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5.3 Discussion 
5.3.1 Summary of results 
• As previously shown, overexpression and knockdown of Snw1 inhibits NC 
development in X. laevis. 
• This function is conserved in zebrafish. 
• Snw1 is required in the NC cells for its function. 
• Loss of Snw1 inhibits BMP activity and Wnt signalling in neurula stage 
embryos. 
• The snw1 morphant phenotype is likely to be conferred by a loss of BMP 
signalling and not inhibition of Wnt signalling.  
• Snw1 depletion leads to a loss of Bmp2b protein expression despite an 
increase in bmp2b transcripts at the NPB.  
• The expression of bmp7a and several NPB markers is unchanged after 
Snw1-depletion. 
5.3.2 Snw1 functions in NC development 
A previous study in our lab provided evidence for a role for Snw1 in vertebrate 
development (Wu et al., 2011). In both X.laevis and zebrafish, depletion of Snw1 
abolishes NC cell fate. RNAi-mediated loss of Snw1 causes gastrulation defects in 
C. elegans and leads to post-gastrulation lethality in Drosophila (Kostrouchova et 
al., 2002, Negeri et al., 2002). Similarly, in vertebrates Snw1 is likely to be required 
for gastrulation. However, maternally deposited protein appears to be stable 
enough to provide Snw1 protein that is sufficient for normal gastrulation. Depletion 
of Snw1 using a morpholino approach seems only to be efficient from mid-late 
gastrulation as measured by Snw1 protein and Smad1/5 phosphorylation levels 
using western blot (Wu et al., 2011). This meant we were able to circumvent 
defects in early embryonic development and determine Snw1 function at later 
developmental stages. 
Combined signals from the NNE and the NP, both abutting the NC, and the 
underlying mesoderm are thought to contribute to NC induction (reviewed in 
(Stuhlmiller and Garcia-Castro, 2012a). I therefore wanted to ask in which cells was 
Snw1 specifically required for its function by using targeted injections of the snw1 
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MO in X. laevis. Only targeting the snw1 MO directly to the prospective NC 
abolished expression of the NC marker slug, whereas loss of Snw1 in adjacent 
cells yielded no effect. This suggests that Snw1 is not required for the expression 
of a secreted factor in the surrounding tissue, but for signals in the NC cell 
population itself as I will further discuss later. 
 
5.3.3 The Snw1 NC phenotype is likely a result of BMP activity inhibition and 
not lack of canonical Wnt signalling 
Snw1 is required for BMP activity at the NPB (Wu et al., 2011) and has also been 
implicated in inhibiting Wnt signalling during NC induction as part of the LEF1/TCF 
transcriptional complex (1.4.2.3) (Wang et al., 2010b). 
During early embryonic development, BMP signalling is indispensable for 
the establishment of the DV axis. BMP pathway mutants display ectodermal 
patterning defects including an expansion of neural tissues at the expense of 
ventral tissues (Schumacher et al., 2011, Tucker et al., 2008). Strong inhibition of 
BMP activity, such as in the zebrafish swirl/bmp2b mutant, results in a loss of NC 
progenitors whereas reduction of BMP activity to intermediate levels as in 
somitabun/smad5 and snailhouse/bmp7a mutants expands the population of NC 
marker positive cells. This suggests that intermediate levels of BMP signalling are 
required to create a NC “competency” zone for initial NC induction. Similarly, I have 
previously shown that inhibition of BMP activity during mid-gastrulation, when the 
NC is induced, abolished expression of NC markers (Figure 3.3). Moreover, BMP 
signalling is essential for NC maintenance during early somitogenesis (Figure 3.3) 
(Steventon et al., 2009).  
The importance for Wnt signalling in the patterning of the vertebrate 
anterior-posterior axis has been extensively studied (Kiecker and Niehrs, 2001, 
Yamaguchi, 2001). Moreover, maternally deposited Wnt8b contributes to DV 
patterning (Pandur et al., 2002). Thus, disturbing Wnt signalling prior to stages 
when NC induction occurs might have indirect effects on NC due to early 
ectodermal patterning defects, similar to early inhibition of BMP activity. This likely 
explains the lack of NC in X. laevis embryos injected with noggin (BMP inhibition) 
or dkk1 (Wnt inhibition) mRNA (Figure 5.8). At later stages, evidence from the 
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ectopic expression of several Wnt ligands argues that Wnt activity is a positive 
regulator of NC induction (Bang et al., 1999, Saint-Jeannet et al., 1997). Also, 
inhibition of Wnt signalling by expressing a truncated version of the tcf3 gene 
headless in response to heat shock at bud stage, but not after 3 somite stage, led 
to a loss of NC, indicating a stage-specific requirement for Wnt activity during NC 
development (Lewis et al., 2004). Lewis et al. went on to identify wnt8a as the 
ligand expressed during NC induction at 80% epiboly. However, wnt8a is not 
expressed in the NC at stages when the authors perform the heat shock 
experiments and show Wnt signals to be important. Moreover, loss of Wnt8 only 
delays the onset of NC marker expression but does not abolish it. In my 
experimental setup, Wnt signalling seemed not to be required for NC induction. 
Abolition of Wnt activity by the use of a chemical inhibitor from gastrulation 
onwards did not affect the NC cell population, in contrast to inhibition of BMP 
signalling. I cannot exclude the possibility that Wnt signals were not sufficiently 
blocked to impair NC induction. Nevertheless, from currently available studies, it is 
still not clear whether Wnt-mediated effects on NC induction are direct or indirect. 
My analysis suggests, that even if loss of Snw1 impairs Wnt as well as BMP 
activity, the effect on NC at the investigated stages is likely a BMP-dependent 
phenotype. Further investigations, for example using heat-shock inducible 
zebrafish models, will be required to further delineate the involvement of both 
signalling pathways in NC development. Moreover, as Wnt is anterior-posterior axis 
formation, it would be interesting to test whether anterior-posterior patterning is 
affected in Snw1 morphants. 
 
5.3.4 Bmp2b can rescue the Snw1 phenotype 
Snw1 plays an essential role in regulating BMP activity post gastrulation. Analyses 
in tissue culture cells have indicated it is not part of the core-signalling pathway, as 
cells depleted of Snw1 show a wild-type response to recombinant Bmp ligand 
exposure (Wu et al., 2011). This is in contrast with previous studies, which reported 
overexpressed Snw1 interacting with Smad proteins to enhance TGF-β-and Bmp-
dependent signalling (Figueroa and Hayman, 2004, Leong et al., 2001). Moreover, 
data from our lab has provided evidence that targeted expression of bmp2b cDNA 
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can rescue the NC phenotype in snw1 X. laevis morphants, demonstrating the 
sustained ability of cells to respond to Bmp ligand stimulation. The injection of 
cDNA also circumvents the regulation via the 5’UTR or 3’UTR and the requirement 
for splicing. It would be interesting to test whether in zebrafish Bmp2b expressed in 
response to a heat shock can also rescue the NC phenotype. Importantly, this 
experiment argues against a Wnt-dependent Snw1 phenotype on NC as re-
expression of Bmp2b alone is sufficient for rescue. Taken together, our evidence 
places Snw1 upstream of receptor activation and at the level/downstream of ligand 
transcription. 
To further elucidate the function of Snw1 I investigated Bmp ligand 
transcription at the NPB of zebrafish embryos. Previous research in had indicated 
that bmp2b transcript levels might not be changed but the expression domain 
sharpened to the NPB {Wu, 2011 #33}. I revisited this observation and could show 
that whereas the expression of bmp7a in snw1 morphants was not altered, the 
abundance of bmp2b transcripts was strongly increased. This effect was limited to 
the neural plate border, where Bmp activity and snw1 expression overlap, arguing 
for a direct effect on bmp2b ligand levels. Importantly, despite increased bmp2b 
transcript levels, Bmp2b protein appears to be reduced in snw1-depleted embryos. 
This indicates a role for Snw1 in co- or post-transcriptional processing of bmp2b 
ligands. Given the broad expression pattern of Snw1, bmp2b is unlikely to be the 
sole target. Therefore it was important to determine how specific the effect of Snw1 
depletion on bmp2b was and whether levels of other transcripts were similarly 
changed, as I will address in the following chapter. 
 
5.3.5 Possible functions of Snw1 
The function of Snw1 in NC is conserved between X. laevis and zebrafish.  
The NC phenotype observed in Snw1-depleted embryos is most likely due to 
impaired BMP activity at the NPB as demonstrated in zebrafish embryos. 
Importantly, despite of inhibition of BMP signalling, bmp2b transcripts can still be 
detected and are actually increased at the NPB where snw1 and bmp2b expression 
overlap. This phenotype can be explained by the loss of Bmp2b protein expression. 
Moreover, it is clear that the cells at the NPB can still respond to a BMP stimulus as 
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targeted injection of bmp2b cDNA can rescue the NC phenotype in X. laevis. This 
approach circumvents the necessity of splicing as well as any regulation conferred 
by the 5’- or 3’ UTR. In summary, the data so far suggests that Snw1 function at 
the level of ligand transcription or co-/post-transcriptional processes.  
Snw1 has been implicated in a range of such processes as described in the 
Introduction. For example, Snw1 was described as a component of the activated 
spliceosome in S.cerevisiae, S.pombe and H.sapiens in several independent 
screens (Ajuh et al., 2000, Gavin et al., 2002, Neubauer et al., 1998, Ohi et al., 
2002, Zhou et al., 2002). The exact function of Snw1 in splicing is yet to be 
revealed, however, a recent publication reports Snw1 contributing to the splicing 
efficiency of substrates not conforming to the consensus (Gahura et al., 2009). It is 
not clear whether snw1 belongs to this class of transcripts.  
Apart from its role in splicing, Snw1 has been implicated as a transcriptional 
co-regulator that recruits, depending on the cellular context, activating or 
repressing complexes to mediate various signalling pathways such as Wnt, VDR, 
Notch and TGF-β signalling (1.4). As explained earlier, we exclude a role for Snw1 
downstream of TGF-β/BMP receptor activation, as Snw1-depleted cells are still 
responsive to BMP signalling in vivo as well as in tissue culture.  
Recent work by the Katherine A. Jones lab suggested a different role for 
Snw1 (Bres et al., 2005, Bres et al., 2009, Chen et al., 2011). As explained in more 
detail in 1.4.3, their work suggests that SNW1 is associated with the P-TEFb 
transcriptional elongation complex and is required for HIV-1 Tat transactivation. 
Moreover, SNW1 binds the U5snRNP and can facilitate the recognition of 
alternative HIV-1 Tat splice sites. Under DNA damage stress, SNW1 and P-TEFb 
become dispensable for HIV1 Tat transactivation. However, SNW1 is then required 
for gene-specific splicing of p21. 
Taken together, Snw1 is an important regulator of BMP activity at the NPB 
and required in the NC cell population for NC development. Interestingly, despite 
inhibition of BMP activity and loss of Bmp2b protein expression in snw1 morphants, 
bmp2b transcript levels are significantly increased. This holds not true for other 
transcripts at the NPB. It is an intriguing possibility that Snw1 is necessary for 
gene-specific splicing during developmental processes. Impaired splicing of the 
bmp2b transcript might then lead to the accumulation of unspliced pre-mRNA and 
would explain the increased transcript levels at the NPB. 
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Chapter 6.  
6.1 Introduction 
As described in the previous chapter, Snw1 is a regulator of NC 
development and BMP activity. Loss of Snw1 inhibits BMP signalling and Bmp2b 
expression despite an increase of bmp2b transcript levels at the NPB.  
Snw1 was first described in Drosophila, where it is called Bx42 and was 
found to be specifically expressed in a series of developmentally-active puffs on 
salivary gland chromosomes (Saumweber et al., 1990). Snw1 has a diverse, highly 
conserved protein structure and has been suggested to act as a scaffold in large 
protein complexes (Figure 1.6). Indeed, Snw1 has been then reported to interact 
with an extensive list of binding partners and has been implicated in a range of 
processes, such as splicing and transcriptional co-regulation (1.4) (Bres et al., 2005, 
Luo et al., 1999, Zhou et al., 2000). The molecular mechanism that leads to the 
embryonic snw1 morphant phenotype and inhibition of BMP activity has not been 
described. In this chapter, I will further investigate Snw1’s mechanism of action 
using global approaches such as mass spectrometry and RNA sequencing. 
 
6.2 Results 
6.2.1 Mass spectrometry analysis of SNW1 interaction partners 
Previous analysis has yielded a plethora of Snw1 interaction partners, many of 
which were identified in yeast-2-hybrid screens and overexpression studies (Barry 
et al., 2003, Bres et al., 2009, Zhou et al., 2000). In an unbiased approach, I aimed 
to confirm and identify SNW1 interaction partners by performing an SNW1 pull-
down and analysing associated proteins by mass spectrometry. This assay was 
aimed to clarify the processes SNW1 is involved in. To this end I generated 
HEK293T cell lines expressing stably Flag-tagged human SNW1 (Figure 6.1A). For 
the further analysis I selected a cell line expressing endogenous levels of Flag-
SNW1. I performed several repeats of the experiment detailed below to ensure the 
accuracy the results. First, a large scale Flag-IP was performed. After initial 
experiments I included a benzonase endonuclease step to minimise indirect 
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interactions mediated by DNA/RNA. A cell line expressing just the Flag-tag was 
used as a control. The protein complexes were then eluted in five fractions using a 
3xFlag peptide. An aliquot of each of the different elution fractions was analysed by 
western blot to determine which elution steps should be pooled and to ensure that 
the samples had not degraded (Figure 6.2). Elutions 2-4 were combined and the 
samples concentrated to a suitable volume. 
 
 
 
Figure 6.1 The Flag-Snw1 expressing cell line 
A HEK393T cells were stably transfected with a plasmid expressing Flag-SNW1 and 
clones were analysed by western blotting.  Cell line B11 was selected for further 
experiments. 
B A representative example of a coomassie stained 12.5% SDS-PAGE of Flag-IP 
samples submitted for mass spectrometry analysis. A Flag expressing cell line was 
used as a control. 
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Figure 6.2 Western blot analysis of Flag elutions 
Western blot analysis of the different Flag elutions using a Flag-HRP antibody to 
determine which elutions should be pooled. 
 
 
The samples were then run on a 12.5% SDS-PAGE and Coomassie stained 
(Figure 6.1B). The relevant lanes were cut into 1 mm thick stripes and submitted for 
analysis by mass spectrometry. To determine SNW1 interaction partners, proteins 
were selected that were only present or significantly more abundant in the Flag-
SNW1-IP compared to the IP from the Flag only expressing cell line (Appendix 4). 
This was subsequently confirmed by intensity-based absolute quantification (iBAQ), 
which normalises peak intensities to the theoretically observable peptides and thus 
provides an accurate estimation of protein levels ((Schwanhausser et al., 2011), 
Appendix 5). Moreover, I considered a published list of common background 
contaminants from the Flag-IP procedure in HEK293 cells (Chen and Gingras, 
2007). 
Snw1 has been described as a component of the spliceosome in 
S.cerevisiae, S.pombe and H.sapiens in several independent screens (Neubauer et 
al., 1998, Ajuh et al., 2000, Gavin et al., 2002, Ohi et al., 2002, Zhou et al., 2002). 
Similarly, I found SNW1 to be associated with splicosomal proteins, especially 
components of the Cdc5/Prp19 subcomplex, which is part of the B* and C 
complexes and the post-spliceosomal species (Albers et al., 2003, Makarov et al., 
2002) Figure 6.3, Appendix 1).  
My analysis also identified interactions with many chromatin-associated 
proteins such as SWI/SNF complex components and histone modifiers such as 
SETD2, RUVBL1 and RUVBL2 (Appendix 2). This is in agreement with the concept 
of a tight coupling of transcriptional processes, chromatin modifications and splicing 
(Montes et al., 2012).  
Chapter 5. Results 
 
 154 
To validate the results obtained using mass spectrometry analysis, I 
performed co-IPs of SNW1 using the Flag-SNW1 expressing cell line (Figure 6.4A) 
as well endogenous IPs when possible (Figure 6.4B). I corroborated the specific 
interaction of SNW1 with several spliceosome-associated proteins. As described in 
the previous chapter, SNW1 was proposed to interact with the transcriptional 
repressor SKI, which is a negative regulator of the BMP signalling pathway (Wang 
et al., 2000)(1.4.2.4). Hence the alternative name for SNW1, SKIP (SKI-interacting 
protein). However, I could not detect such an interaction either by mass 
spectrometry or co-IP, consistent with previous results from our lab (Wu et al., 
2011). 
 
 
 
 
 
Figure 6.3 Schematic diagram of spliceosomal and snRNP remodelling events 
(adapted from (Makarov et al., 2002)) 
Complexes in dark blue contain SNW1.  
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Figure 6.4 Validation of SNW1 interaction partners using IP 
(A) Flag-IP from whole cell extracts of HEK293T cells expressing FLAG-SNW1. 
(B) Endogenous IP for SNW1 from HEK293T whole cell extracts. 
Western blotting was performed using the indicated antibodies. 
 
 
Taken together, my analyses confirmed that SNW1 is associated with the splicing 
machinery. It was therefore important to analyse transcripts isolated from snw1 
morphants for splicing defects. I also identified interactions with factors involved in 
chromatin remodelling and transcriptional processes, thus confirming known and 
identifying new Snw1 binding proteins. 
 
6.2.2 SNW1 is phosphorylated 
Analysis by mass spectrometry not only provides information about the peptide 
sequences present in a specific sample but also about certain posttranslational 
modifications such as phosphorylation, acetylation and ubiquitination (Witze et al., 
2007). I found that SNW1 is phosphorylated at serine 224 (S224) close to the 
central SNW motif (Figure 6.5A). Treatment of 293T cell lysates with calf intestinal 
phosphatase (CIP) led to a shift in the migration of SNW1 on a SDS-PAGE (Figure 
6.5B). This shift is specific to phosphorylation at S224 as mutation of this site to 
Chapter 5. Results 
 
 156 
alanine (S224A) resulted in a loss of the SNW1 shift upon addition of CIP (the 
mutation of S224 was introduced by Becky Randall). The efficiency of the CIP 
treatment was demonstrated by monitoring the loss of PSmad1/5 in the treated 
lysates (Figure 6.5C).  
 
 
 
Figure 6.5 SNW1 is phosphorylated at serine 224 (S224) 
(A) SNW1 protein detected by mass spectrometry and visualised using Scaffold 
software. The sequence coverage is highlighted in yellow. Green marks the amino 
acids oxidised methionine (M) and carbamidomethyl cysteine (C). Red Boxes indicate 
the motif surrounding the phosphorylated S224 and the central SNW motif.  
(B) Whole cell extract from HEK293T cells expressing either wild-type (wt) Flag-SNW1 
or Flag-SNW1 S224 were treated with CIP and analysed by western blotting using an 
antibody against Flag. 
(C) Whole cell extracts were treated with CIP and analysed by western blotting using 
an antibody against PSmad1/5. MCM6 is a loading control. 
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This PPSPP motif containing the S224 phosphorylation site is conserved 
across species, indicating an important role in regulating SNW1 function (Wu et al., 
2011). It will be necessary to determine the function of the phosphorylation for 
example regarding whether it is required for the interaction with other proteins. 
 
6.2.3 Analysis of bmp2b transcripts in snw1 morphant zebrafish embryos 
As described in the previous chapter, zebrafish snw1 morphants lack BMP activity 
and Bmp2b protein despite an increase in bmp2b transcript levels at the NPB. This 
strongly suggests a possible defect in mRNA processing. My mass spectrometry as 
well as analysis of the spliceosome in other studies implicated Snw1 in pre-mRNA 
splicing. Therefore I asked whether I could observe an increase in unspliced 
bmp2b in embryos lacking Snw1. For this purpose I designed various primer pairs 
along the bmp2b transcript covering exon/exon and exon/intron boundaries (Figure 
6.6). 
 
 
Figure 6.6 Primers designed for qRT-PCR along the bmp2b transcript 
Primer pairs were designed to cover the bmp2b transcript and evaluate relative 
amounts of spliced and unspliced mRNA present in a sample. Arrows indicate the 
location of the primer pair along the transcript. 
 
I then isolated total RNA from snw1 morphants and generated cDNA. As it 
was not clear whether potentially unspliced mRNA is polyadenylated or is rapidly 
degraded, I tested oligodT versus random primers for the cDNA reaction but did not 
find any significant difference in the subsequent analysis (data not shown). For 
each primer pair the data is depicted relative to the transcript levels present in 
control MO injected embryos (set as 1). This allows for the comparison of transcript 
levels amplified by a specific primer pair but not between primer pairs. Injection of 
Chapter 5. Results 
 
 158 
an increasing amount of snw1 MO resulted in higher levels of bmp2b as observed 
in ISH (Figure 6.7A, Figure 5.12). However, there did not appear to be a bias 
towards unspliced versus spliced bmp2b mRNA, but a general, partially dose-
dependent, increase in transcript abundance. This was not a general effect on 
transcripts at the NPB, as for example dlx3b expression was not changed (Figure 
6.7B). A previous study had shown that the effect of Snw1 depletion on BMP 
activity monitored by PSmad1/5 levels can only be observed after the end of 
gastrulation/early somitogenesis (Wu et al., 2011).  
 
 
Figure 6.7 qRT-PCR analysis of bmp2b and dlx3b mRNA in zebrafish snw1 
morphants 
(A) qRT-PCR analysis of bmp2b mRNA from 4 somite stage embryos injected with the 
indicated MO. Primers used cover the exon/intron and exon/exon boundaries as 
indicated on the x-axis.  
(B) Analysis on embryos as above using primers against dlx3b. 
(C) bmp2b qRT-PCR analysis from 75% epiboly stage embryos. 
All RNA levels were normalised to ef1α. Shown are representative experiments. Error 
bars are standard deviations from technical replicates.  
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Similarly there is no effect of loss of Snw1 on the bmp2b transcript at 75% 
epiboly (Figure 6.7C), presumably as maternally deposited protein is still present at 
this stage (Wu et al., 2011). 
In summary, qRT-PCR confirmed a specific increase in bmp2b mRNA levels 
during early somite stages as observed with ISH. However, this did not seem to be 
due to an accumulation of unspliced versus spliced transcripts. 
 
6.2.4 RNA sequencing to identify Snw1 targets 
Snw1 is broadly expressed during development ( 
Figure 5.4) and interacts with components of ubiquitously used protein complexes, 
suggesting that very likely additional Snw1 targets exist. I therefore wanted to 
perform RNA sequencing to monitor global changes in the RNA expression pattern 
in snw1 morphants. The initial approach was to perform total RNA sequencing as I 
was concerned I might miss crucial effects if I was enriching for polyadenylated 
mRNA. The caveat of this approach, however, is that approximately 80% of the 
total RNA is comprised of rRNA, which can complicate the noise/signal detection 
by RNA sequencing. I therefore tested a rRNA removal kit that was predicted to 
work for zebrafish total RNA (Ribo-ZeroTM). The technical difficulties of 
“accumulating” sufficient purified RNA for efficient RNA sequencing, however, were 
such that I decided to perform conventional mRNA sequencing, especially as qRT-
PCR analysis suggested that data acquired using polyadenylated RNA yielded 
similar results to using total RNA (6.2.3).  
 
 
  NGS  MO Reads Alignments Unique Alignments 
NGS-1406  cont. 44600082 42857846 10620088 
NGS-1407 15 ng snw1 42471691 41539904 9440902 
NGS-1408  20 ng snw1 44216231 34498353 4340922 
NGS-1409 cont. 40758884 36528173 4114581 
NGS-1410  10 ng snw1 27233645 29286162 4463890 
NGS-1411 15 ng snw1 27928944 25086140 4288667 
 
Table 6.1 RNA sequencing raw data 
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 NGS-1406 NGS-1407 NGS-1408  NGS-1409 NGS-1410  NGS-1411 
 
cont. 
15 ng 
snw1 
20 ng 
snw1 cont. 
10 ng 
snw1 
15 ng 
snw1 
bmp2b 638 1673 1888 693 1357 2334 
dlx3b 2204 2440 1839 1651 2124 2223 
 
Table 6.2 bmp2b and dlx3b raw reads 
 
RNA sequencing was performed on RNA extracts from embryos injected 
with either control or snw1 MO. Two independent experiments were analysed. For 
each experiment a different batch of snw1 MO was used. Please note that the 
second batch of snw1 MO was more active compared to the one used for the first 
set of experiments. Therefore, I lowered the amount of MO injected from 15 and 20 
ng to 10 and 15 ng. For subsequent statistical analysis the data was grouped in 
lower and higher MO dose. 
The analysis of the RNA sequencing data was performed in collaboration 
with Richard Mitter (LRI Bioinformatics Department). The library size slightly varied 
for the different samples (Table 6.1) but encouragingly the read counts for bmp2b 
followed the expected pattern (Table 6.2). We therefore decided to go ahead with 
the analysis using the following parameters: A false discovery rate (FDR) ≤	 0.05 
and an absolute fold change between control and the lower amount of snw1 MO of 
at least 2 fold. I also included only genes with a raw read count of 200 or more in 
either the control sample or the sample injected with the lower dose of snw1 MO 
(heatmap in Appendix 3). For comparison of samples from the different libraries, 
the count numbers were normalised to counts per million reads (CPM). Thus we 
identified 418 gene transcripts that were significantly changed upon loss of Snw1 in 
the cont. versus lower dose of snw1 MO samples. Around two/thirds of these 
genes were significantly increased, where 130 were decreased. The complete lists 
of the datasets with the cut off can be found on a disc as Appendix 6 and 7: (FDR) 
≤	 0.05, fold change > 2 between cont. MO and lower/higher amount of snw1 MO, 
read count ≥ 200 in one of the samples. 
 I also wanted to test whether intronic reads are overrepresented in Snw1-depleted 
samples. For a crude analysis it was assumed that all reads that map within a 
transcript but were not overlapping with an exon must be intronic. The cut off 
criteria were as above but a read number of ≥ 30 was accepted. Although statistical 
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analysis yielded some significantly changed targets, the read number in introns 
overall was low, so no general trend could be identified (Appendix 8). Visual 
analysis of the data using IGV software indicated that there might be a 3’-UTR bias 
present in snw1 morphants. Therefore the average RNA sequencing read coverage 
along the transcripts of significantly changed genes was analysed to identify 
whether there is a general 3’ bias as an artefact of the RNA sequencing or a 
significant Snw1-dependent change. However, the read coverage seemed even 
along the transcripts with the exception of NGS-1409, which is a control sample, 
and thus the effect is most likely an artefact of the library preparation (Figure 6.8). 
 Taken together, embryonic loss of Snw1 effects the transcript levels of many 
genes and mostly leads to an increase rather than a reduction in transcript 
abundance. However, no obvious defect in splicing could be detected nor a bias in 
read numbers along transcripts. This reflects what I had observed analysing bmp2b 
transcript by qRT-PCR (Figure 6.7). I next validated selected targets by qRT-PCR. 
 
6.2.5 RNA sequencing validation 
I next went on to validate possible targets identified in the RNA sequence analysis 
and designed primers for qRT-PCR along the transcripts (Table 6.3). I chose 
targets that were expressed at the right developmental stage and domain to be 
snw1 dependent (Thisse et al., 2001). More than one primer pair was designed if 
there were interesting features regarding reads along the transcripts observed, 
such as high read density in an intron. 
All the differentially expressed transcripts selected validated in qRT-PCR, giving 
me confidence in the general RNA sequencing setup and analysis (Figure 6.9). In 
general, when several primer pairs per transcript were chosen, there did not seem 
to be strong differences in the expression levels, confirming the previous analyses 
that loss of Snw1 does not result in a significant change in pre-mRNA processing. 
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Figure 6.8 RNA sequencing coverage along the transcript 
Read density along the transcript depicts the normalised coverage (with regard to 
library size) over the normalised distance along the transcript to identify a possible 
accumulation of reads in a specific region of the transcript. 
 
 
  
Symbol
15ng_Vs_
Ctrl.FDR
20ng_Vs_
Ctrl.FDR Description
NGS-
1406.CPM
NGS-
1409.CPM
NGS-
1407.CPM
NGS-
1410.CPM
NGS-
1408.CPM
NGS-
1411.CPM
cont. cont.
15 ng 
snw1
20 ng 
snw1
10 ng 
snw1
15 ng 
snw1
gadd45aa 1.87E-16 4.16E-20
growth arrest and DNA-
damage-inducible, alpha, 
a 4 2 139 202 141 434
RBL2 1.69E-12 2.20E-13
retinoblastoma-like 2 
(p130) 11 2 241 253 212 348
foxo3b 1.36E-08 5.31E-09 forkhead box O3b 26 7 294 359 223 488
sesn3 1.36E-08 1.71E-09 sestrin 3 87 37 1042 863 841 1414
mdm2 7.69E-09 7.66E-10
transformed 3T3 cell 
double minute 2 homolog 105 59 1111 1186 1000 1687
mat2al 5.65E-09 3.64E-12
methionine 
adenosyltransferase II, 
alpha-like 20 19 201 173 243 321
phlda2 5.89E-06 1.33E-08
pleckstrin homology-like 
domain, family A, member 
2 12 6 75 65 64 154
lnx1 2.87E-08 1.31E-08 ligand of numb-protein X 1 16 8 150 99 119 141
rasl11b 0.00271 4.89E-06
RAS-like, family 11, 
member B 25 47 123 263 177 513
DEM1 4.45E-10 2.28E-09
defects in morphology 1 
homolog (S. cerevisiae) 17 18 179 145 129 166
rps6ka3a 9.49E-05 9.21E-06
ribosomal protein S6 
kinase, polypeptide 3a 56 36 306 204 275 329
foxi1 0.00015 1.05E-05 forkhead box i1 18 16 73 104 71 143
cdkn1a 
(p21) 6.80E-05 7.76E-06
cyclin-dependent kinase 
inhibitor 1A 10 9 47 56 55 65
 
Table 6.3 List of RNA sequencing targets for validation 
List of selected targets for validation. Read numbers were normalised to counts per 
million (CPM). Control MO (NGS-1406; NGS-1409), 10 ng (NGS-1407; NGS-1410) 
snw1 MO, 15 ng (NGS-1408; NGS-1411) snw1 MO. 
 
 
 
Taken together, global analysis of mRNA transcripts in zebrafish snw1 
morphants does not suggest an accumulation of unspliced mRNA upon Snw1 
depletion. However, transcript levels are significantly increased for specific genes 
suggesting that Snw1 indeed is important for the regulation of transcriptional 
processes. 
 
 
Chapter 5. Results 
 
 164 
 
 
 
Figure 6.9 qRT-PCR for RNA sequencing validation 
All RNA levels were normalised to ef1α. The values detected for the control situation 
were set to 1 and morphants adjusted accordingly to measure the fold-induction. 
 
6.2.6 Function of SNW1 interaction partner 
I and others have demonstrated that Snw1 is associated with components of the 
splicing machinery (6.2.1, (Zhou et al., 2002)). I therefore asked next, whether loss 
of spliceosomal interaction partners recapitulates the phenotype as depletion of 
Snw1. I chose spliceosome-associated proteins that were either U5 specific (Prp8), 
part of the Prp19 complex, which is involved U5 remodelling, (Prp19) and an RNA 
helicase, required for release of the RNA from the spliceosome, (Dhx8). Using a 
morpholino approach I knocked down prp8, prp19 and dhx8, which all display a 
similar expression pattern to snw1 (Thisse et al., 2001), and monitored levels of the 
NC marker sox10. Loss of Prp8 and Prp19 reduced expression of sox10, whereas 
depletion of Dhx8 did not have any effect on NC (Figure 6.10).  
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Figure 6.10 NC development in Snw1 interaction partner morphants 
ISH against sox10 on embryos injected with 10 ng of cont. MO, prp8 Mo, prp19 MO or 
dhx8 MO. Numbers indicate the embryos with the observed phenotype for a 
representative experiment. Dorsal view with anterior to the top. 
 
 
 
 
 
Figure 6.11 bmp2b transcript levels in Snw1 interaction partner morphants 
ISH against sox10 and bmp2b on embryos injected with 10 ng of the indicated MO. All 
views are dorsal anterior, anterior to the op. The embryos in the bottom panel 
correspond to embryos above but are laterally tilted to allow for a better view of the 
NPB. Numbers indicate the embryos with the observed phenotype for a representative 
experiment. Dorsal view with anterior to the top. 
Embryos were fixed at 3 somites.  
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As I previously demonstrated snw1 morphants have increased bmp2b 
transcript levels at the neural plate border (Figure 5.12). I therefore tested whether 
this can be observed in other “splicing” morphants as well.  Although, both loss of 
Prp8 and Prp19 resulted in a NC phenotype, only prp8 morphants displayed 
increased levels of bmp2b specifically at the NPB (Figure 6.11). This observation 
could be confirmed in qRT-PCR (Figure 6.12).  
To test whether targets identified in the RNA sequencing are dependent on 
other splicing factors similar to Snw1, I performed qRT-PCR analysis for bmp2b 
and some of the validated targets. Interestingly, loss of Prp8 had a similar effect on 
the transcript levels as snw1 depletion, indicating that both proteins must function 
using a similar mechanism (Figure 6.12, Figure 6.7). Similarly, the abundance of 
Snw1 targets identified by RNAseq increased in prp8 morphants (Figure 6.13). Also 
the fold-increase for the specific transcripts was very similar in snw1 and prp8 
morphants (Figure 6.9). Loss of prp19 or dhx8 only had a mild effect on transcript 
levels, however it was significant in the cases of the more strongly induced targets 
such as gadd45aa and rbl2. This indicated, that loss of these proteins has similar 
effects to loss of Snw1 and Prp8, however, less pronounced. I can not exclude that 
the knockdown of the splicing components Prp19 and Dhx8 did not yield the same 
phenotype because their function could partly be rescued by redundant factors as 
opposed to both proteins being involved in a different mechanism.  
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Figure 6.12 qRT-PCR for bmp2b 
qRT-PCR on RNA isolated from embryos injected with 10 ng of the indicated MO. RNA 
levels were normalised to ODC. The values detected for the control situation were set 
to 1 and morphants adjusted accordingly to measure the fold-induction. 
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Figure 6.13 qRT-PCR on RNA sequencing targets 
qRT-PCR on RNA isolated from embryos injected with 10 ng of the indicated MO. RNA 
levels were normalised to ODC. The values detected for the control situation were set 
to 1 and morphants adjusted accordingly to measure the fold-induction. 
 
 
6.2.7 The NC/BMP activity are sensitive to defects in the transcriptional 
machinery 
A recent study identified a small molecule suppressor of NC development in 
zebrafish (White et al., 2011). Leflunomide belongs to a class of compounds that 
inhibit dihydroorotate dehydrogenase (DHODH), an enzyme required for pyrimidine 
synthesis. Inhibition of DHODH thus results in an impairment of transcriptional 
elongation.  
 As the phenotype and the processes involved are similar to what I observed 
in snw1 morphants, I asked whether inhibition of transcriptional elongation could 
have an effect on BMP activity as well and might thus explain the NC phenotype in 
leflunomide-treated embryos. Indeed, embryos exposed to leflunomide displayed a 
defect in NC development and reduced sox10 expression. Interestingly, BMP 
activity was inhibited in treated Tg(BRE:mRFP) embryos and consistent with a loss 
of BMP signalling phenotype the krox20 expression domain, marking the hindbrain, 
was slightly expanded. Expression of ncad in the NP and hgg in the hatching glad 
was not altered. Preliminary data indicates that there is no increase in bmp2b 
transcript levels detected by ISH and qRT-PCR (data not shown). 
In summary this result suggests that BMP signalling is sensitive to 
alterations in transcriptional elongation/splicing processes but that Leflunomide and 
Snw1 perturb BMP activity by different mechanisms. 
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Figure 6.14 Leflunomide inhibits BMP activity 
ISH using the indicated probes on embryos treated from 4 hpf onwards with DMSO or 
6.5 µM Leflunomide. Numbers indicate the embryos with the observed phenotype for a 
representative experiment. Dorsal view with anterior to the top. 
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6.3 Discussion 
6.3.1 Summary of results 
• Snw1 is part of the protein machinery that regulates splicing and 
transcriptional processes.  
• Snw1 is phosphorylated at serine 224. 
• bmp2b mRNA levels are increased in snw1 morphants, but there is no 
accumulation of unspliced transcripts. 
• RNA sequencing identified more than 400 transcript that were significantly 
changed upon depletion of Snw1. 
• The read-density was equally distributed along transcripts and there was no 
apparent bias towards unspliced pre-mRNAs. 
• Depletion of Snw1 interaction partners partly recapitulates the Snw1 
morphant phenotype. 
• Chemical inhibition of transcriptional elongation also affects NC 
development and BMP activity. 
6.3.2 SNW1 interaction partners 
As discussed in the previous chapter, Snw1 has been identified as part of the 
active spliceosome in several independent analyses. Using mass spectrometry I 
confirmed many of the reported interactions, predominantly with U5snRNP specific 
proteins such as PRP8 and SNRNP200, and catalytic step II and late acting 
proteins such as DHX8 and DHX38 (Figure 6.3). In addition, SNW1 associates with 
non-snRNP spliceosome assembly proteins, for example CDC5L, CRNKL1 and 
PRP19.  
Interestingly SNW1 also interacts with many histone modifiers that might act 
to control transcriptional and co-/post-transcriptional processes such as 
components of the SWI/SNF complex (Tyagi et al., 2009) and SETD2 (Carvalho et 
al., 2013). There has been accumulating evidence for a functional connection 
between transcription and splicing, with these processes co-regulating each other 
(Montes et al., 2012). Splicing is now thought to occur co-transcriptionally and that 
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this is important for the regulation of gene expression such as through alternative 
splicing. How this is thought to be regulated I will discuss in the following section.  
Although I could confirm some of the reported interactions, I failed to detect many 
other binding partners. In fission yeast the Snw1 homologue spSNW1 has 
previously been shown to interact with the 3’ recognition complex subunit U2AF35 
(Ambrozkova et al., 2001) and recombinant SNW1 has been reported to bind 
U2AF65 from HCT116 nuclear extracts (Chen et al., 2011). As already mentioned 
in the introduction, this interaction is proposed to be required for loading of U2AF65 
onto the unspliced p21 pre-mRNA in a gene specific manner. In my analysis I only 
identified very low numbers of peptides for these U2snRNP specific proteins. In 
general, components of the U2snRNP particle were underrepresented and 
appeared more nonspecific/indirect compared to, for example, proteins of the 
activated spliceosome and the U5snRNP. Thus, my data suggest an involvement 
of SNW1 in the splicing process after splice site recognition. 
In addition to splicing, Snw1 has been implicated in many cellular processes 
and pathways as outline in Chapter I (1.4.2). Snw1 was reported to interact with 
and enhance the activity of transcription factors such as Smad2/3, vitamin D 
receptor and the Notch intracellular domain (NotchICD) amongst others (for review 
(Folk et al., 2004)). Also, Snw1 has also been demonstrated to interact with 
components of the Wnt signaling pathway, such as β-catenin, thereby regulating 
Wnt signaling activity during NC development (Wang et al., 2010b). I could not 
detect binding with any of these suggested partners. The reason for this could be 
varying stringencies in the experimental setup. In addition, some of the interactions 
might be cell type/tissue specific. However, many of the proposed binding partners 
have been identified using yeast two-hybrid, recombinant proteins and 
immunoprecipitation with high overexpression of at least one of the components. In 
my analysis I used Flag-SNW1 expressed at endogenous levels and validated 
interaction partners by endogenous IPs. Overall, I detected traces of many proteins 
at low number in mass spectrometry that appeared to be nonspecific contaminants. 
It is conceivable that when hugely overexpressed, the system is forced into false-
positive interactions. Interestingly, stretches of the Snw1 protein are suggested to 
be present as partially unfolded in a native state and undergo refolding upon 
binding of an interaction partner (Folk et al., 2004). It thus presents a structure, 
which is ideal to flexibly interact with many proteins. However, this fact might also 
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render Snw1 prone to nonspecific binding under the above-mentioned conditions. 
Thus my analysis shows the difficulties in genuinely validating in vivo protein 
interactions and indicates that some of the reported Snw1 interactions may have to 
be reevaluated. However, the association of Snw1 with the spliceosome has been 
sufficiently proven. Given the array of additional binding partners it is possible that 
Snw1 plays a role in the coupling of transcription and splicing. I will discuss this 
further below. It will also be important to assess the function of Snw1 S224 
phosphorylation revealed by mass spectrometry. 
6.3.3 The role of Snw1 in co-transcriptional processes 
RNA polymerase II (RNAPII) binding to the core promoter of genes depends on the 
promoter sequence and the surrounding chromatin landscape and requires a wide 
range of transcription factors. During the transcriptional process, modification of the 
carboxyl terminal domain (CTD) of the large RNAPII subunit is important for the 
control of transcriptional and co-transcriptional processes such as pre-mRNA 
capping, 3’ end-processing and splicing (Hsin and Manley, 2012). The different 
modification patterns lead to the timely recruitment of factors to the CTD and thus 
the nascent transcript, which are required at various specific transcriptional stages 
for correct processing of the transcript (Figure 6.15A). Phosphorylation of the CTD 
at Ser5 triggers release of RNAPII from the promoter and the recruitment of histone 
modifying complexes for the trimethylation of histone H3 at Lys4 (H3K4me3) at 
proximal nucleosomes. H3K4me3 is required for transcription initiation (Vermeulen 
et al., 2007) and recruitment of splicing machinery (Sims et al., 2007). After 
initiation the RNAPII is temporally paused through the negative elongation factor 
complex (NELF) possibly to give time for recruitment of necessary factors. Pausing 
is reversed by the positive transcription elongation factor P-TEFb (Cyclin T1:CDK9), 
which phosphorylates Ser2 in the CTD of RNAPII. This in turn facilitates the 
recruitment of the SETD2 histone modification complex and H3K36me3 during 
transcriptional elongation. H3K36me3 marks are not evenly distributed along the 
gene, but are, for example, enriched in exons over introns (Kolasinska-Zwierz et al., 
2009, Wilhelm et al., 2011) and towards the 3’ end of a gene (Bannister et al., 
2005). This might influence the pausing and elongation rate of RNAPII. 
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Interestingly, splicing increases the recruitment of SETD2 and subsequently 
trimethylation of H3K36 (de Almeida et al., 2011). 
So far it is clear that Snw1-depletion in zebrafish does not lead to the 
general repression of bmp2b transcription, which might have explained the loss of 
BMP activity at the neural plate border. In contrast, bmp2b transcript levels are 
locally increased at the NPB, where Snw1 is no longer expressed. However, these 
accumulated transcripts do not appear to be translated into Bmp2b protein 
indicating defects in correct pre-mRNA processing. 
Snw1 binds to promoters as well as transcribed regions, and has been 
implicated in both, transcriptional elongation and co-transcriptional splicing as 
already described in the introduction (Bres et al., 2005, Bres et al., 2009, Chen et 
al., 2011). SNW1 associates with PTEFb and is required for Tat-dependent HIV-1 
transactivation (Bres et al., 2005, Bres et al., 2009). This step is dispensable under 
stress such as UV-treatment. However, SNW1 is necessary for p53 stress-induced 
p21 protein expression by gene specifically controlling p21 splicing (Chen et al., 
2011). Interestingly, CDK9 was one of the interaction partners I detected using 
mass spectrometry, albeit in comparably small amounts. I therefore tested whether 
similar effects as described in Chen et al. can be observed in zebrafish snw1 
morphants. Indeed, p21 is a possible target of zebrafish Snw1 as identified by 
RNAseq. However, in contrast to my observations, Chen et al. did not detect 
elevated but reduced levels of p21 mRNA. I confirmed the reduction in p21 mRNA 
in MDA-MB-231 cells upon loss of SNW1, thus there seems to be an opposite 
effect in embryos and tissue culture cells. Due to the lack of a specific antibody I 
could not test p21 protein expression in Snw1-depleted zebrafish embryos. I did not 
observe differences in the splicing efficiency between wild-type and morphant 
embryos. It is not clear how exactly the authors calculated the ratio of 
spliced/unspliced transcripts and to what extent, for example, primer efficiencies 
were taken into account. It will be interesting to test whether in addition to p21 there 
is an overlap of targets affected in tissue culture cells and in embryos when Snw1 
is lost. However, my data do not indicate a general defect of bmp2b pre-mRNA 
splicing nor did I find evidence for other transcripts not being spliced. 
An explanation for the observed discrepancies might be that differences in 
the regulation of co-transcriptional processes during development and mammalian 
cells, as used by Chen et al., exist. The cell cycle rate is much higher in the 
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developing embryo and the timing and pattern of transcriptional processes are 
critical. This may account for mechanistic differences in ensuring robust, 
coordinated gene expression. The stability of unspliced pre-mRNA and RNA 
turnover processes in general, for example, could differ. Work in yeast shows that 
unspliced pre-mRNA is usually rapidly degraded. Depending on which splicing step 
is disturbed, this occurs by a nuclear or a cytoplasmic decay pathway or nonsense-
mediated decay (Bousquet-Antonelli et al., 2000, Hilleren and Parker, 2003, Sayani 
et al., 2008). These pathways could be leveraged differentially in different biological 
setups. Moreover, it has been suggested that RNA surveillance mechanisms can 
mask the effects of mutations in spliceosomal components (Kawashima et al., 
2009). Snw1 has also been implicated in the nuclear export of mRNA (Farny et al., 
2008). Impaired transport of mRNA into the cytoplasm might account for the 
transcript accumulation I observe and prevent protein translation. It will be 
important to test whether mRNA decay and/or cellular localisation is changed upon 
loss of Snw1. In SNW1 depleted mammalian cells, the nuclear export of mRNAs 
under DNA damage conditions was not changed (Chen et al., 2011). However, this 
may differ during vertebrate development.  
Another possible explanation for the accumulation of transcripts in snw1 
morphants, is a change in RNAPII occupancy/elongation rate, assuming that none 
of the required factors is limiting (Figure 6.15B). Interestingly, a change in the 
elongation rate has been linked to the use of cryptic splice sites as well as 
alternative splicing (de la Mata et al., 2003) and there is data suggesting that this 
can be influenced by histone deacetylation (Hnilicova et al., 2011, Allo et al., 2009). 
Loss of SETD2, and thus H3K36me3, results in an increased occupancy at internal 
exons and intragenic transcription initiation in a subset of active genes (Carvalho et 
al., 2013). Data also suggests that H3K36 methyl groups is required to dampen the 
activity potential of just transcribed regions thus regulating transcription levels 
{Carrozza, 2005 #434;Keogh, 2005 #435}. It is possible that Snw1 is required to 
recruit factors such as SETD2 that modulate RNAPII travelling speed and pausing 
thus altering the abundance of the wild-type ‘mature” transcript. Indeed, 
unpublished data from yeast suggests that in temperature sensitive Snw1 mutants 
the RNAPII elongation rate as well as transcript levels are increased (Prof. Jean 
Beggs, personal communication). 
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Figure 6.15 Possible role of SNW1 in co-transcriptional processes 
(A) Transcription by RNAPII is regulated at various steps. After initiation Ser5 (S5) 
phosphorylation of the CTD leads to the release of RNAPII from the promoter whereas 
subsequent Ser2 (S2) phosphorylation results in the elongating form RNAPII. This is 
accompanied my modification of the surrounding chromatin. SNW1 can be found in 
complexes containing PTEFb (yellow), which is required for Ser2 phosphorylation. It 
might also interact with SETD2 a factor important for H3K36me3.  
(B) Loss of SNW1 could possibly interfere with RNAPII Ser2 phosphorylation as well 
as directly or indirectly with H3K36me3 thus leading to an accumulation of un- or 
alternatively spliced transcript. 
 
It will be important to further analyse the RNAseq data also using newly available 
custom-built libraries to accurately analyse for example the use of cryptic splice 
sites {Markmiller, 2014 #433} 
 As previously described, Snw1 is part of the PRP19 splicing complex (6.2.1). 
A recent study has identified that in yeast this complex is absolutely required for the 
recruitment of the TREX complex, which couples transcription to mRNP export, to 
actively transcribed genes (Jimeno et al., 2010, Chanarat et al., 2011). This 
complex is conserved in higher eukaryotes. Depletion of the PRP19 complex 
component Syf1 (the yeast homologue of XAB2, another Snw1 binding partner, 
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Appendix 1) and the resulting loss of TREX recruitment decreases transcriptional 
activity (Chanarat et al., 2011). The lower mRNA level observed in this 
experimental setup more resembles the phenotype observed in mammalian cells 
lacking SNW1 and does not reflect the observations in zebrafish snw1 morphants. 
However, I have shown that depletion of Prp19 in zebrafish embryos results in an 
impaired NC development and an increase in mRNA levels of specific targets, 
although the phenotype on transcripts is not as pronounced as upon loss of Snw1. 
This may again indicate that disruption of similar processes can have different 
outcomes during development versus cell maintenance.  
Taken together, Snw1 possibly is another player in the functional coupling of 
transcription and co-transcriptional processes. It will be important to assess 
transcriptional elongation rates in Snw1 depleted cells as well as modifications to 
the histone landscape. Moreover, Snw1 ChIPs on DNA from zebrafish embryos for 
targets identified by RNAseq will answer whether Snw1 directly binds to these 
genes or whether the increase in some transcript levels is an indirect effect of 
Snw1 depletion. I am also testing antibodies to determine whether protein 
expression is abolished even if certain mRNAs are more abundant in snw1 
morphants, similar to bmp2b. This is currently hampered by a lack of suitable 
antibodies against many zebrafish proteins. In addition, I will perform RNAPII 
ChIPs or global analysis like global run-on sequencing (GRO-seq) to identify 
whether presence of RNAPII is augmented in Snw1 depleted embryos and whether 
there are differences in RNAPII dynamics. 
 Although I did not observe an increase in unspliced transcript in snw1 
morphants it is still a possibility that alternative splicing through for example RNAPII 
elongation rate results in a non-functional mRNA. This would explain the loss of 
Bmp2b proteins despite the presence of bmp2b. 
6.3.4 RNAseq reveals differential transcript levels in Snw1 zebrafish 
morphants 
Global analysis of the altered transcripts identified in RNAseq using the Database 
for Annotation, Visualization and Integrated Discovery (DAVID) suggests an 
overrepresentation of genes involved in DNA replication, DNA metabolic processes, 
the p53 signalling pathway and the regulation of apoptosis (data not shown). This is 
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in line with Fluorescence-activated cell sorting (FACS) experiments showing that 
tissue culture cells undergo G1 cell cycle arrest upon loss of SNW1 (data not 
shown). However, it is difficult to distinguish between direct and indirect effects of 
Snw1 loss in zebrafish as the RNA was isolated from around 13 hour old embryos. 
This means that the upregulation of genes related to cellular stress responses 
could be a result of the loss of crucial survival factors, which in turn leads to the 
induction cell cycle arrest and apoptosis by the time the analysis of the 
transcriptome was conducted. Gadd45aa for example is a growth arrest and DNA-
damage-inducible factor playing a role in this process. Similarly, Rbl2 and p21 
function as regulators of cell cycle progression and can mediate cell cycle arrest. 
As previously mentioned p21 has been identified as a SNW1 target in tissue culture 
cells {Chen, 2011 #161}. According to this Snw1 would be required for p21 protein 
expression thus higher transcript levels of p21 might not result in higher protein 
levels similar to our obervations regarding bmp2b. This example highlights another 
level of complication in the RNAseq data analysis. As mentioned in the previous 
chapter it will be crucial to identify if higher mRNA levels translate in higher protein 
abundance in order to speculate on a possible role of the identified targets. I will 
thus conduct more experiments using the tissue culture system as this will allow 
me to more easily distinguish between direct and indirect effects and give me 
access to a larger panel of antibodies to test protein expression levels of potential 
SNW1 targets. Moreover, my phenotypical analysis of Snw1 morphants has so far 
be restricted to ectodermal patterning. It is very likely that loss of Snw1 results in 
other developmental defects and it will be interesting to identify these and possibly 
correlate them with genes identified in the RNAseq. 
6.3.5 Depletion of Snw1 binding partners leads to gene specific effects 
As mentioned in the previous section, depletion of Prp19 resulted in a 
moderate increase of certain mRNA transcript levels and interfered with NC 
development. Loss of Prp8, another U5 snRNP specific protein, also abolished 
expression of NC cell markers. Interestingly, qRT-PCR revealed a similarly strong 
effect of Prp8 depletion on, for example, gadd45aa and rbl2 as loss of Snw1, 
indicating that both are part of the same mechanistic network. In contrast, loss of 
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Dxh8 did not have an effect on NC, although levels of some transcripts were 
elevated.  
Overall, it is astonishing that the depletion of general, and in yeast essential, 
splicing factors affects selective tissues such as the NC. However, this has been 
observed in several other contexts. Mutations in PRP8 cause the retina-specific 
disease retinitis pigmentosa, the most common form of inherited blindness (McKie 
et al., 2001). Similarly, zebrafish Dhx8 mutants display defects in early 
haematopoiesis (English et al., 2012). There are several possible explanations for 
these selective phenotypes. It is conceivable that some tissues are more sensitive 
to splicing/transcription defects than others. The retina is among the 
biosynthetically most active tissues in the body (Graziotto et al., 2011). Similarly, 
hematopoietic progenitors are highly proliferative. This might render these tissues 
more susceptible to suboptimal levels of pre-mRNA processing factors. However, 
other cell types are probably affected as well to a lesser extent and dhx8 and snw1 
mutant fish die within several days of development (Amsterdam et al., 2004, 
English et al., 2012). Another possibility is that splicing factors display gene 
specificity depending on the cellular context or different signalling inputs. This has 
been demonstrated for p21 pre-mRNA in the case of SNW1 (Chen et al., 2011). A 
microarray based approach in yeast also revealed transcript specific splicing of pre-
mRNAs for several core components of the splicing machinery (Pleiss et al., 2007). 
Thus, it is possible that some cell-specific pre-mRNAs are more affected by 
perturbation of co-/transcriptional processes leading to tissue-specific phenotypes. 
It would be interesting to determine whether Snw1 interacts gene specifically with a 
subset of binding partners. 
  
6.3.6 The neural crest is sensitive to defects in transcription elongation 
As discussed earlier, the rate of transcription elongation i.e. the speed RNAPII 
travels along a gene is an important regulatory mechanism for gene expression. 
Thus organisms should be sensitive to perturbation of transcription elongation rates. 
Indeed, in zebrafish mutants for the elongation factors Spt5 (foggy) and Spt6 
(pandora) show defects in heart and neuronal development (Cooper et al., 2005, 
Guo et al., 2000, Keegan et al., 2002). The specificity of the phenotypes is further 
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evidence supporting the idea that controlling processes such as transcription 
elongation and splicing is more critical in particular cell types and tissues. That this 
can have therapeutic implications has been demonstrated recently in zebrafish. A 
large-scale chemical screen identified a regulator for NC development that also 
inhibits melanoma growth (White et al., 2011). Leflunomide is an inhibitor of 
dihydroorotate dehydrogenase (DHODH), required for pyrimidine synthesis. 
Inhibition of DHODH thus impairs transcriptional elongation. I reasoned that if 
bmp2b is vulnerable to disruption of co-transcriptional/transcriptional processes, 
the NC phenotype observed in embryos treated with leflunomide might be due to 
an inhibition of BMP activity. Indeed, BMP activity, but not Wnt activity, was 
strongly reduced, underlining the sensitivity of particular transcripts to disruptions in 
transcriptional kinetics.  
 
Taken together, SNW1 appears to have functional roles outside of simply 
disrupting splicing, possibly in linking splicing to transcript elongation or nuclear 
export. There is accumulating evidence that changing levels of general factors of 
the transcriptional machinery can have gene specific as opposed to global effects 
thus affected particular tissues. How this is accomplished on a mechanistic level 
will be important to determine.  
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Chapter 7. Concluding Remarks and Future 
Perspectives  
The temporal and spatial control of signalling pathways is essential for tissue and 
organ formation during embryonic development. Elucidating the underlying 
mechanism has important implications for understanding diseases, as many of the 
embryonic circuits are redeployed in pathological contexts, for example in cancer.  
 For my PhD thesis project I wanted to understand how the BMP signalling 
pathway is regulated to allow for the induction and specification of the NC and 
other progenitor cells at the NPB. I identified a novel network of BMP regulators 
that explains how cell types with different requirements for BMP activity can be 
specified in close proximity. My work expands on the current gradient model and 
gives evidence for a two-step model, with distinct domains of BMP activity after 
gastrulation. Moreover, I investigated the function of the nuclear factor Snw1 in 
regulating BMP activity at the NPB during neural crest development. Interestingly, 
Snw1 is not directly involved in pathway activity downstream of the receptors, but 
appears to regulate gene-specific co-transcriptional processes with bmp2b being 
one of the targets.  
 Thus my work gives novel insight into processes regulating ectodermal 
patterning. I provide direct evidence for the existence of distinct BMP signalling 
domains at the NPB and suggest mechanisms by which they are established. I will 
discuss the implications of my studies in the following sections  
 
7.1 The use of transgenic zebrafish reporter lines 
With the emergence of different genetic and imaging tools, the zebrafish has 
increasingly proven to be an excellent model organism with which to study early 
vertebrate development and signalling dynamics. Transgenic lines, expressing 
fluorescent reporters under the control of tissue-specific promoters, have been 
used to analyses cell fate decisions and tissue interactions. Sox10:eGFP lines for 
example have been exploited extensively to identify and analyse NC derivatives 
(Carney et al., 2006, Kwak et al., 2013, Saxena et al., 2013). In order to fully 
understand tissue specification during development, as well as tissue homeostasis 
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and tumour growth, it is crucial to study the signalling pathways that regulate these 
processes. Many of the important pathways have been dissected at the cellular 
level and considerable effort has been made to understand how different pathways 
influence each other. Although this approach provides important information on the 
signal transduction cascades themselves, it lacks in vivo relevance. The 
identification of signalling pathway responsive cis-elements from relevant target 
genes has allowed for the generation of transgenic zebrafish lines suitable for 
studying in vivo signalling dynamics.  
For the BMP/GDF signalling pathway such a reporter line was generated in 
our lab using a well-characterised, specific BMP-responsive element (BRE) from 
the mouse Id1 enhancer, which binds phosphorylated Smad1/5–Smad4 complexes 
(Ramel and Hill, 2013, Wu et al., 2011). This line proved to be crucial for my 
studies of the BMP signalling dynamics at the NPB during ectodermal patterning, 
as it is more sensitive than immunostaining for PSmad1/5. To rely on transgenic 
reporter lines as a genuine read-out for pathway activity, several points have to be 
taken into account, such as the nature of the pathway responsive element and the 
selection of an appropriate reporter protein. The sensitivity of a reporter line can 
depend on the number of tandem repeats of the cis-elements used. Increasing this 
number can lead to an enhanced responsiveness, as seen for two independent 
Wnt reporter lines with 4 or 7 TCF/Lef elements upstream of a minimal promoter 
(Dorsky et al., 2002, Moro et al., 2012). The TCFsiam line, which contains 7 
elements, displays higher levels of mRNA and fluorescence as well as broader 
expression domains compared to the TOPdGFP line, which contains only 4. 
However, the two lines also make use of different minimal promoters (c-fos in case 
of TOPdGFP, siamois for TCFsiam), which could account for these differences. 
Moreover, the TOPdGFP transgenic line uses a destabilised version of GFP and 
thus fluorescent protein accumulation is inherently lower than would be expected in 
the TCFsiam line, which uses eGFP or mCHERRY. Thus in the TCFsiam line some 
of the domains where fluorescence is detected might indicate areas where Wnt 
signalling is no longer active. As mRNA is usually less stable than proteins, using 
mRNA expression as a readout can aid to give a more dynamic picture of the 
signalling events. This is also the case for the Tg(BRE:mRFP). I was using. The 
mRNA half-life of mRFP is less than 20 min compared to more than 12 hours for 
the protein. This is not only of importance with regard to the reporter protein but 
Chapter 6. Discussion 
 
 182 
also the mRNA. Whilst mRFP mRNA has a short half-life, for example, the half-life 
of eGFP is around 5 hours. This reflects the importance of choosing the right 
fluorescent protein for the intended purpose, as well stringent validation of 
transgenic reporter lines. To study dynamic signalling a short half-life of the 
reporter is desirable, whereas for cell linage tracking for example, a long half-life 
fluorophore is more useful. Generating reporter lines for different signalling 
pathways using distinct fluorophores enables simultaneous study of multiple 
pathways. 
Transgenic reporter lines have to be rigorously validated as genuine pathway 
read-out. There are different methods to validate ranging from genetic analysis to 
validation using pharmacological compounds. Thus modulating the targeted 
signalling pathways gives crucial information on the dynamic nature of the readout 
as well as signal specificity. This is important, as random multiple integration 
events of the transgene, as it occurs for example using Tol2 transgenesis, can 
result in a reporter being under the influence of their genomic environment e.g. 
enhancer elements. In order to eliminate false readouts by such positional effects, 
it is important to screen the progeny of several independent founder fish. Current 
literature can also give information on the expected reporter expression. The 
Tg(BRE:mRFP) has been validated in such a manner as outlined in the 
Introduction (1.3). 
Taken together, zebrafish transgenic reporter lines are proving to be a crucial 
tool to study signalling dynamics in living vertebrates as zebrafish are easy to 
manipulate and optically accessible. Already, pharmacological screens have 
identified novel pathway regulators (Gorelick and Halpern, 2011, Molina et al., 2009, 
Sanvitale et al., 2013). Moreover, pathway reporter lines will be very useful in 
combination with the emerging zebrafish disease models, for example for studying 
the signalling environment during tumour progression. Recent advances in 
developing direct tools for gene manipulation, such as zinc finger nucleases (Meng 
et al., 2008, Sander et al., 2011), TALEN mutagenesis (Bedell et al., 2012, Doyon 
et al., 2008, Huang et al., 2011) and the CRISPR/Cas system (Hwang et al., 2013), 
will open up a range new possibilities to target specific genes and create mutants 
with high efficiency. 
Chapter 6. Discussion 
 
 183 
7.2 Integrating Snw1 function into the two-step model of BMP 
activity 
As discussed earlier, previous studies in our lab identified Snw1 as a regulator of 
BMP activity during vertebrate neural crest development (Wu et al., 2011). I could 
demonstrate that loss of Snw1 led to increased bmp2b transcript levels. This effect, 
however, is confined to the NPB although bmp2b transcripts are present in the 
entire NNE. Snw1 is expressed only dorsally, in the NP region, during 
somitogenesis, thus overlapping with bmp2b expression only where the horseshoe-
shaped domain of BMP activity is initially detected. This suggests a tissue specific 
requirement for the control of bmp2b transcription and thus BMP activity at the NPB.  
Interestingly, Snw1 is only essential for BMP activity after gastrulation. Partly, 
this could be due to maternally deposited Snw1. However, depletion of Snw1 using 
morpholinos in zebrafish indicated a loss of Snw1 protein during gastrulation 
without affecting BMP activity during gastrulation as measured by PSmad1/5 
western blotting (Wu et al., 2011). It is an intriguing possibility that Snw1 
contributes to the switch from a gradient of BMP activity to distinct domains at the 
neural plate border. Interestingly, BMP activity is initially restricted to the NPB after 
gastrulation although transcripts can be detected I the entire NNE. This could be 
due to the requirement for Cvl2 to focus BMP activity or a BMP repressor such as 
Bambi-b might inhibit BMP activity in the lateral and ventral ectoderm. There is also 
the possibility that Snw1 is required for proper bmp2b processing after gastrulation, 
which is why active Bmp2b proteins would only be synthesised at the NPB. This 
hypothesis will have to be tested in the future possibly by the use of photo-
cleavable morpholinos that give temporal control over gene expression.  
 
7.3 Implications for cancer  
Studying signalling during early development and organogenesis also has 
implications outside of understanding developmental processes. Many of the 
underlying signalling pathways are redeployed in diseases such as cancer. Thus 
identifying pathway regulators might provide novel therapeutic targets. An example 
for this is leflunomide, which was identified in a chemical screen for regulators of 
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NC development (White et al., 2011). Leflunomide not only inhibits NC cell fate, but 
also melanoma growth in tissue culture and a transgenic zebrafish melanoma 
model. I have demonstrated that leflunomide possibly acts by inhibiting BMP 
activity after gastrulation. It is not clear yet whether this is due to defects at the 
level of bmp2b regulation. Currently, leflunomide is being tested in a phase I clinical 
trial (Prof. Leonard Zon, personal communication).  
 Many of the components I have identified to be part of the BMP gene 
regulatory network have been implicated in disease. Mutations of DLX3 in humans 
result in defects in tooth development (Dong et al., 2005, Nieminen et al., 2011), 
which is likely to be a result of impaired NC development. In contrast, increased 
levels of Cvl2/BMPER have been reported in malignant tumours of several tissues 
(Heinke et al., 2012). Similarly, the BMP inhibitor BAMBI is linked to cancer 
development. BAMBI is present at high levels in ovarian cancer (Pils et al., 2010) 
and overexpression of BAMBI in colorectal cancer increases the metastatic 
potential (Fritzmann et al., 2009, Togo et al., 2008), whereas BAMBI expression is 
silenced in a subset of high-grade bladder cancer (Khin et al., 2009). This 
discrepancy might reflect the dual role, as a tumour promoting and inhibiting factor, 
of BMP/TGF-β signalling (Connolly et al., 2012, Thawani et al., 2010, Wakefield 
and Hill, 2013).  
Snw1 has not yet been directly implicated in tumourigenesis. However, 
there are indications that Snw1 might play a role in some cancers. The catalogue of 
somatic mutations (COSMIC) is a database that collects mutation data from 
primary literature (http://cancer.sanger.ac.uk/cosmic). According to the collected 
data 42 unique mutations have been identified for Snw1, 29 of which are missense 
and 7 are silent mutation and whereas 3 mutation lead to a frameshift. There are 
no obvious clusters and the mutations are distributed along the whole length of the 
transcript. Also it is not clear whether any of the mutations are driving mutations but 
several amino acids are mutated in different tissues. No mutation of the S224 
phosphorylation site has so far been identified. 
Snw1 is an essential survival factor and in my analysis, loss of Snw1 leads 
to cell cycle arrest in G2 (data not shown). However, during development, NC is 
most sensitive to Snw1 depletion, indicating a increased dependency on Snw1 
function compared to other tissues. Since melanocytes are a derivative of NC, I 
tested Snw1 expression in commonly used melanoma cell lines compared to 
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melanocytes. I identified several melanoma cells lines with dramatically increased 
Snw1 protein levels (data not shown). Interestingly, this correlated with activation of 
BMP signalling and growth rate. It will be exciting to further test a possible role of 
Snw1 by for example overexpression of Snw1 in melanocytes to induce 
tumourigenic properties. As genetic tools become more readily available it will be 
interesting to study some of the factors I identified in this study in zebrafish tumours 
models. For example, it would be exciting to test the function of Snw1 in skin 
cancer using an established zebrafish model for melanoma formation (White et al., 
2011). Using such disease models in combination with the Tg(BRE:mRFP) reporter 
will also give novel insight into the regulation of BMP activity at different stages of 
tumour progression and metastasis. 
 
Taken together, my research demonstrates the relevance of studying in vivo 
regulators of signalling pathways. I hope that my results will contribute not only to 
the understanding of the regulation and contribution of BMP signalling during 
ectodermal patterning, but will also help to decipher the processes underlying 
diseases. 
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Chapter 8. Appendix 
Appendix 1:  Selected list of spliceosome-associated proteins identified using 
mass spectrometry with Flag-SNW1 as a bait. 
 
Appendix 2:  Selected list of non-spliceosome associated proteins identified using 
mass spectrometry with Flag-SNW1 as a bait. 
 
Appendix 3: Heat map for following data set: (FDR) ≤	 0.05, fold change > 2 
between cont. MO and lower amount of snw1 MO, read count ≥ 200 
in one of the samples. 
 
On CD: 
 
Appendix 4: Original data file of a representative experiment (including 
benzonase step) containing proteins identified using mass 
spectrometry. To be opened using scaffold. 
 
Appendix 5:  iBAQ analysis of the above mentioned experiment. 
 
Appendix 6: complete list of Snw1 targets identified in the RNA sequencing with 
following cut off criteria: (FDR) ≤	 0.05, fold change > 2 between cont. 
MO and lower amount of snw1 MO, read count ≥ 200 in one of the 
samples. 
 
Appendix 7: complete list of Snw1 targets with following cut off criteria: (FDR) ≤	 
0.05, fold change > 2 between cont. MO and higher amount of snw1 
MO, read count ≥ 200 in one of the samples. 
 
Appendix 8: Intronic reads: (FDR) ≤	 0.05, fold change > 2 between cont. MO and 
higher amount of snw1 MO, read count ≥ 30 in one of the samples. 
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